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ABSTRACT
PLANT-DELIVERED CHOLERA TOXIN B SUBUNIT AS AN
IMMUNOMODULATORY MOLECULE
by Takeshi Arakawa

The B subunit of cholera toxin (CTB) functions as an effective mucosal carrier
molecule of chemically or genetically conjugated antigens. Orally delivered CTB or CTB
fusion protein binds to Givn-ganglioside receptor molecules located on cells in the gutassociated lymphoid tissues, the site of immunological induction. We have generated
transgenic plants synthesizing CTB conjugated with vaccine antigens for food plant-based
prevention of cholera and rotavirus toxin-induced diarrhea and for autoimmune diseases
such as insulin-dependent diabetes mellitus (IDDM).
Mice fed with transgenic potato tubers synthesizing 0.3% of CTB as total tuber
protein generated serum and mucosal antibodies with toxin neutralizing capability. The
immunized mice were partially protected from diarrhea induced by intraileal inoculation
of cholera holotoxin. A 22-amino acid rotavirus enterotoxin NSP4 epitope was fused at
the C-terminus of the CTB subunit. Transgenic potato tubers synthesized up to 0.1% of
total soluble protein as the pentameric CTB-NSP4 fusion peptide.
To prevent IDDM, we generated transgenic potato plants synthesizing the IDDM
autoantigens, insulin and glutamic acid decarboxylase and their conjugate proteins with
CTB. Transgenic potato plants synthesizing the fusion proteins significantly reduced
pancreatic inflammation (insulitis) and clinical diabetes when fed to nonobese diabetic
mice. Potato tissues producing comparable amounts of insulin or glutamic acid

decarboxylase alone conferred only low levels of protection against insulitis, suggesting
that conjugation with CTB markedly increases the tolerogenicity of autoantigens.
Since autoimmune diabetes is often linked to the consumption of bovine milk and
its products, we took a novel approach to prevention of DDDM in non-breast fed infants
and children by producing transgenic food plants synthesizing human milk proteins. We
have synthesized human p-casein and lactoferrin in food plants as these are prototypical
casein and whey proteins in human milk. In addition to nutritional enhancement,
lactoferrin may provide antimicrobial activity against a variety of enteropathogens
including rotavirus. Construction of food plants synthesizing vaccine antigens as well as
antimicrobial human milk proteins may be a safe, inexpensive, and convenient method
for the prevention of infectious and autoimmune diseases for people living in developing
countries.
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I. INTRODUCTION
A. General
Recent advances in genetic engineering technology of plants and animals for the
synthesis of recombinant proteins permits the exploitation of genetically modified higher
organisms for the production and delivery of multiple protein antigens with increased
industrial, pharmaceutical, and medical values. The scientific and practical significance
of transgenic research is based on understanding several advantages of higher transgenic
organism as an alternative production systems, and how transgenic organism-synthesized
products contribute to the human race. Our research goal is to combine state-of-the-art
technology of plant molecular biology and recent advances in preventive medicine to
develop a novel approach towards the prevention and cure of some life-threatening
infectious and autoimmune diseases. Here we will focus our attention on the
development of a novel food plant-based oral vaccination strategy against cholera and
rotavirus (prototypical adult and infant infectious diarrheal diseases), and insulindependent diabetes mellitus (a prototypical autoimmune disease in children). In our
vaccine approach against infectious and autoimmune diseases, the cholera toxin B subunit
(CTB) was used as an effective carrier molecule for targeting vaccine antigens produced
in plants to the mucosal immune system. We will also discuss a novel approach for
prevention of infant rotavirus infection and bovine-milk induced insulin-dependent
diabetes mellitus through the production of biologically active human milk proteins in
transgenic food plants. These innovative applications of food plants in the fields of
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medicine may in the near future provide a safe and cost-effective strategy for disease
prevention in man and animals both in industrialized and economically emerging nations.

B. Cholera toxin B Subunit (CTB) and Its Biological Effects
1.

CTB as a Carrier Molecule for Vaccine Antigens

Oral administration of Vibrio cholerae enterotoxin (CT) and its nontoxic B
subunit (CTB) induce a strong systemic and mucosal immunity (Fujita and Finkelstein,
1972; Fuhrman and Cebra, 1981; Lycke et ai, 1983; Elson and Balding, 1984; Lycke et
al., 1985). CT is an effective adjuvant for physically unlinked co-administered antigens
(Lycke and Holmgren, 1986; Jackson et al., 1993; Holmgren et al., 1993). The B subunit
of cholera toxin acts as a ligand for cellular surface receptors located on many vertebrate
cell types to translocate the A subunit of cholera toxin (CTA) across cell membranes
resulting in elevating of intracellular cAMP levels through activation of adenylate cyclase
(Gill and Meren, 1978).
CTB is a somewhat weaker adjuvant than CT for co-administered antigens.
However, it is an effective carrier molecule for induction of mucosal immunity to
polypeptides to which it is chemically or genetically conjugated (McKenzie and Halsey,
1984; Czerkinsky et al., 1989; Dertzbaugh and Elson, 1993a). Recently, CTB was found
to act as a carrier of conjugated peptides for induction of immunological tolerance (Sun et
al., 1994, 1996). When human gamma-globulin (HGG) was chemically conjugated with
CTB, a single oral administration of minute amounts (75 pg) of CTB-HGG molecule
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markedly suppressed the systemic immune response (delayed-type hypersensitivity) in
both naive and immune animals (Sun et al., 1994). Since free CTB has no effect on the
induction of the systemic tolerance for co-administered antigens, the physical linkage of
CTB to the antigen is essential for tolerance induction.
Presence of trace amount of CTA subunit completely abrogates the tolerogenic
effects of CTB (Sun et al., 1994). The molecular mechanisms of how the A subunit
abrogates tolerogenic effect of CTB have not yet been elucidated. It has been suggested
that the toxicity of the A subunit to mucosal epithelial cells may be responsible for
changing the regulatory environment in GALT resulting in the induction of an immune
response instead of tolerance. Producing recombinant CTB rather than purifying the CTB
subunits from V. cholerae or Escherichia coli, the possibility of contamination of CTB
with A subunits is eliminated.
Therefore, CTB functions as an immunological carrier for peptides for both
immunization and immunotolerization. This unique characteristic of an
immunomodulatory carrier molecule is primarily due to its strong affinity for natural
receptor GMi-ganglioside, on the surface of mammalian intestinal epithelial cells,
including M cells in the Peyer’s patches of the gut-associated lymphoid tissues (GALT)
(Svennerholm, 1976). Conjugation with CTB may greatly facilitate antigen delivery and
presentation to the GALT for increased uptake and immunological recognition
(Sun et al., 1994; Weiner, 1994).
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2.

Gut-Associated Lymphoid Tissue (GALT) as a Target Site of CTB

Gut-associated lymphoid tissue consists of Peyer’s patches (lymphoid nodules),
lamina propria, and epithelial cells containing villi (Weiner et al., 1994). The villi
contain epithelial cells termed enterocytes, intraepithelial lymphocytes, and goblet cells.
Peyer’s patches appear as a dome-shaped structure scattered within the villi. They are
highly organized lymphoid nodules containing T and B lymphocytes, macrophages,
dendritic cells, and germinal center containing B lymphocytes. Peyer’s patches are
covered with membranous specialized epithelial cells called M cells which are overlying
the subepithelial lymphoid follicles. The M cells take up and transfer macromolecules
and particulate antigens to underlying lymphocytes, macrophages and dendritic cells
(Wolf and Bye, 1984). Various antigens, including some viruses and bacteria, penetrate
the mucosal barrier via the M cell, which endocytoses and transports antigens and
microorganisms into the Peyer's patch. The cell membrane at the base of the M cell is
invaginated, which facilitates cellular contact with underlying lymphoid cells. Peyer’s
patches of GALT are primarily involved in generation of specific immune response
against ingested antigens. The Peyer’s patches are a major source of IgA-secreting
B lymphocytes and T lymphocytes which preferentially induce IgA-secreting B cells into
plasma cells. Th2 type of responses are primarily generated in Peyer’s patches as IL-4
secreting T cells are predominantly activated, in contrast to nonmucosal lymphoid organs
such as axillary and inguinal lymph nodes where EL-2 secretion is dominant. Peyer’s
patches preferentially mediate Th2-type immune responses which are important in
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generation of oral tolerance and prevention of microbial infections in which humoral
responses with secretory IgA production is a critical factor for disease prevention.
Therefore, oral administration of antigens can induce systemic hyporesponsiveness in the
presence of mucosal IgA responses.
The cholera toxin B subunits bind human intestinal epithelial cell lines such as
HT-29 and T84 by binding the apical receptor GMi-ganglioside (Apter et al., 1993).
Specific binding of CT to its natural receptor has been documented in vitro (Schon and
Freire, 1989; de Wolf et al., 1981a,b). Thus, immunogenic hybrid proteins between CTB
and an unrelated antigen peptide may specifically target mucosal lymphoid tissues to
markedly potentiate immune responses against the conjugated peptide.

C. Life-Threatening Infectious Diarrheal Diseases
1.

Cholera

Diarrheal disease is a major infectious disease in the world causing a high
morbidity and mortality rate especially in young children. The etiology of diarrheal
disease in both developed and developing countries includes rotavirus, Norwalk virus,
enterotoxigenic Escherichia coli (ETEC), Vibrio cholerae, Clostridium perfringens and
Campylobacter jejuni.
Cholera is a devastating infectious diarrheal disease which has caused recurrent
pandemics throughout the world since 1871. The total number of annual cholera cases
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and deaths around the globe probably exceeds 5 million and 200,000, respectively
(Holmgren and Svennerholm, 1996). More than 1 million cholera cases and
10,000 deaths were reported from Latin America alone in 1994 (Tauxe et al., 1995). The
etiologic agent responsible for the first six pandemics was the classical biotype of
Vibrio choleras serogroup 01. The seventh and the most recent pandemic was caused by
the V. choleras 01 El Tor biotype which emerged in Indonesia in 1961, and spread
throughout Asia and Africa, reaching Peru in 1991.
Emergence of a serotypically novel strain of V. cholerae non-Ol, designated as
0139 synonym Bengal in 1992, caused a major epidemic in Asian countries (Albert et al.,
1993; Shimada et al., 1993). Genetic studies indicated that the V. cholerae 0139
probably arose from the present pandemic strain V. cholerae 01 El Tor, by replacement
of a part of O antigen gene cluster of the recipient strain with otnAB DNA of a non-Ol
strain, which involved in capsule and O antigen synthesis (Berche et al., 1994; Bik et al..
1995). Environmental changes occurring in southern Bangladesh may be responsible for
emergence of the new V. cholerae strain (Siddique et al., 1994). Although V. cholerae
0139 is presently confined to Asian countries, there is an obvious risk that this highly
contagious strain will follow the track of its ancestral strain V. cholerae 01 El Tor,
threatening both African and Latin American countries, because the spread of cholera
infection can be rapid and unpredictable due to rapid transmission factors such as
international travel, shipping, and population emigration (Crowcroft, 1994).
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Although it has long been considered that humans are the only known long-term
host of V. cholerae, untreated human feces also results in long-term bacterial survival in
contaminated water supplies from which bacterial eradication is difficult. Pathogenic
V. cholerae was introduced from cholera endemic countries into the U.S. by cargo ships
which had taken on ballast water in those countries (McCarthy and Khambaty, 1994).
The most effective prevention of cholera dissemination is provision of safe water sources
and improved sanitation systems in cholera-endemic countries. However, poor economic
situations in countries where cholera is endemic makes the cost of building large-scale
water treatment and sanitation systems (more than S200 billion for all of Latin America)
prohibitive (Tauxe et al., 1995). The costs become astronomical if similar infrastructures
are proposed for cholera-endemic countries in Asia. Thus, the ultimate challenge for
cholera prevention lies in establishment of low-cost alternatives which include single
dose effective oral vaccines providing lasting protection against cholera, or convenient
and readily available oral vaccines which can be frequently administered to people living
in those areas of the world where cholera is endemic.
2.

Human Rotavirus-Induced Infant Diarrhea

Human rotavirus has a tremendous public health impact worldwide. Especially in
emerging nations, this non-enveloped virus possessing 11 segmented double-stranded
RNA is the most important etiological agent of infantile gastroenteritis. Nearly every
child in the first few years of life are infected with rotavirus (Kapikian et al., 1985).
Rotavirus infection is responsible for 18 million hospitalizations and approximately
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1 million deaths each year. Approximately 20 to 40% of the hospitalizations are for
childhood diarrhea which results in the most important cause of diarrheal mortality
among children (Glass et al., 1994). Public health impact of this virus as a cause of acute
infantile diarrhea in industrialized nations is not negligible either; acute gastroenteritis is
second only to acute respiratory disease in the United States, even though mortality rates
are relatively low (75 to 125 deaths each year) in comparison with mortality in
developing countries (Jawetz et al., 1989). Rotavirus also has a tremendous economic
impact in the US; direct medical expenses exceed $500 million and total costs exceed
$1 billion (Glass et al., 1994). Although medical treatment for rotavirus gastroenteritis is
routine in hospitals in the US, early epidemiological studies conducted in Finland
indicated that rotavirus might be best controlled through vaccination (Vesikari et al..
1986). Natural passive immunity seems to protect children under 2 years of age.
Reinfection with the same rotavirus occurs infrequently, and repeated illness tend to be
less severe or even asymptomatic. Thus, even if protective immunity against rotavirus is
not fully protective against reinfection, neonatal rotavirus infection confers protection
from the development of clinically severe disease later in life (Bishop et al., 1983).
Human rotavirus belongs to family Reoviridae, which includes six genera;
reovirus, rotavirus, and orbivirus as well as three additional genera which infect only
plants and insects (Jawetz et al., 1989). Human rotavirus belongs to the genus rotavirus
which contains 11 segments of double-stranded RNA, each encoding a viral protein. Two
important virus-neutralizing glycoproteins are the outer capsid protein VP7 and VP4
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(hemagglutinin). Four serologically common types of VP7 glycoprotein (G1 through G4)
as well as two common VP4 serotypes (P4 and P8) are all found in children with diarrhea
(Glass et al., 1994). Protection against rotavirus gastroenteritis is generally serotype
specific and seems to be related to levels of antibodies against homotypic virus (Chiba et
al., 1993). Thus, an effective rotavirus vaccine should protect against all of these
common viral serotypes. However, a live bovine strain of rotavirus vaccine (RIT) with
serologically distinctive VP7 and VP4 has been found to be protective both in adults and
in children, significantly reducing the incidence of gastroenteritis (Vesikari et al., 1986).
Therefore, a vaccine strain marginally immunogenic in humans might prevent the disease
process through heterotypic protection.
Recent discovery of a rotavirus non-structural protein, NSP4 and its 22-amino
acid peptide which functions as a viral enterotoxin may provide new insights into the
development of effective rotavirus vaccines. Induction of antibody against NSP4 alone
may confer cross protection from clinical disease without the need for induction of
antibodies against viral structural proteins (Ball et al., 1996; Conner et al., 1996).
Induction of immune response against NSP4 or its 22-amino acid peptide conferred
protection in pups bom to immunized dams, and decreased incidence and severity of
diarrhea (Ball et al., 1996).
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D. Autoimmune Diseases: Insulin-dependent Diabetes Mellitus (IDDM)
The autoimmune process that results in insulin-dependent diabetes mellitus
(IDDM) may be viewed as a failure to develop or maintain tolerance to self-antigens
expressed in p cells in the pancreatic islets of Langerhans, which ultimately leads to the
destruction of the pancreatic p cells (Eisenbarth, 1986; Tisch and McDevitt, 1996).
During T-cell development in the thymus, cells that are reactive with self antigens
encountered there may undergo clonal deletion or clonal anergy which effectively
removes these autoreactive cells from the pool of mature antigen reactive T cells.
Dendritic cells that surround the islets of Langerhans have been shown to be responsible
for presentation of islet antigens to the immune system. B-cell tolerance can also involve
mechanisms of clonal deletion or clonal anergy similar to that occurring with T cells.
Thus, both humoral and cellular types of immunity are involved in the pathogenesis of the
disease, although destruction of pancreatic p cells appears to be mediated predominantly
by the activity of CD4+ and CD8+ T-cells. There are several autoantigens recognized by
the T-cell repertoire. Insulin appears to have a critical role in the diabetogenic response
and it has been shown that a major subset of T-cells infiltrating the islet respond to
insulin in the nonobese diabetic (NOD) mouse.
Another major autoantigen, glutamic acid decarboxylase (GAD), has been
identified by Baekkeskov et al. (Baekkeskov et al., 1990). This 64-kDa enzyme is
responsible for conversion of glutamic acid to y-aminobutyric acid (GABA) which is
produced not only by P cells but is also some in other organs such as brain, kidney,
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thyroid, adrenal, pituitary, testes, ovary, and liver. Autoantibodies against GAD were
first detected in a human subject with “Stiff-man” syndrome (SMS), a rare neurological
disorder caused by a impairment of GABA-associated pathways (Solimena et al., 1991).
SMS is associated with polyendocrine autoimmunity, including IDDM (Solimena et al..
1990). GAD65, an isoform of GAD in IDDM, is predominantly immunogenic in view of
the fact that in human pancreatic islets only the GAD65 isoform is expressed. The
GAD65 protein is synthesized as a hydrophilic molecule, which is palmitoylated and
becomes anchored to the membrane of small vesicles identical in size to the small
synaptic-like microvesicles of the neuron (Reetz et al., 1991). Splenic T-cells from NOD
mice were found to proliferate when incubated with human GAD65, but only marginally
after incubation with another isoform of GAD, GAD67, indicating the importance of
GAD65 isotype in diabetogenesis in NOD mice (Bieg et al., 1994). The temporal
sequence of T-cell and antibody responses in NOD mice indicated that antibody and
T-cell responses specific for the two isoforms of GAD (GAD65 and GAD67) are first
detected in 4-week-old NOD mice (Tisch et al., 1993). This GAD-specific reactivity
coincides with the earliest detectable response to an islet extract, and with the onset of
insulitis, indicating that the spontaneous response to p-cell antigens arises very early in
life and that the anti-GAD immune response may have a critical role in the disease
process.
The NOD mouse, established as an inbred strain, is an excellent animal model for
complex polygenic disease, human Type 1 (insulin-dependent) diabetes mellitus in many
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aspects, including genetics, immunology, virology, and prevention and therapy (Hanafusa
et al., 1994). Mice spontaneously develop insulitis (lymphocyte infiltration to the
pancreatic islet) and hyperglycemia. Insulitis is detectable as early as 2 weeks of age, and
as the insulitis progresses p cell mass decreases and hyperglycemia starts to develop
around 14 weeks of age. Hyperglycemia starts when the insulin level drops below 10%
of the normal level (Hanafusa et ai, 1994). By 30 weeks of age, the incidence of diabetes
in NOD mice reaches 80% in female and 20% in male. Microsatellite genetic markers
detected by PCR have been utilized for genetic analysis of NOD mice (Miyazaki et ai.
1994). Development of insulitis and diabetes in NOD mice is controlled by at least 14
distinct loci. One of these loci, designated Idd-1, has been linked to the MHC on
chromosome 17 (Wicker et al., 1995). Transgenic mouse experiments indicated that Idd1 is composed of MHC class II genes I-A beta and I-E alpha (Miyazaki et al., 1994). The
MHC congenic strains of mice have shown that the NOD MHC is essential but, by itself,
insufficient for diabetes development (Wicker et al., 1995). The contributions of
non-MHC Idd loci have also been assessed. Identifying Idd genes and defining their
biological functions should further our understanding of autoimmune disease
pathogenesis and facilitate development of new treatments for diabetes. Viral infection
(retrovirus and coxsackievirus) may also play a role in the pathogenesis. Diabetes
develops only when many diabetogenic factors assemble.
Infiltrating lymphocytes in the pancreas are mainly CD4+ T cells: CD8+ T cells.
B cells, and NK cells are in less abundance (Miyazaki et al., 1985). The B lymphocytes
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tend to increase in number with insulitis progression. The T lymphocytes are localized
close to islet cells, while B cells are located adjacent to blood vessels and surrounding
T cell clusters. The percentage of splenic T lymphocytes is markedly increased in the
initial stage of insulitis as compared with control mice. As for splenic T cell subsets,
cytotoxic suppressor T cells are increased in NOD mice.
Although, the role of class II-restricted CD4+ T lymphocytes in the development
of diabetes in the NOD mouse is well documented, involvement of CD8+ T cells remain
unclear. However, a class of NOD mouse that lacks expression of p2-microglobulin,
which lacks both class I expression and CD8+ T cells in the periphery, not only failed to
develop diabetes but were completely free of insulitis, suggesting an essential role for
class I-restricted CD8+ T lymphocytes in the initiation of the autoimmune response to
p cells in the NOD mouse (Wicker et al., 1994). The induction of insulitis and diabetes
in NOD athymic nude mice by means of T cell transfer was evaluated (Matsumoto et al..
1993). Transfer of either CD4+ cell-depleted or CD8+ cell-depleted splenic lymphocytes
of diabetic mice did not cause diabetes for at least 60 days after lymphocyte transfer.
Also, transfer of only the CD4+ T cell-depleted fraction did not cause insulitis. In
contrast, transfer of only the CD8+ T cell-depleted fraction induced less potent insulitis in
all the recipients with a low insulitis score, indicating that CD4+ T cells are primarily
responsible for insulitis. The CD8+ T cells migrate into islets and are differentiated into
mature killer cells against p cells with the aid of CD4+ T cells.
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The role of the humoral response in diabetogenesis is not well understood.
However, early studies indicated that autoantibodies may bind to NOD pancreatic p cells,
indicating the possible importance of an early humoral response to the initiation of
insulitis and subsequent disease (Shieh et al., 1993). A small percentage of the p cells of
NOD mice have autoantibodies bound to their surface prior to insulitis (Shieh et al..
1993). The autoantibodies which bind pancreatic p cells are predominantly IgM and to a
lesser extent IgG and IgA. These findings suggest that insulitis may develop in response
to initial autoantibody-mediated p cell injury. Although T cell involvement in insulitis
development and diabetes in NOD mice is well documented, the role of B cells remains
unclear. In B cell-deficient NOD mice, the extent of insulitis was significantly reduced,
and the incidence of diabetes was suppressed by 40 weeks of age, while control
littermates suffered from a high proportion of diabetes (Akashi et al., 1997). The insulin
reactivity of control NOD mice was significantly impaired, while the B cell-deficient
NOD mice showed a good insulin response. This result suggests that p cell function is
preserved in B cell-deficient NOD mice. These results provide direct evidence that
B cells are essential for the progression of insulitis and the development of diabetes in
NOD mice.
The role of macrophages in the development of insulitis in NOD mice has been
implicated (Lee et al., 1988). Administration of cyclophosphamide to NOD mice resulted
in a significant increase in severity of insulitis and the incidence of diabetes compared
with untreated NOD mice. Intraperitoneal injections of silica completely prevented the
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development of insulitis and diabetes in both cyclophosphamide-treated and untreated
animals, suggesting that macrophages play an important role in the initiation of insulitis
in NOD mice, because silica is known to be selectively toxic to macrophages (Lee et al..
1988).

E. Oral Vaccination against Infectious and Autoimmune Diseases
1.

Oral Vaccine against Infectious Diseases

It is widely recognized that oral vaccination is more effective than parenteral
vaccination against pathogens which invade through mucosal surfaces. Furthermore, oral
vaccines are easier and safer to administer. Antibacterial as well as antitoxin mucosal
secretory antibodies are important factors for protection against V. cholerae infection and
its pathological effects in the intestine (Fujita and Finkelstein, 1972; Lange and
Holmgren, 1978). For protection against enteric pathogens like V. cholerae, parenteral
administration of bacterial antigens confer a weak or short-term immunity (Levine et al..
1983). This is due mainly to failure in the induction of mucosal immunity which is an
essential feature for prevention and convalescence from cholera. Based on the fact that
enteropathogens are controlled better by mucosal rather than parenteral immunizations,
both killed whole-cell and recombinant live-attenuated oral cholera vaccine candidates
have been extensively tested in field trials (Levine, 1990; Simanjuntak et al., 1993;
Mekalanos and Sadoff, 1994; Finkelstein, 1995; Waldor and Mekalanos, 1996; Holmgren
and Svennerholm, 1996).
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Killed whole-cell (WC) oral cholera vaccines consist of inactivated V cholerae 01
bacteria alone, or in combination with the B subunit of cholera toxin (BS-WC). Efficacy
of both WC and BS-WC vaccines was evaluated in U.S. healthy adult volunteers 18 to 35
years old. The WC and the BS-WC vaccines provided 56% and 64% protection against
cholera infection, respectively (Black et al., 1987). The efficacy and safety of killed oral
cholera vaccines was also established in a large-scale, placebo-controlled field trial in
rural Bangladesh (Clemens et al., 1991; Clemens et al., 1992). The BS-WC vaccine
provided 85% protection in all age groups for the first six months, and decreased to 51%
protection after 36 months (Clemens et al., 1990). This vaccine also demonstrated
protection against enterotoxigenic Escherichia coli (ETEC) for the first 3 months of the
trial, indicating immunological cross-protection between V. cholerae and ETEC. Thus,
killed oral cholera vaccines effectively protect against intestinal colonization and
infection by V. cholerae Ol (Clemens et al., 1992).
Several recombinant live-attenuated oral cholera vaccines have been in clinical
trials (Waldor and Mekalanos, 1996). Genetically engineered strains CVD 103
(ctxA IctxE^) and CVD 103-HgR {ctxA IctxB^) (derivatives of the classical Inaba
V. cholerae Ol strain 569B) were well tolerated by children and adults in the US and
Indonesia, and was highly immunogenic following administration of a single oral dose,
which provided substantial protection against classical biotype (both Inaba and Ogawa
serotype) and El Tor biotype (Inaba serotype) of pathogenic V. cholerae Ol (Levine et al..
1988a,b; Simanjuntak et al., 1993). Since live attenuated vaccines mimic V. cholerae
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natural infection, they confer significant protection against diarrheal disease. Safety is a
major concern when using recombinant attenuated live vaccines due to the possibility of
reactogenicity in vaccinees and reversion of recombinant strains to the virulent wild-type
(Pearson et al., 1993). However, reacquisition of the ctxA gene by V. cholerae Ol CVD
103-HgR in vivo and in vitro was found to be unlikely, making this vaccine strain
potentially safe and effective against V. cholerae 01 (Kaper et al., 1994).
2.

Oral Tolerization Vaccine against Autoimmune Diseases and

Mechanism of Oral Tolerance
Although oral tolerance has been known for many years, its mechanism has not
been fully elucidated. The primary mechanisms by which orally administered antigen
induces tolerance are (1) the generation of active suppression, (2) clonal anergy, or (3)
clonal deletion in the GALT. Oral tolerance to ingested antigens is beneficial, or even
essential for animal survival, because the immune system is developed in such a way that
food materials which reach the GALT tend to induce antigen specific tolerance rather
than immunity, thus preventing immune reactions against essential nutrients. Low doses
of orally administered antigen favor active suppression whereas higher doses favor clonal
anergy and clonal deletion (Weiner et al., 1994; Chen et al., 1995; Bergerot et al., 1996).
Particulate antigens are nonspecifically absorbed by a population of gut epithelial
cells called M cells which overlay the surface of the Peyer's patches. Underlying the
M cells are lymphoid tissues in which suppressor T-cells and IgA-producing B-cells are
predominantly localized. Thus, antigens stimulating the GALT preferentially generate a
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Th2 type response. Undigested or partially digested antigens which pass through the
M cells are presented to the underlying lymphocytes. Once activated, these suppressor
T-cells migrate from the GALT to the systemic circulation and upon encountering the
same antigen elsewhere in the body, the T cells secrete suppressor lymphokines such as
interleukin-4 (IL-4), IL-10, and transforming growth factor (TGF)-P, which are known to
suppress autoreactive T-cells. These suppressor T-cells are believed to belong to the
T-helper subpopulation of CD4+ T lymphocytes. Because the regulatory cells generated
following oral tolerization are triggered in an antigen-specific fashion but suppress in an
antigen nonspecific fashion, they mediate immunological suppression known as
"bystander suppression" when they encounter the autoantigen at the target organ (Weiner
et al., 1994).
T lymphocytes respond to foreign antigens by lymphokine production and by
proliferation. Activation of T lymphocytes requires two signals, one through the antigenspecific T-cell receptor (TCR) and one through the receptor for a costimulatory molecule.
In the absence of second signal, T cells enter clonal anergy, an unresponsive state in
which the T cell is incapable of producing LL-2, diminished expression of IL-2 receptor,
and proliferation on restimulation. High doses of orally administered antigen induce
unresponsiveness of Thl cell function, primarily via the mechanism of clonal anergy
(Schwartz, 1990). In addition, extrathymic deletion of antigen-reactive Thl and Th2 cells
by apoptosis in Peyer's patches has been reported (clonal deletion) when high dose of
antigen was orally administered (Chen et ai, 1995). The deletion was dependent on
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dosage and frequency of feeding; at lower doses deletion was not observed: instead, there
was induction of antigen-specific cells that produced TGF-P and IL-4 and IL-10
cytokines; at higher doses, both Thl and Th2 cells were deleted following their initial
activation, whereas cells which secrete TGF-p were resistant to deletion (Chen et al.,
1995).
Since induction of oral tolerance is dependent upon several parameters such as the
antigens used, antigen dosage, and mechanisms by which antigens are presented to the
GALT system, and the method of carrier-antigen conjugation, fine tuning of these
parameters are required to achieve maximum induction of immunological tolerance.
Orally administered autoantigens suppress several experimental autoimmune models in a
disease- and antigen-specific fashion with no apparent toxicity. Thus, oral administration
of pancreatic tissue-specific autoantigens may provide a convenient and safe clinical
approach for the prevention of spontaneous autoimmune diabetes (Zhang et al., 1991;
Weiner et al., 1994; Hancock et al., 1995). It has been shown that oral feeding of porcine
or human insulin prevents clinical onset of diabetes in the NOD mouse (Zhang et al..
1991; Bergerot et al., 1994). Oral tolerization has also demonstrated its efficacy in the
prevention of autoimmune diseases such as autoimmune encephalomyelitis (EAE),
multiple sclerosis, uveitis, and collagen-induced arthritis. However, the therapeutic
potential of this approach is limited by the requirement for repeated administration of
large amounts of tolerogens, and it is usually less efficient in already sensitized hosts.
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F. Human Milk Proteins for prevention of Bovine Milk-Induced IDDM and
Rotavirus-Induced Diarrhea
1.

IDDM and Bovine Milk

It is generally accepted that human milk is superior to all other milk substitutes for
the growing infant. However, there remains a large market for milk substitutes since not
all mothers are able to nurture their infants by the breast milk due to adverse physical,
psychological or socioeconomic conditions. Baby formulas based on bovine milk or
soybean proteins have been, until recently, the traditional substitutes for mother’s milk.
However, bovine milk has been designed by nature to promote the rapid growth of a
100 lb ungulate. Bovine milk is substantially different from human milk in both protein
content and composition. Although, cow’s milk has been recognized as an excellent
source of proteins, vitamins and minerals, its consumption is often related to excessive
weight gain and cow’s milk protein allergy and intolerance (CMPA/CMPI) which may
effect the gastrointestinal tract, respiratory tract, skin and blood (Johansson et al., 1994;
Wilson and Hamburger, 1988). CMPA is a disease of infancy and usually appears in the
first few months of life. Prenatal or early neonatal exposure to cow's milk protein
increases the risk, not only of adverse reactions to this milk but also for development of
allergies to other foods, especially soy and egg (Host, 1991; Host et al, 1995). Over 25
protein fractions in bovine milk have been demonstrated to induce allergic responses in
humans, and many are capable of inducing IgE-mediated (type I) reactions. Most clinical
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cases of infant food allergy induced by consumption of cow’s milk or its products are
believed to be related to bovine casein (Perkin, 1990; Karjalainen et al., 1992).
Soy-based infant formulas have been recommended as hypoallergic alternatives for
nonbreast-fed infants. However, many infants with food allergy to bovine milk are also
allergic to soy proteins. Therefore, soy formulas are no longer considered to be suitable
substitutes for cow’s milk formulas under such conditions. Although soybean allergenic
proteins have not been fully identified, the globulin components (2S, 7S and 1 IS) and
hemagglutinin (soybean trypsin inhibitor) have been implicated as allergens (Perkin,
1990).
There are a number of reports indicating a possible link between consumption of
cow’s milk and development of insulin-dependent diabetes mellitus (IDDM) (Daneman,
et al., 1987; Savilahti, et al., 1988; Karjalainen et al., 1992). Animal experiments
indicated that development of diabetes can be prevented in diabetes-prone rodents if
animals are given bovine milk-free diet in their early life (Daneman et al., 1987). Shorter
duration of breast-feeding and early introduction of dairy products was associated with an
increased risk of IDDM in Finnish and Brazilian children (Virtanen et al., 1991, 1994;
Gimeno and de Souza, 1997). It has also been reported that patients with insulindependent diabetes mellitus (IDDM) have elevated levels of serum IgG and IgA anti-BSA
antibodies which cross react with p69, one of the target P-cell antigens in IDDM patients
(Karjalainen et al., 1992).
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Infant formulas, which contain essential protein components of human milk
obtained from food plants, could provide alternative nutrition for nonbreast-fed infants as
well as prevention of immunological problems associated with the consumption of bovine
milk or soy-based synthetic infant formulas. Moreover, food plants are not only a
feasible production system for multiple protein components of human milk but can also
be considered as an oral delivery system for people in all age groups. Cultivation and
harvest of transformed plants producing human milk proteins require only conventional
available agricultural technologies, after which the plant materials can be extracted for
formula constituents or simply delivered by the plant directly in the diet. Further,
production of several human milk proteins in vegetables and fruits could provide a novel
source of improved nutrition for children and malnourished human populations in
economically emerging countries. The generation of individual transgenic food plants
producing several milk proteins in addition to vaccine protein antigens can contribute to a
cost-effective and nutritionally superior vegetable-based diet for people in need of more
complete nutrition and protection against infectious and autoimmune diseases.
2.

Rotavirus Infection and Human Milk Protein Lactoferrin

Some proteins in human milk and other mammals such as lactoferrin, lysozyme,
and mucin have been reported to have antimicrobial activities (Otnaess and Orstavik,
1980; el Agamy et al., 1992; Superti et al, 1997; Grover et al., 1997). Lactoferrin may
have antiviral properties in human milk in addition to antibacterial functions. Superti et
al. reported that lactoferrin and (3-lactoglobulin were able to inhibit the replication of
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rotavirus in the human cell line HT-29 in a dose-dependent manner (Superti et ai, 1997).
Lactoferrin was shown to hinder virus attachment to cell receptors by binding to the viral
particles and to prevent viral binding to susceptible cells. In addition, lactoferrin may
interfere with early phases of rotavirus infection, as rotavirus protein synthesis and yield
in HT-29 cells was significantly reduced when added during the early phase of viral
infection (Superti et al., 1997). Moreover, lactoferrin was also shown to inhibit the
growth of respiratory syncytial virus at a concentration tenfold lower than that normally
present in human milk (Grover et ai, 1997).

G. Transgenic Biotechnology for Production of Recombinant Proteins in Higher
Organisms
1.

Genetic Engineering of Crop Plants

The practice of agriculture is a unique human activity which began in antiquity
and has gradually enabled man to improve the nutritional value of edible plants,
permitting him to escape his nomadic existence for the development of civilization. Until
recently, the methods of crossing and inbreeding of plant species has been the only tool
for improvement in the nutritional quality of plant products. However, during the past
two decades the advent of modem recombinant DNA techniques has enabled us to clone
a large number of plant genes, to identify their genetic regulatory signals, and to improve
and confer valuable traits on plant species. Examples include the introduction of: a yeast
halotolerance gene for increased resistance of melons to salinity (Bordas et ai, 1997); a
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gene encoding flounder antifreeze protein into tobacco for improved frost resistance
(Kenward et al., 1993); genes from the resurrection plant Craterostigma into tobacco for
improved drought resistance (Iturriaga et al., 1996); plant genes of the phenylpropanoid
pathway for increased resistance to plant pathogens (Logemann et al., 1995); the Bacillus
thuringiensis delta endotoxin gene into cotton for greater resistance to insect pests
(Sutton et al., 1992); the 5-enolpyruvylshikimate-3-phosphate synthase gene and mutant
photosystem B genes for improved resistance of crop plants to the herbicides glyphosate
and atrazine (Suh et al., 1993; Smeda et al., 1993).
2.

Transgenic Animals as Bioreactors for the Production of Foreign

Proteins
More than a decade has passed since transgenic farm animals were first
considered as factories for production of high value proteins in their blood or milk, and
“molecular farming” is rapidly becoming one of the most promising fields of
contemporary biotechnology. Blood, a byproduct of animal slaughter, is readily available
in large quantities. Because of its complex chemical nature, however, it may be difficult
to separate the recombinant proteins from endogenous proteins. Furthermore,
recombinant foreign proteins circulating in the blood may damage the health of the
animal. In contrast, the milk of large farm animals (such as cattle and goats) are
particularly useful sources of recombinant proteins. They can be synthesized at high
levels and may often be readily extracted or, perhaps, directly consumed. With the aid of
recombinant DNA technology and the development of embryo manipulation techniques,
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increasing numbers of foreign genes have been introduced and expressed in the milk of
transgenic livestock. Examples include human protein C in pigs (van Cott et al., 1997),
human tissue-type plasminogen activator in goats (Ebert et al., 1991), bovine (3-casein in
mice (Hitchin et al., 1996), and human insulin-like growth factor I (IGF-I) in rabbits
(Walf£tftf/., 1997).
The use of mammary glands as bioreactors for the production of biologicallyactive proteins with pharmaceutical and therapeutic value has several advantages over
conventional bacterial production systems. The production of antimicrobial peptides in
bacterial systems can result in self-toxicity, transgene protein insolubility, and the lack of
post-translational modifications (e.g. glycosylation and phosphorylation). Because of
their eukaryotic origin, animal cell culture production systems often modify and fold
proteins appropriately. However, the requirement for a rich culture medium frequently
makes animal cell systems economically prohibitive for large-scale production purposes.
In contrast, mammary gland-specific expression of foreign genes and secretion of their
products in high amounts in the milk of large animals (e.g. cow, goat, pig, and sheep) can
be reliably achieved using mammary gland-specific promoters and regulatory elements.
However, this procedure has practical limitations in that the complete native protein is
sometimes not secreted into the milk and occasionally the protein is transferred from the
mammary gland into the blood, causing allergic reactions. Economic drawbacks of using
large animals such as cows are their long time to reach sexual maturity, gestation period,
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and time to reach lactation, making it at least a 3 year period before the beginning of
product availability.
3.

Transgenic Plants as Bioreactors for the Production of Foreign

Proteins
Plant-based molecular farming has attracted the attention of the pharmaceutical
industry for several reasons: (1) the potential economic advantage of plant-based versus
animal-based production systems, (2) the lack of contamination with animal microbial
pathogens and other infectious agents like prions, and (3) the reduction in ethical issues in
comparison with the creation of transgenic animals. Plant cells are inexpensive to culture
in comparison with animal cells. Due to their photoautotrophic nature; they require only
water, CO2, soil minerals, nitrogen, and sunlight for growth. Of greatest importance,
plant cells, like animal cells, are able to carry out post-translational modifications
essential for the biological activity of some proteins of animal origin (Lomonossoff and
Johnson, 1995; Mushegian and Shepherd, 1995). Pharmaceutically valuable proteins like
a-trichosanthin, an anti-HIV polypeptide, have been produced in a tobacco mosaic virus
(TMV)-based production system at the level of at least 2% of total tobacco leaf proteins
(Kumagai et al., 1993). Plant virus expression systems for protein production have at
present a distinct advantage over animal cell-based systems since high-biomass plants,
like tobacco, can be cultivated relatively easily. Virtually the whole plant can be
converted into a bioreactor and harvested, through a single inoculation of virus, resulting
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in the availability of the recombinant protein within 3-4 weeks following virus
inoculation (Kumagai et al., 1993; Turpen et al., 1995).
Plant virus-based production systems have a broad range of practical value. For
example, various pathogenic microbial and viral antigens have been produced and
purified from plants such as tobacco and black-eyed bean for the production of vaccines
(Mason et al., 1992, 1996; Thanavala et al., 1995; Turpen et al., 1995; Dalsgaard et al..
1997). Other examples include antioxidants, melanin, defensins, and cosmetic colorants
(Biosource Technologies, Inc.). A second plant-based production system involves the
stable integration of foreign genes into the plant chromosome, eliminating the process of
repeated virus inoculation for each time of plant harvest (Arakawa and Langridge, 1998).
Simple clonal expansion of the transgenic plant e.g., potato, can pass on the integrated
foreign genes from generation to generation in a Mendelian fashion and if desired,
homozygotes with increased levels of foreign gene expression can be selected. Despite
the presently lower production levels achieved through stable transformation of food
plants, ranging from 0.01% to 0.4% of total plant protein, this system, in comparison with
viral production methods which require the extraction of recombinant protein products or
modified viral particles, may present a distinct advantage especially in situations where
extraction processes are impractical due to economic or technological limitations.
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H. Production of Recombinant Protein in Food Plants for Prevention of Human
Diseases
1.

Production of Vaccine Antigen Proteins in Transgenic Food Plants

Within the last several years, the goals of plant genetic engineering have
broadened to include the addition of medicinal functions, such as genes encoding
immunoglobulins (Hiatt et al., 1989; de Neve et al., 1993; Ma et al., 1995, 1998;
Arakawa and Langridge, 1998), and vaccine antigens for protection against bacterial
enterotoxins (Haq et al., 1995; Arakawa et al., 1997; Arakawa et al., 1998; Tacket et al.,
1998; Arakawa and Langridge, 1998) and viral infections (Mason et al., 1992, 1996;
Thanavala et al., 1995).
Ma et al. reported that successive sexual crosses between four different transgenic
Nicotiana tabacum plants expressing four individual component of secretory
immunoglobulin (a light chain, a heavy chain, a joining chain, and a secretory
component) resulted in a plant that expressed all four chains simultaneously, which
assembled into a functional, high molecular weight secretory IgA molecule that
specifically recognized the native streptococcal antigen I/D cell surface adhesion
molecule (Ma et al., 1995, 1998). This result indicates that transgenic plants may be
suitable for large-scale production of recombinant secretory immunoglobulin A for
passive mucosal immunotherapy.
Experimental report by Haq et al. indicated the potential usefulness of food plants
for expression of bacterial enterotoxins. They reported that the B subunit of
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Escherichia coli heat-labile enterotoxin (LT-B) was produced in transgenic tobacco and
potato plants, which when orally administered to mice, induced serum and gut mucosal
anti-LT-B antibody response (Haq et al, 1995). Moreover, antibody was found to
neutralize the enterotoxin in cell protection assays.
Plant-based oral vaccines against hepatitis B virus was previously demonstrated
(Mason et al, 1992; Thanavala et al, 1995). Tobacco plants were genetically
transformed with the gene encoding hepatitis B surface antigen (HBsAg), and found to
produce HBsAg gene product (Mason et al, 1992). Microscopic examination of tobacco
leaf tissue homogenate revealed spherical particles with an average diameter of 22 nm,
which has similar physical and antigenic properties with human serum-derived and
recombinant yeast-derived HBsAg. They also found that plant-derived HBsAg is
immunologically similar to commercial vaccine derived from recombinant yeast
(Thanavala et al., 1995). Both B and T-cell epitopes of HBsAg were preserved when the
antigen was expressed in a transgenic plant.
Plants were found to be feasible production system of another viral neutralizing
proteins from Norwalk virus, a calicivirus that causes epidemic acute gastroenteritis in
humans (Mason et al., 1996). Transgenic tobacco and potato plants were generated that
express Norwalk virus capsid protein (rNVCP). Norwalk virus-like particles (VLPs) with
a diameter of 38-nm was extracted from tobacco leaves. The rNVCP produced in tobacco
leaves and potato tubers showed similar physical and antigenic properties with insect cell-
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derived rNVCP. The plant-expressed rNVCP was found to be orally immunogenic in
CD-I mice, developing both serum IgG and secretory IgA specific for rNVCP.
Expression of animal virus epitopes on the surface of a plant virus capsid protein
has been found to be successful (Dalsgaard et al., 1997). Recombinant cowpea mosaic
virus carrying short oligopeptide from the VP2 capsid protein of mink enteritis virus
(MEV) was generated when propagated in the black-eyed bean. One subcutaneous
infection of 1 mg of the recombinant cowpea mosaic virus in mink conferred protection
against clinical disease and abolished virus shedding after challenge with virulent MEV
(Dalsgaard et al., 1997).
Therefore, plant cells possess the requisite mechanisms for assembly and
expression of complex recombinant protein molecules. These results, taken together,
clearly indicate the potential usefulness of plants for large-scale production and delivery
of edible vaccines, which would be an appropriate technology for economically emerging
countries where vaccines are urgently needed.
2.

Production of Milk Proteins in Transgenic Food Plants

Recently, improvements have been made in the protein quality of food plants for
human nutrition e.g., the introduction of lysine and methionine biosynthesis genes from
bacteria into grain proteins to improve wheat protein quality for bread-making (Keeler et
al., 1997). The introduction of cDNAs encoding galacturonase and the DNA sequence
for antisense RNA to down-regulate the ethylene biosynthetic pathway have delayed
tomato fruit ripening for the improvement of tomato and melon storage and flavor quality
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(Flavr Savr) (Meyer, 1995). The thaumatin sweet protein genes (Zemanek and
Wasserman, 1995) have been considered for introduction into vegetable plants to increase
food palatability. Genes encoding omega-3 fatty acids have been introduced into plants
for prevention of cancer and arterial plaque formation to prevent atherosclerosis and
stroke (Arondel et al., 1992). Recently, the gene encoding the human milk protein
p-casein has been introduced into potato and tomato to supplement a mother’s milk
protein for improved nutritional quality of infant formula and baby foods (Chong et al..
1997). The human milk protein lactoferrin with antimicrobial activity (Superti et al.,
1997; Grover et al., 1997) has been produced in tobacco callus (Mitra and Zhang, 1994)
and in potato and tomato plants (Chong et al., unpublished results). The production of
additional milk proteins such as cc-lactalbumin and p-lactoglobulin in food plants may
increase nutrition quality as well as prevent enteric infectious diseases. Moreover, partial
or possibly complete substitution of major bovine milk proteins with plant-synthesized
human milk proteins in baby formulas may contribute to the prevention of cow’s milk
protein allergy and intolerance (Host et al., 1995), and autoimmune diabetes (Virtanen et
al., 1991, 1994) for non-breast fed infants, without total sacrifice of nutritionally
important milk proteins. In addition, human milk protein lactoferrin has antibacterial as
well as antiviral activities against rotavirus and respiratory syncytial virus at a
concentration lower than that normally present in human milk (Otnaess and Orstavik,
1980; el Agamy et al., 1992; Superti et al., 1997; Grover et al., 1997).
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The focus of our research is to discover a novel plant technology that will make
plant vaccines and food plant-derived antimicrobial peptides more readily available to
developing countries. Our strategy has been to genetically engineer plants for expression
of candidate vaccine antigens and human milk proteins with the goal of using the edible
plant organs for economical delivery systems. Alternatives to cell culture systems for
production of recombinant proteins could make very safe medically valuable edible plants
at a lower cost.

H. MATERIALS AND METHODS
A. Reagents
All solutions were made from commercially available chemicals and ultra-pure
water (Nanopure II system, Bamstead/Thermolyne Corp., Dubuque, Iowa). If necessary
solutions were autoclaved.

B. Bacterial strains and growth media
Escherichia coli strains HB101 and DH5a were grown at 37 °C in liquid LuriaBertani (LB) medium (10 g/1 Tryptone, 5 g/1 Bacto yeast extract, 10 g/1 NaCl, pH 7.3)
with vigorous shaking (approximately 250 to 300 rpm) or on solid media (liquid LB
medium plus 15g Bacto Agar). For transformed E. coli containing a plant expression
vector, ampicillin (100 |ig/ml) was added for selection. Agrobacterium tumefaciens
strain GV3101 pMP90RK was grown at 29 °C in YEB medium (beef extract 5.0 g/1,
Bacto yeast extract 1.0 g/1, Bacto peptone 1.0 g/1, sucrose 5.0 g/1, MgS04-7H20 0.1 g/1,
pH 5.3) containing the antibiotics rifampicin (100 pg/ml), kanamycin (25 pg/ml), and
gentamycin (25 pg/ml). For A tumefaciens cells transformed with a plant expression
vector, carbenicillin (100 gg/ml) was added for selection.
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C. Restriction enzyme digestion and ligation of DNA
Plasmid or plant genomic DNA was digested with restriction endonucleases
purchased from New England BioLabs, Inc. (Beverly, Massachusetts), according to the
manufacturer’s instruction. Approximately 100 to 400 ng/pl of DNA in 10 to 50 pi
reaction volume was incubated with 1 to 5 U enzyme/pg DNA at 37 °C for 1 to 2 h.
After digestion, reaction mixture was analyzed by agarose gel electrophoresis. For
storage of digested DNA, the restriction endonuclease(s) was heat-inactivated by
incubation at 65 °C for 10 min. and stored at -20 °C.
For ligation reactions of DNA fragments with cohesive ends, T4 DNA ligase or
E. coli DNA ligase (New England BioLabs) was used (approximately 400 Units).
Approximately 400 ng of total DNA was used in a 10 to 20pl reaction volume. Vectorto-insert molar concentration ration was approximately 1:2 to 1:5. Ligation reactions
were incubated at 16 °C for at least 15 h. After the ligation reaction, 1 to 2 pi aliquots of
the ligation mixture were added to electro-competent cells (E. coli HB101 or DH5a) and
transformed as described below.

D. DNA sequence analysis and oligonucleotide synthesis
DNA sequence analysis was performed using a model 373A DNA Sequencer
(Applied Biosystems, Inc.), and oligonucleotides were synthesized using a model 394
DNA/RNA Synthesizer (Applied Biosystems, Inc.) in the DNA Core Facility at the
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Center for Molecular Biology and Gene Therapy, Loma Linda University, School of
Medicine.
For DNA sequencing, the PRISM Ready Reaction DyeDeoxy Terminator Cycle
Sequencing Kit (Applied Biosystems, Inc.) was used according to the manufacturer’s
instruction. Highly purified DNA templates with a concentration of 200 ng/pl was
prepared in autoclaved ultra-pure water. The following reaction components were mixed
in a 0.6 ml microcentrifuge tube: 9.5 pi terminator mix; 5.0 pi DNA template; 3.2 pmol
DNA primer in water). Total volume was adjusted to 20 pi with water. Thermal cycling
parameter was performed as follows: preheating the apparatus at 96 °C, 96 °C for 10 s,
50 °C for 5 s, 60 °C for 4 min, total of 25 cycles. Centri-Sep columns were used for
purification of samples. The columns were hydrated with 800 pi of dH20 for 30 min.
The columns were centrifuged at 750 x g for 2 min. The samples were loaded onto the
center of the column. The columns were centrifuged as before to collect the flow-through
in 1.5 ml centrifuge tube. The DNA samples were completely dried in a vacuum
centrifuge and rehydrated with 4 pi of loading buffer (5 pi deionized formamide, 1 pi
50 mM EDTA, pH 8.0). The samples were heat denatured at 90 °C for 2 min and placed
on ice. The samples were loaded on an Applied Biosystems 373A DNA sequencer.

38
E. Agarose gel electrophoresis of DNA
DNA samples were mixed with 1/5 volume of 6x sample loading buffer (30%
glycerol, 1.8x TBE, pH 8.0, 0.06% bromophenol blue, 60 mM disodium EDTA,
0.12 mg/ml DNase-free RNase). A 1% agarose gel (wt/vol) dissolved in TAE
(50 mM Tris base, 50 mM boric acid, ImM disodium EDTA, pH 8.0) was used as a
buffer. The DNA samples were loaded in wells and current was applied (approximately
100 V for 30 min.). Gels were removed from the electrophoresis apparatus (BioRad) and
incubated in TAE buffer containing ethidium bromide (0.5 pg/ml, final) for 15 min.
DNA bands were observed using ultraviolet transilluminator.

F. Bacterial transformation by electroporation
Plasmid vectors were introduced into E. coli or A. tumefaciens cells by
electroporation method using electro-competent cells. Gene Pulser (Bio-Rad, Inc.
Hercules, CA) at a setting of 250 pFD, 200 Q, and 2.5 kV, and 0.5 cm electroporation
cuvette was used for both E. coli and A. tumefaciens. For E. coli, Ampicillin resistant
colonies were isolated after overnight culture at 37 °C. For A tumefaciens, carbenicillin
resistant colonies were isolated after incubation at 29 °C for at least 48 h. Presence of
plasmids was confirmed by isolating the plasmids with Plasmid MiniPrep Kit
(Boehringer Mannheim) from an E. coli transformant and subsequent restriction enzyme
analysis. Plasmids within A. tumefaciens transformants were transferred back into E. coli
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HB101, by electroporation and analyzed by restriction endonuclease digestion to confirm
that no significant deletion had occurred in the gene or the vector. Structural
confirmation of the plasmid was required because recombination events within the rec
A. tumefaciens strain may alter plasmid structure. Transfer of the plasmid from
A. tumefaciens back to the E. coli host is necessary because significant amounts of
plasmid are difficult to isolate directly from A. tumefaciens.

G. Potato plant cell transformation
Sterile potato plants Solanum tuberosum cv. Bintje were grown in Magenta boxes
(Sigma Chemical, St. Louis, Missouri) or Mason jars on solid Murashige and Skoog (MS)
complete organic medium (JRH Biosciences No. 56-750-015) containing 3.0% sucrose
and 0.2% gelrite (a clear Psudomonas polysaccharide solid support medium). Leaf
explants were excised from the young plants and laterally bisected in a 9 cm diameter
culture dish containing an overnight culture of A. tumefaciens suspension
9

(2-5 x 10 cells/ml) harboring the plant expression vector. Acetosyringone (370 pM,
final) was added to the bacterial suspension to facilitate transformation. The leaf explants
were incubated in the bacterial suspension for 5 min, blotted on sterile filter paper, and
transferred to MS solid medium, pH 5.7, containing the plant hormones auxin (0.1 pg/ml
naphthalene acetic acid (NAA) and cytokinin (1.0 pg/ml trans-zeatin). The leaf explants
were incubated for 48-72 h at room temperature on MS solid medium to permit T-DNA
transfer into the plant genome. The leaf explants were transferred to MS solid medium
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containing the antibiotics kanamycin (100 fig/ml) and claforan (400 |ig/ml), for selection
of transformed plant cells and for counterselection against continued Agrobacterium
growth, respectively. Transformed plant cells formed calli on the selective medium after
continuous incubation for 2-3 weeks at 25 °C in a light room under cool white
fluorescent tubes on a 12-h photoperiod regime. When transformed calli grew to
5-10 mm in diameter, the leaf tissue was transferred to MS medium containing 1.0 pg/ml
trans-zeatin, 50 pg/ml kanamycin and 400 pg/ml claforan for shoot induction.
After 4-5 weeks incubation, regenerated shoots were excised at the base from the calli
and transferred to MS solid medium without plant hormones or antibiotics to stimulate
root formation. Plantlets were obtained after about 6 weeks further growth under sterile
conditions in Mason jars. The plantlets were grown into mature plants (4-6 weeks) in
potting soil in the greenhouse under a 12-h photoperiod. Activity of a luciferase reporter
gene was detected in leaf tissues of the putative transformed plants by low-light image
analysis with a Hamamatsu Argus-100 intensified camera system (Hamamatsu Photonics,
K. K., Japan).

H. Luciferase assay
To detect the presence of the plant expression vector in agrobacteria, bacterial
luciferase gene expression under control of the mas PI promoter was monitored by lowlight image analysis (Langridge et al., 1991). To perform the bioluminescent assay for
bacterial luciferase, the volatile substrate N-decyl aldehyde (Sigma D-7384) was applied
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to a 9 cm diameter glass culture plate lid by swabbing the plate with substrate-saturated
cotton. A culture plate containing bacterial colonies grown for 24-48 h on YEB solid
medium, was covered with the substrate coated glass lid, and the culture plate was
transferred into the photon counting chamber of the Argus-100 intensified camera system
for photon counting for a period of 1-5 min.
Bacterial luciferase bioluminescence was also used to detect insertion of the
T-DNA into the plant genome and to estimate the level of mas P2 promoter driven
expression of foreign genes by the level of mas PI driven expression of the luxF gene.
Leaves excised from putative transformants were wounded by cutting perpendicular to
the central vein with a sterile scalpel blade followed by incubation of the wounded leaf
tissue on MS solid medium containing NAA (5.0 mg/1) and 2,4-dichlorophenoxy acetic
acid (2,4-D) (6.0 mg/1) for 48 h. Wounding and subsequent incubation on high auxin
medium for several days is necessary to detect the maximum amount of gene expression
from the mas promoters in potato plant tissues. Light emission from the wounded leaf
tissues was detected as described for agrobacteria. Approximately 5-30 min exposure
was required to obtain an coherent photon emission image.

I. Western blot analysis of protein product in plant cells
Transgenic potato tissues were evaluated for the presence of gene products by
immunoblot analysis using a Bio-Rad Immun-Lite Assay Kit (Bio-Rad 170-6471). Callus
tissues were derived from leaf or tuber tissues incubated for 5-7 weeks on MS solid
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medium containing NAA (5.0 mg/1) and 2,4-D (6.0 mg/1). Tissues (~ 1 g fresh weight)
were homogenized by grinding in a mortar and pestle on ice in 1.0 ml of extraction buffer
(200 mM Tris-Cl, pH 8.0, 100 mM NaCl, 400 mM sucrose, 10 mM EDTA, 14 mM
2-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, 0.05% Tween-20). The tissue
homogenate was centrifuged twice at 17,000 x g in a Beckman GS-15R centrifuge for
15 min at 4 °C to remove insoluble cell debris. An aliquot of 10-20 pi of supernatant,
containing 50-100 pg of total soluble protein, as determined by Bradford protein assay
(Bio-Rad, Inc.), was separated by 15% sodium dodecylsulfate polyacrylamide gel
electrophoresis (SDS-PAGE) at 125 V for 30-45 min in Tris-glycine buffer (25 mM Tris,
250 mM glycine, pH 8.3, 0.1% SDS). Samples of the plant homogenate and purified
CTB (Sigma C-9903) were either loaded directly on the gel or boiled for 3 min prior to
electrophoresis.
The separated protein bands were transferred from the gel to Immun-Lite
membranes by electroblotting on a semi-dry blotter (Labconco) for 60-90 min at 15 V
and 100 mA. Nonspecific antibody reactions were blocked by incubation of the
membrane in 25 ml of 5% non-fat dry milk in TBS buffer (20 mM Tris, pH 7.5 and
500 mM NaCl) for 1 h on a rotary shaker (40 rpm), followed by washing in TBS buffer
for 5 min with gentle agitation. The membrane was incubated overnight at room
temperature with gentle agitation in 30 ml of a primary antibody in antibody dilution
buffer [TEST (TBS with 0.05% Tween-20) containing 1% non-fat dry milk] followed by
washing three times in TBST buffer. The membrane was incubated for 1 h at room
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temperature with gentle agitation in 30 ml of an alkaline phosphatase-conjugated
secondary antibody in antibody dilution buffer. The membrane was washed three times
in TEST buffer as before and once with TBS buffer, followed by incubation in 20 ml of
lx substrate buffer containing 36 pi of chemiluminescent substrate CSPD™ (BioRad) for
5 min at room temperature with gentle agitation. The membrane was placed inside a
household seal-a-meal bag after removing excess substrate buffer and placed in a
photocassette on Kodak X-OMAT film (No. 1651454).

J. Chemiluminescent ELISA
Chemiluminescent ELISA was performed for antibody titer measurement and
quantitative analysis of recombinant proteins in transgenic plants. A 96-well microtiter
plate (Microlite™ 2, Dynatech Laboratories), loaded with 100 pl/well of selected
concentrations of total soluble potato protein in bicarbonate buffer, pH 9.6 (15 mM
Na2C03, 35mM NaHCOs) was incubated overnight at 4 °C. The plate was washed three
times in PBST (phosphate buffered saline (PBS) containing 0.05% Tween-20). The
background was blocked by incubation in 1% bovine serum albumin (BSA) in PBS
(300 p 1/well) at 37 °C for 2 h followed by washing three times with PBST. The plate was
incubated in an appropriate concentration of a primary antibody (100 pl/well) for 2 h at
37 °C, followed by washing the wells three times with PBST. The plate was incubated
with an appropriate concentration of a secondary antibody-conjugated with alkaline

44
phosphatase (lOOpl/well) for 2 h at 37 °C and washed three times with PBST. The plate
was finally incubated with 100 pl/well of Lumi-Phos® Plus (Lumigen, Inc., MI) for
20 min at 37 °C to maximize the reaction rate. The plate was cooled to room temperature
before the enzyme-substrate reaction was measured in a Microlite™ ML3000 Microtiter®
Plate Luminometer (Dynatech Laboratories), operated according to the manufacturer’s
instructions.

K. Gmi-ELISA
A Gmi-ELISA assay was performed to determine the affinity of plant derived CTB
and CTB-conjugate peptides for GMi-ganglioside. The microtiter plate was first coated
with monosialoganglioside-GMi (Sigma G-7641) by incubating the plate with 100 pl/well
of GMi-ganglioside (3.0 pg/ml) in bicarbonate buffer, pH 9.6 (15 mM Na2CC>3, 35 mM
NaHCOs) at 4 °C overnight. The plates were incubated with transformed plant
homogenate total soluble protein in PBS (100p 1/well) overnight at 4 °C. The remainder
of the procedure was identical to the chemiluminescent ELISA described above.

L. Laboratory mice and oral immunization and oral tolerization
For oral immunization experiments using plant tissues producing CTB, adult
female CD-I mice were purchased from Charles River Co., (Charles River, MA) and
were maintained in the University animal care facility. Sex and age-matched,
untransformed potato placebo-immunized control animals were used. Mice were fed ad
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libitum auxin-induced transgenic (microtuber or leaf callus) potato tissues containing
approximately 30 pg CTB/g fresh weight, previously determined by chemiluminescent
ELISA and immunoblot experiments with transformed plant tissue homogenates.
Transgenic plant tissues were placed in a plastic culture plate and replaced with Rodent
Chow provided by animal care facility. Control group of mice were given 30 pg of
bacterial CTB in sodium bicarbonate buffer (350 mM), pH 8.5 by oral feeding tube
(gavage).
For oral tolerization experiments using plant tissues producing IDDM autoantigen
gene products or their CTB-conjugate peptides, four-week old female NOD mice were
purchased from Jackson Laboratory (Bar Harbor, Maine) and maintained in our animal
facility. At age 5 weeks, each mouse was started to be fed potato tubers weekly until they
were 9-weeks old (total of five feeding). At age 10-week, animals were sacrificed and the
pancreas was removed for histopathological analysis for insulitis scoring. Mice were
suffocated by inserting them into a box containing dry ice. The abdomen was opened and
pancreas was removed. Mice were immediately exsanguinated to collect blood by hear
puncture for serum analysis. The small intestine was also removed for intestinal washing
for intestinal antibody analysis.

46
M. Pancreatic tissue slides preparation
The pancreas was inserted into Bonin’s fixative (75 ml picric acid, saturated
aqueous; 25 ml formalin, concentrated; 5 ml glacial acetic acid) for two days. The
pancreas dehydrated by inserting the tissue into a increasing concentration of alcohol
(30, 50, 70, 80, 95% and absolute alcohol) until yellow color disappears. Each stem
required approximately 2 to 3 h. The tissue was incubated in a absolute alcohol once
more to insure complete removal of water.
Paraffin was melted by heating to 56 to 58 °C. The tissue was placed in small
container filled with melted paraffin and the whole is cooled rapidly in water. The
paraffin embedded tissue was sliced by microtome for slide preparation. Thickness of
each section was 5 microns. The slides were stained with hematoxylin and
counterstained with eosin.

N. Serum and fecal sample preparation and endpoint titer measurement
For serum antibody titer determinations, animals were bled from tail vein with
27-gauge needle by puncturing the vein, or by hear puncture by scissors. The blood
samples were collected in 1.5 ml-centrifuge tubes and allowed to stand for 4 to 5 h at
room temperature and 4 °C overnight. Blood clot was carefully removed from the tubes
using sterilized forceps. Serum was transferred to a clean new centrifuge tubes.
Remaining blood cells and debris were removed by centrifugation (2700 x g for 10 min.)
at 4 °C. The supernatant was stored at -20 °C.
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Fecal antibodies were isolated using an extraction method described by de Vos
and Dick (de Vos and Dick, 1991). Fecal pellets were collected by transferring individual
mouse to a small cage without wood shavings. Fecal samples were weighed and
extracted immediately or stored at -80 °C. Samples were mixed with 10 volumes (wt/vol)
of PBS containing ImM phenylmethylsulfonyl fluoride (a protease inhibitor), and the
mixture incubated at room temperature for 20 min. Samples were vigorously vortexed,
and were incubated again at room temperature for 20 min. Samples were vortexed and
then centrifuged for 10 min. to remove insoluble debris. The supernatant was removed
and stored at -80 °C.
Serum and fecal endpoint titers were determined as described by Jackson et al.
(Jackson et al, 1996). Briefly, serial dilutions of serum or fecal extracts from immunized
or unimmunized mice were transferred in duplicate into microtiter plates for
chemiluminescent ELISA. Background relative light units (RLU) from the fecal or serum
sample of unimmunized mice was subtracted from the RLU of samples from immunized
mice. The resultant RLU was plotted on a logio scale against twofold dilutions (log2) of
the samples. The graphic data were extrapolated for sample groups of immunized mice
to the level of baseline RLU, which was the nonspecific background signal generated
from the enzyme-substrate reaction alone.
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O. Ileal loop ligation assay
A mouse ileal loop ligation experiment was conducted essentially as described by
Punyashthiti and Finkelstein (Punyashthiti and Finkelstein, 1971). Animals were starved
for 48 h prior to anesthesia with intraperitoneal injection of ketamine (50 mg/kg) and
xylazine (10 mg/kg). Abdomen of fully unconscious mice (checked by eyelid reflex)
were opened with surgical scissors and small intestine was extracted from abdominal
cavity. The cecum was identified and a section of small intestine just upstream of cecum
was used for loop ligation. Three equal loops 2 to 3 cm in length were ligated by sterile
surgical thread without disturbing the mesenteric veins. Cholera toxin (125 ng in 30 pi
physiological saline) was injected into each of the two loops by a 1.0 ml-Tuberculin
syringe fitted with a 27-gauge needles, and the third loop was injected with saline only as
a negative control. Abdomen was closed with the surgical thread, and animals were
returned to the cage without solid food but water. After 24 h animals were anesthetized
as before and killed by exsanguination. The abdomen was reopened and the three
consecutive ileal loops were excised. Each loop was punctured with scissors to collect
the intestinal fluid in a 1.5 ml-microcentrifuge tube. The tube was centrifuged to remove
insoluble debris from the fluid. The fluid volume and the length of the empty loops were
measured for data analysis.
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P. Vero-cell based cholera toxin neutralization assay
Vero cells were grown at 37 °C in DMEM media (Sigma) supplemented with 5%
fetal calf serum (FCS) (Sigma) in a 5% CO2 atmosphere. The concentrations of CT
required for a cytotoxic response were determined initially by adding serial dilutions of
CT to Vero cell monolayers (Stavric et al., 1978). The changes in cellular morphology
(refractile, thick-walled with several filamentous tendrils) were scored as 0, 1, 2, 3, 4, or
5, corresponding roughly to 0, < 25, 25-50, 50-75, 75-90, or > 90% cells affected. A
final concentration of 25-30 ng CT/ml, was found to give scores above 3 and was used
for toxin neutralization assays. The relative efficacy of toxin neutralization of antisera
was assayed by incubating 100 pi of twofold dilutions of pooled anti-CTB serum in PBS
prepared from immunized or unimmunized mice with 25 ng CT for 1 h at 35 °C. Prior to
addition of the toxin-antiserum mixture to confluent monolayers, the growth medium was
replaced with 1 ml of fresh medium containing 5% FCS, followed by 1 h incubation at
37 °C in a 5% CO2 atmosphere. The toxin-antiserum mixture was added to the cell
monolayers and cytotoxic responses were observed after 20 h incubation at 37 °C.

Q. Histopathological analysis of pancreatic islets
For evaluation of oral tolerization experiment, insulitis levels were measured
based on the extent of lymphocyte infiltration in the islets of Langerhans. Mice at
10 weeks of age were sacrificed and the pancreas removed. The pancreatic tissues were
fixed with Bouin’s fixative and stained with hematoxylin and eosin as described above.

50
The degree of lymphocyte infiltration of pancreatic tissues (insulitis) were scored using a
7-level semiquantitative scale ranging from 0 to 6: 0, normal islet with no sign of T-cell
infiltration: 1, focal peri-islet T-cell infiltration but with lymphocytes less than one-third
of the peri-islet area; 2, more extensive peri-islet T-cell infiltration but with lymphocytes
less than two-thirds of the peri-islet area; 3, peri-islet T-cell infiltration with lymphocytes
more than two-thirds of the peri-islet area; 4, intra-islet T-cell infiltration with
lymphocytes less than one-third of the islet area; 5, more extensive intra-islet T-cell
infiltration but lymphocytes less than two-thirds of the islet area; 6, massive T-cell
infiltration involving more than two-thirds of the islet area. Scores 1-3 and 4-6 indicate
increasing levels of peri-insulitis and intra-insulitis, respectively. The Student’s t test was
used for statistical analysis of the data.

R. Assessment of diabetic symptoms
Incidence of diabetic symptoms was compared between mice fed potatoes
synthesizing IDDM autoantigens and their CTB-conjugates. The NOD mice were
monitored weekly starting at 10-week of age for development of diabetes by urinary
glucose test strips (Clinistix® and Diastix®, Bayer). Individual mice were placed in a
small cage without wood shavings. The mice were allowed to stay in the cage until they
urinated. Tips of the glucose test strips were immediately immersed into the fresh urine
and the glucose levels were determined according to strip color change. Normal mice
were returned to the original cage, and glycosuric mice were bled to check for glycemia
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using a glucose analyzer (Accu-Chek® ADVANTAGE®, Boehringer Mannheim). To
check blood glucose levels, a mouse was placed inside of the plastic mouse trap with its
tail extruding from the trap. The tail vein was located and punctured with a 27-gauge
needle attached to a 1.0 ml-Tuberculin syringe to collect approximately 50 pi of blood
with pipet. Blood was immediately dropped onto the blood glucose test strip inserted into
the glucose analyzer. Mice with blood glucose levels higher than 250 mg/dl (13.8 mM)
were placed in a separate cage labeled “hyperglycemic”. One week after taking blood the
mice were bled again for a second glucose analysis. Clinical diabetes was confirmed by
hyperglycemia (> 250 mg/dl) for two consecutive weeks (Zhang et al, 1991).
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Abstract
A gene encoding the cholera toxin B subunit protein (CTB), fused to an
endoplasmic reticulum (ER) retention signal (SEKDEL) was inserted adjacent to the bi
directional mannopine synthase P2 promoter in a plant expression vector containing a
bacterial luciferase AB fusion gene (luxF) linked to the PI promoter. Potato leaf explants
were transformed by Agrobacterium tumefaciens carrying the vector and kanamycinresistant plants were regenerated. The CTB-SEKDEL fusion gene was identified in the
genomic DNA of bioluminescent plants by polymerase chain reaction amplification.
Immunoblot analysis indicated that plant-derived CTB was antigenically
indistinguishable from bacterial CTB, and that oligomeric CTB molecules (Mr ~ 50 kDa)
were the dominant molecular species isolated from transgenic potato leaf and tuber
tissues. Similar to bacterial CTB, plant-synthesized CTB dissociated into monomers
(Mr ~ 15 kDa) during heat or acid treatment. The maximum amount of CTB detected in
auxin-induced transgenic potato leaf and tuber tissues was approximately 0.3% of total
soluble plant protein. Enzyme-linked immunosorbent assay indicated that plantsynthesized CTB protein bound specifically to GMi-ganglioside, the natural membrane
receptor of cholera toxin. In the presence of the SEKDEL signal, CTB accumulates in
potato tissues and is assembled into an oligomeric form which retains native biochemical
and immunological properties. The expression of oligomeric CTB with immunological
and biochemical properties identical to native CTB in edible plants opens the way for
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preparation of inexpensive food plant-based oral vaccines for protection against cholera
and other pathogens in endemic areas throughout the world.
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Introduction
Oral administration of Vibrio cholerae enterotoxin (CTX) and its nontoxic B
subunit (CTB) induce both systemic and mucosal antibody production in animals and
man (Fujita and Finkelstein, 1972; Fuhrman and Cebra, 1981; Lycke et al., 1983; Elson
and Balding, 1984; Lycke et al., 1985). CTX acts as a strong immunological adjuvant for
co-administered antigens (Lycke and Holmgren, 1986; Jackson et al., 1993; Holmgren et
al., 1993). The strong adjuvant effect of CTX is due to its ability to interact with many
vertebrate cell types by elevating intracellular cAMP levels through activation of
adenylate cyclase (Gill and Meren, 1978). Although, CTB is not generally considered to
be a strong adjuvant for co-administered antigens, it has been demonstrated to be an
effective carrier molecule for induction of mucosal immunity to polypeptides to which it
is chemically or genetically conjugated (McKenzie and Halsey, 1984; Czerkinsky et al..
1989; Dertzbaugh and Elson, 1993). In addition, CTB has been shown to function as a
carrier of conjugated peptides for induction of immunological tolerance (Sun et al., 1994,
1996). The characteristic of CTB as a immunomodulatory carrier molecule may be due
largely to the ability of CTB to avidly bind to its natural receptor GMi-ganglioside, on the
surface of mammalian intestinal epithelial cells, including M cells of the gut-associated
lymphoid tissues (GALT) (Svennerholm, 1976). It is widely recognized that oral
vaccination is more effective than parenteral vaccination against pathogens which invade
through mucosal surfaces. Furthermore, oral vaccines are easier and safer to administer.
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The development of transformation methods for stable integration of foreign DNA
into plants (Schell, 1987) has enabled the production of transgenic plants capable of
expressing a wide variety of foreign genes e.g., bacterial luciferase in tobacco (Koncz et
al., 1987), secretory antibodies in tobacco (Ma et ai, 1995), and the human milk protein
p-casein in potato (Chong et al., 1997). The production of immunomodulatory
transmucosal carrier molecules, such as CTB, in food plants may greatly improve the
efficacy of edible plant-based vaccines (Haq et al., 1995; Thanavala et al., 1995; Mason
et al., 1996), and may also provide novel oral tolerization agents for prevention of such
autoimmune diseases as type I diabetes (Zhang et al., 1991), collagen-induced arthritis
(Trentham et al., 1993), and multiple sclerosis (Khoury et al., 1990; Miller et al., 1992;
Weiner et al., 1993), as well as the prevention of allergic and allograft rejection reactions
(Sayegh et al., 1992; Hancock et al., 1993).
It is presently unknown whether the cholera toxin B subunit can be produced in
transgenic food plant tissues for assembly into the pentameric structure essential for high
binding affinity for the natural toxin receptor (GMi-ganglioside). In this report we
transfer the CTB gene, linked to an oligonucleotide sequence encoding an ER retention
signal (Munro and Pelham, 1987) into potato leaf explants by an Agrobacterium
tumefaciens mediated stable transformation method (de Block, 1988). Transgenic plants
were analyzed for production of CTB retaining native antigenicity, oligomeric structure
and GMi-ganglioside binding capacity.
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Materials and Methods
Construction ofplant expression vector pPCV701FM4-CTB:SEKDEL
The plant expression vector pPCV701FM4 was derived from plasmid pPCV701 by
addition of multiple cloning sites immediately downstream from the mannopine synthase
(mas) P2 promoter. The vector was digested with Xbal and Sad restriction
endonucleases within the multiple cloning site to insert a gene encoding the cholera toxin
B subunit from plasmid pRT42 containing the ctxAB operon. The oligonucleotide 5’
primer (5 ’-GCTCTAGAGCCACCATGATTAAATTAAAATTTGGTG-3 ’) and the 3’
primer (5 ’-CTGGAGCTC ATAGCTCATCTTTCTCAGAATTTGCCATACTAATTG
CGG-3’) were synthesized (model 394 DNA/RNA Synthesizer Applied Biosystems, Inc.)
in the DNA Core Facility at Loma Linda University, with Xbal and Sad restriction
endonuclease recognition sites for amplification and cloning of the CTBiSEKDEL fusion
gene construct (393 bp) in vector pPCV701FM4. The 3’ primer was designed to contain
a nucleotide sequence encoding a hexapeptide ER retention signal (SEKDEL) in frame
with the CTB open reading frame. After PCR amplification (Perkin Elmer Gene Amp
PCR System 9600) and ligation of the CTB: SEKDEL coding sequence into the plant
expression vector to create pPCV701FM4-CTB: SEKDEL, the reaction mixture was used
to transform Escherichia coli strain HB101 by electroporation (Gene Pulser, Bio-Rad,
Inc. Hercules, CA) at a setting of 250 pFD, 200 Q, and 2,500 V. Ampicillin resistant
colonies were isolated after overnight culture at 37 °C. To confirm the presence of the
correct CTB fusion gene sequence in transformed E. coli cells, the plasmid was isolated
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from individual colonies of transformants and subjected to DNA sequence analysis with
the forward primer (S’-ACCAATACATTACACTAGCATCTG-B’) specific for the mas
P2 promoter and the reverse primer (S’-GACTGAGTGCGATATTATGTGTA ATAC-3’)
specific for the gene 7 poly(A) signal in a model 373A DNA Sequencer (Applied
Biosystems, Inc.).
Following confirmation of the correct CTB fusion DNA sequence, the shuttle
vector was transferred into A. tumefaciens recipient strain GV3101 pMP90RK by the
same electroporation conditions described for E. coli transformation. For selection of
transformants, the bacteria were grown at 29 °C in culture plants containing YEB solid
medium (beef extract 5.0 g/1, Bacto yeast extract 1.0 g/1, Bacto peptone 1.0 g/1, sucrose
5.0 g/1, MgS04*7H20 0.1 g/1) containing the antibiotics carbenicillin (100 pg/ml),
rifampicin (100 jig/ml), kanamycin (25 pg/ml), and gentamycin (25 pg/ml). The plasmid
was isolated from an A. tumefaciens transformant and transferred back into E. coli
HB101, by electroporation to confirm by restriction endonuclease analysis, that no
significant deletion had occurred in the vector. Structural confirmation of the plasmid
was required because recombination events within the rec A. tumefaciens strain could
alter the T-DNA sequence. This process was necessary because significant amounts of
plasmid are difficult to isolate directly from A. tumefaciens. Agrobacteria carrying the
plant expression vector were grown on YEB solid medium containing all antibiotics for
48 h at 29 °C and directly used for transformation of sterile potato leaf explants.
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Plant transformation
Sterile potato plants Solanum tuberosum cv. Bintje were grown in Magenta boxes
(Sigma) or Mason jars on solid Murashige and Skoog (MS) complete organic medium
(JRH Biosciences No. 56-750-015) containing 3.0% sucrose and 0.2% gelrite (a clear
Psudomonas polysaccharide solid support medium). Leaf explants were excised from the
young plants and laterally bisected in a 9 cm diameter culture dish containing an
overnight culture of A. tumefaciens suspension (2-5 x 109 cells/ml) harboring
pPCV701FM4-CTB:SEKDEL. Acetosyringone (370 pM) was added to the bacterial
suspension to facilitate transformation. The explants were incubated in the bacterial
suspension for 5 min, blotted on sterile filter paper, and transferred to MS solid medium,
pH 5.7, containing the plant hormones auxin [0.1 fig/ml naphthalene acetic acid (NAA)]
and cytokinin (1.0 pg/ml trans-zeatin). The leaf explants were incubated for 48-72 h at
room temperature on MS solid medium to permit T-DNA transfer into the plant genome.
The leaf explants were transferred to MS solid medium containing the antibiotics
kanamycin (100 pg/ml) and claforan (400 pg/ml), for selection of transformed plant cells
and for counterselection against continued Agrobacterium growth, respectively.
Transformed plant cells formed calli on the selective medium after continuous incubation
for 2-3 weeks at 25 °C in a light room under cool white fluorescent tubes on a 12-h
photoperiod regime. When transformed calli grew to 5-10 mm in diameter, the leaf
tissue was transferred to MS medium containing 1.0 pg/ml trans-zeatin, 50 pg/ml
kanamycin and 400 pg/ml claforan for shoot induction. After 4-5 weeks incubation,
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regenerated shoots were excised at the base from the calli and transferred to MS solid
medium without plant hormones or antibiotics to stimulate root formation. Plantlets were
obtained after about 6 weeks further growth under sterile conditions in Mason jars. The
plantlets were grown into mature plants (4-6 weeks) in potting soil in the greenhouse
under a 12-h photoperiod. Activity of the luciferase reporter gene was detected in leaf
tissues of the putative transformed plants by low-light image analysis with a Hamamatsu
Argus-100 intensified camera system (Hamamatsu Photonics, K.K., Japan).

Detection of luciferase activity in transformed A. tumefaciens and transgenic plants
To detect the presence of the plant expression vector in agrobacteria, bacterial luciferase
gene expression under control of the mas PI promoter was monitored by low-light image
analysis (Langridge et al., 1991). To perform the bioluminescent assay for bacterial
luciferase, the volatile substrate N-decyl aldehyde (Sigma D-7384) was applied to a 9 cm
diameter glass culture plate lid by swabbing the plate with substrate-saturated cotton. A
culture plate containing bacterial colonies grown for 24-48 h on YEB solid medium, was
covered with the substrate coated glass lid, and the culture plate was transferred into the
photon counting chamber of the Argus-100 intensified camera system for photon
counting for a period of 1-5 min.
Bacterial luciferase bioluminescence was also used to detect the presence of the
T-DNA into the plant genome and to estimate the level of mas P2 promoter driven
expression of the CTB gene by the level of mas PI driven expression of the luxF gene.
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Leaves excised from putative transformants were wounded by cutting perpendicular to
the central vein with a sterile scalpel blade followed by incubation of the wounded leaf
tissue on MS solid medium containing NAA (5.0 mg/1) and 2,4-dichlorophenoxy acetic
acid (2,4-D) (6.0 mg/1) for 48 h. Wounding and subsequent incubation on high auxin
medium for several days is necessary to detect the maximum amount of gene expression
from the mas promoters in potato plant tissues. Light emission from the wounded leaf
tissues was detected as described for agrobacteria. Approximately 5-30 min exposure
was required to obtain an coherent photon emission image.

Detection of the CTB gene in transformed plant genomic DNA
Genomic DNA was isolated from transformed potato leaf tissues as described by Doyle
and Doyle (1992) with the following modification, biological grinding spheres
(Boehringer Mannheim) were used instead of a mortar and pestle for grinding the plant
tissues. Presence of the CTB gene was determined by PCR analysis using the
oligonucleotide forward and reverse primers specific for the pPCV701FM4 vector.
Transformed plant genomic DNA (500 ng) was used as a template to detect the CTB gene
under the following PCR conditions: 94 °C for 45 sec, 55 °C for 1 min, and 72 °C for
Imin for a total of 30 cycles. PCR samples were separated by electrophoresis on a 1%
agarose gel and stained with ethidium bromide.
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Immunoblot detection of CTB protein in transformed potato tissues
Transgenic potato tissues were evaluated for the presence of CTB protein by immunoblot
analysis using a Bio-Rad Immun-Lite Assay Kit (Bio-Rad 170-6471). Callus tissues were
derived from leaf or tuber tissues incubated for 5-7 weeks on MS solid medium
containing NAA (5.0 mg/1) and 2,4-D (6.0 mg/1). Tissues (approximately 1 g fresh
weight) were homogenized by grinding in a mortar and pestle on ice in 1 ml of extraction
buffer (200 mM Tris-Cl, pH 8.0, 100 mM NaCl, 400 mM sucrose, 10 mM EDTA, 14 mM
2-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, 0.05% Tween-20). The tissue
homogenate was centrifuged twice at 17,000 x g in a Beckman GS-15R centrifuge for
15 min at 4 °C to remove insoluble cell debris. An aliquot of 10-20 pi of supernatant,
containing 50-100 pg of total soluble protein, as determined by Bradford protein assay
(Bio-Rad, Inc.), was separated by 15% sodium dodecylsulfate polyacrylamide gel
electrophoresis (SDS-PAGE) at 125 V for 30-45 min in Tris-glycine buffer (25 mM Tris,
250 mM glycine, pH 8.3, 0.1% SDS). Samples of the plant homogenate and purified
CTB (Sigma C-9903) were either loaded directly on the gel or boiled for 3 min prior to
electrophoresis.
The separated protein bands were transferred from the gel to Immun-Lite
membranes by electroblotting on a semi-dry blotter (Labconco) for 60-90 min at 15 V
and 100 mA. Nonspecific antibody reactions were blocked by incubation of the
membrane in 25 ml of 5% non-fat dry milk in TBS buffer (20 mM Tris, pH 7.5, 500 mM
NaCl) for 1 h on a rotary shaker (40 rpm), followed by washing in TBS buffer for 5 min
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with gentle agitation. The membrane was incubated overnight at room temperature with
gentle agitation in 30 ml of a 1:5,000 dilution of rabbit anti-cholera antiserum (Sigma
C-3062) in antibody dilution buffer [TEST (TBS with 0.05% Tween-20] containing 1%
non-fat dry milk) followed by washing three times in TEST buffer. The membrane was
incubated for 1 h at room temperature with gentle agitation in 30 ml of a 1:10,000
dilution of mouse anti-rabbit IgG conjugated with alkaline phosphatase (Sigma A-2556)
in antibody dilution buffer. The membrane was washed three times in TEST buffer as
before and once with TBS buffer, followed by incubation in 20 ml of 1 x substrate buffer
containing 36 pi of chemiluminescent substrate CSPD™ for 5 min at room temperature
with gentle agitation. The membrane was placed inside a household seal-a-meal bag after
removing excess substrate buffer and placed in a photocassette on Kodak X-OMAT film
(No. 1651454). (The membrane was also used to image chemiluminescent light intensity
in both the numerical and graphic form by the Argus-100 video image analysis.) The film
was subjected to 1-15 min exposure at room temperature in the dark for optimal image
development. The exposed film was developed in a Kodak M3 5A X-OMAT Processor.

Quantitation of CTB protein level in transgenic potato tissues
CTB protein levels in transgenic potato plants were determined by quantitative
chemiluminescent ELISA assays. A 96-well microtiter plate (Microlite™ 2, Dynatech
Laboratories), loaded with 100 pl/well of selected concentrations of total soluble potato
protein in bicarbonate buffer, pH 9.6 (15 mM Na2C03, 35mM NaHCOs) was incubated

65
overnight at 4 °C. The plate was washed three times in PBST (phosphate buffered saline
(PBS) containing 0.05% Tween-20). The background was blocked by incubation in 1%
bovine serum albumin (BSA) in PBS (300 pl/well) at 37 °C for 2 h followed by washing
three times with PBST. The plate was incubated in a 1:8,000 dilution of rabbit anti
cholera toxin antibody (Sigma C-3062), (100 pl/well) for 2 h at 37 °C, followed by
washing the wells three times with PBST. The plate was incubated with a 1:80,000
dilution of anti-rabbit IgG conjugated with alkaline phosphatase (Sigma A-2556),
(lOOpl/well) for 2 h at 37 °C and washed three times with PBST. The plate was finally
incubated with 100 p 1/well of Lumi-Phos® Plus (Lumigen, Inc. P-701) for 20 min at
37 °C to maximize the reaction rate. The plate was cooled to room temperature before
the enzyme-substrate reaction was measured in a Microlite™ ML3000 Microtiter® Plate
Luminometer (Dynatech Laboratories), operated according to the manufacturer’s
instructions.
Alternatively, chemiluminescent light intensities of the enzyme-substrate reaction
from bacterial and plant CTB protein bands blotted on the Immun-Lite membranes after
SDS-PAGE were quantified by the Argus-100 Data Analysis Program (Hamamatsu
Photonics, K.K.). The numeric value of the total light intensity of the area defined by a
rectangular window surrounding the plant CTB protein band was compared with the
bacterial CTB band, and the amount of plant CTB was estimated based on the known
amount of bacterial CTB.
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CTB-Gmi binding assay
A Gmi-ELISA assay was performed to determine the affinity of plant derived CTB for
GMi-ganglioside. The microtiter plate was coated with monosialoganglioside-GMi
(Sigma G-7641) by incubating the plate with 100 pl/well of Gmi (3.0 pg/ml) in
bicarbonate buffer, pH 9.6 (15 mM Na2C03, 35mM NaHCG3) at 4 °C overnight.
Alternatively, the wells were coated with 100 p 1/well of BSA, sucrose, or galactose
(3.0 pg/ml each) as controls. The plates were incubated with transformed plant total
soluble protein, bacterial CTB (Sigma C-9903), or CTX (Sigma C-8052) in PBS
(100p 1/well) overnight at 4 °C. The remainder of the procedure was identical to the
ELISA described above.

Results and Discussion
Plant expression vector harboring CTB. SEKDEL fusion gene
The CTBiSEKDEL fusion gene was inserted into the plant expression vector
pPCV701FM4 resulting in pPCV701FM4-CTB:SEKDEL (Fig. 1). Plant expression
vector pPCV701FM4 harbors a 430 bp DNA fragment containing the A. tumefaciens
bi-directional mannopine synthase (mas PI, P2) promoters (Koncz et al., 1987). The PI
promoter is fused to the bacterial luciferase reporter gene (luxF) (Escher et al., 1989), and
the P2 promoter is linked to the CTB:SEKDEL fusion gene. In addition, the plant
expression vector contains the p-lactamase gene which confers ampicillin resistance in
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E. coli and carbenicillin resistance in A. tumefaciens. The neomycin phosphotransferase
II gene (NPT-II) linked to the nopaline synthase (NOS) promoter provides selection for
transformed plant cells. We changed the oligonucleotide sequence surrounding the
translation initiation codon of the CTB gene to a preferred nucleotide context for
translation in eukaryotic cells (Kozak, 1981), and a putative Shine-Dalgamo sequence
(AGGA) present in the ctxAB operon in plasmid pPT42 was also removed. The DNA
fragment encoding the 21-amino acid leader peptide of the CTB protein was retained to
direct the newly synthesized CTB protein into the lumen of the ER. An oligonucleotide
sequence encoding the ER retention signal (SEKDEL) and using codon usage favored in
potato was inserted at the 3’ end of the coding sequence of the CTB gene to sequester
CTB protein within the lumen of the ER. The CTB:SEKDEL fusion gene was inserted
into the multiple cloning site immediately downstream of the mas P2 promoter.

Detection of luciferase activities from putative transgenic potato plants
After Agrobacterium-mQd\aX.Q& transformation of potato leaf explants with the plant
expression vector pPCV701FM4-CTB: SEKDEL, six independent kanamycin-resistant
plants were regenerated. All of the plants were found to express luciferase activities
(Fig. 2, rows 1-6 AB) above background levels from untransformed plants (Fig. 2, rows
7-12 CD). Thus, 100% of kanamycin-resistant plants were found to express luciferase
activities in this plant transformation experiment. However, in additional potato plant
transformation experiments using lower levels of kanamycin for selection, we observed
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transformation efficiencies as low as 5% (2 luciferase positive plants out of 40
kanamycin-resistant plants). Potato plant transformation efficiencies were found to vary
considerably between experiments, suggesting the possibility that differences in aspects
of the transformation method such as physiological state of leaf explants and the growth
state of the agrobacteria used for transformation may result in substantial differences in
transformation efficiency. In addition, the number of kanamycin-resistant plants
regenerated per transformation experiment varied dramatically ranging from 0 to 200 per
50 leaf explants transformed. Therefore, the presence of a convenient detectable marker
gene, such as luciferase, in addition to selectable marker gene significantly enhances the
process of screening large numbers of antibiotic resistant putative transformants.

PCR detection of CTB fusion gene in transgenic potato plants
Three transformed potato plants showing high luciferase activities were analyzed for the
presence of the CTB:SEKDEL fusion gene in genomic DNA isolated from leaf tissues
(Fig. 3). A 540 bp DNA fragment, including both 5’ and 3’ flanking sequences of the
CTB:SEKDEL fusion gene, was amplified from transformed potato genomic DNA. No
nonspecific amplification was observed in any of the samples, indicating a high
specificity of primers used for the PCR reaction. The DNA fragment amplified from
plasmid vector pPCV701FM4-CTB:SEKDEL (Fig. 3, lane 2) and the DNA fragments
amplified from transformed plant genomic DNA (lanes 4-6) migrated to the same
position in the gel. Although, identical amounts of template genomic DNA (500 ng) was
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used for the PCR reaction, the plant exhibiting the highest luciferase activity (Fig. 2, plant
No. 4) also demonstrated the highest level of PCR amplification (Fig. 3, lane 6). The
correlation between PCR product level and luciferase activity suggests the possibility of
increased T-DNA copy number in this transformant.

Immunoblot analysis ofplant synthesized CTB protein
The three selected transformed plants were analyzed for the presence of CTB protein by
immunoblot analysis (data not shown). Plant No. 4 which demonstrated the highest
detectable CTB level was selected for CTB protein characterization. Transgenic potato
leaf callus tissues were shown to contain CTB protein that strongly reacted with anti
cholera antibodies produced against the cholera holotoxin (Fig. 4A). The presence in
bacterial CTB preparations of a band with an approximate molecular weight of 85 kDa
(Fig. 4A, lanes 1 and 2, and B, lane 1) suggests the presence of cholera toxin A subunit
(27 kDa) as part of the heterohexameric AB5 holotoxin complex (Zhang et al., 1995).
Owing to its recombinant origin, plant-synthesized CTB did not show the presence of the
A subunit (Fig. 4A, lane 4). Homogenates from untransformed plants did not interfere
with the antigenicity of exogenously added cholera toxin B subunit (Fig. 4A, lane 2).
Anti-cholera toxin antibodies did not show a significant cross reaction with potato plant
proteins (Fig. 4A, lane 3). Plant-produced CTB protein dissociated into monomers with
molecular weight of approximately 15 kDa when the homogenate was boiled for 3 min
prior to SDS-PAGE (Fig. 4B, lane 4). Comparative Coomassie blue staining of boiled
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and unboiled CTB proteins after SDS-PAGE showed that disappearance of multimeric
CTB was due to disassembly of CTB oligomers rather than due to protein degradation
(data not shown). Heat-induced dissociation of CTB multimers (Fig. 4A, lane 4, B lane
5) into monomers (Fig. 4B, lane 4), as previously demonstrated for bacterial enterotoxins
(Gill, 1976; Hirst and Holmgren, 1987; Hardy et al., 1988), confirmed the oligomeric
(possibly pentameric) status of CTB protein in transformed potato tissues. Acid-induced
dissociation of plant-derived CTB protein, similar to that seen for bacterial enterotoxin
(Hardy et al, 1988), was also detected (data not shown). However, dissociation into the
monomeric form was not as complete as observed after heat treatment. These results
suggest that the plant ER, similar to the periplasmic space of Gram-negative bacteria
(Hirst and Holmgren, 1987), provides an intracellular environment in which monomeric
B subunits are concentrated and assembled into oligomeric form. Presence of the
SEKDEL hexapeptide at the C-terminus of proteins has been shown to significantly
increase protein accumulation within plant tissues such as potato leaves and tubers,
tobacco and alfalfa leaves as well as in COS cells (Munro and Pelham, 1987; Wandelt et
ai, 1992; Haq et ai, 1995), thereby facilitating protein subunit oligomerization.
Immunoblot analysis of plant-synthesized CTB showed that the monomers were
significantly less immunoreactive in comparison to the multimeric form (Fig. 4B,
compare lanes 4 and 5). Similarly, bacterial CTB was found to be substantially less
reactive when dissociated by heat. The use of antibody raised in rabbits against cholera
holotoxin, which may recognize native conformation of CTB pentamer molecules more
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efficiently than denatured and altered subunit conformation of CTB monomers, may
explain this result. Pentameric CTB protein progressively dissociated into the monomeric
form upon storage at 4 °C over a period of several months (Fig. 4B, lane 1). Both
multimeric and monomeric forms of plant-derived CTB were of slightly higher molecular
weight than bacteria-derived CTB (50 kDa versus 45 kDa for the pentamer and 15 kDa
versus 12 kDa for the monomer, respectively). This result may be due to presence of the
hexapeptide ER retention signal, or possibly to failure of plant cells to remove the leader
peptide. Molecular weight differences of approximately 3 kDa between the monomers of
bacteria and plant-derived CTB (Fig. 4B, lanes 1 and 4) suggest that the presence of both
ER retention signal and extra N-terminal peptide contribute to the molecular weight
increase of the plant-synthesized CTB molecule. Based on gel electrophoresis data, the
apparent molecular weight of bacterial and plant CTB multimers is slightly smaller than
the molecular weight of their monomers multiplied fivefold, which suggests a compact
oligomeric configuration.
Transgenic potato microtuber tissues were analyzed for the presence of multimeric
CTB proteins (Fig. 4C). Following auxin induction, homogenates prepared from
microtuber tissues revealed biochemical characteristics of multimeric CTB protein
identical to that found in leaf callus tissues, confirming auxin-induced CTB gene
expression in all tissues of transformed potato plants.
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CTB protein levels in transformed potato plants
To obtain quantitative estimates of CTB protein levels in leaf callus tissues of transgenic
plant No. 4, both chemiluminescent ELISA and chemiluminescent immunoblot assays
were employed.
In the chemiluminescent Gmi-ELISA method, the amount of plant CTB protein
was measured by comparison of the relative light units (RLU) from a known amount of
bacterial CTB protein-antibody complex with that emitted from a known amount of
transformed plant soluble protein. The expression level of CTB was approximately 0.4%
of total soluble plant protein (Fig. 5).
In the chemiluminescent immunoblot method, luminescent intensities of bacterial
and plant CTB protein bands blotted on Immun-Lite membranes after SDS-PAGE were
measured by the Argus-100 low-light imager Data Analysis Program. The number of
photons emitted from either bacterial CTB (Fig. 4B, lane 1) or plant CTB (Fig. 4B, lane
5) protein bands was quantified, and their values compared to provide a semi-quantitative
estimate of the amount of plant synthesized-CTB protein. Based on the amount of light
emission detected from a known amount of bacterial CTB protein (100 ng), the amount of
plant CTB protein was calculated to be approximately 350 ng. The percentage of CTB
protein in the plant was calculated based on the amount of soluble plant protein (100 pg)
used in the assay. Based on this method, the percentage of plant CTB protein was found
to be approximately 0.35% of total soluble plant protein, a value in close agreement with
measurements made by the chemiluminescent Gmi-ELISA method. Based on the results
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of the chemiluminescent Gmi-ELISA and immunoblot assays, 1 g of callus tissues (fresh
weight) obtained from auxin-induced potato leaves contained 30-35 pg of recombinant
plant CTB protein. In a parallel set of experiments, auxin-induced microtuber tissues
were analyzed for the expression of CTB protein. The potato tuber tissues produced
approximately 2-3 fold less CTB protein than detected in leaf callus tissues (compare
Fig. 4A lane 4 with Fig. 4C lane 5).
Transgenic plant No. 4, with the greatest PCR amplification of the CTB fusion
gene (Fig. 3, lane 6 versus lanes 4 and 5), exhibited the highest luciferase activity (Fig. 2,
row 4 AB versus rows 1-3 AB and 5-6 AB) and the highest CTB protein accumulation,
indicating that increased T-DNA copy numbers in the plant genome can contribute to
increased expression levels of genes driven by the mas PI and P2 promoters. In addition
to increased copy numbers of T-DNA in the plant genome, favorable random position
effects of the incoming gene may also explain range of protein levels between individual
transformants.

Binding capacity ofplant-derived CTB protein for the Gmi receptor
In Gmi-ELISA binding assays, plant-produced CTB protein, as well as bacterial CTB and
CTX proteins, demonstrated a strong affinity for GMi-ganglioside but not for BSA, or
alternative sugar molecules, such as sucrose and galactose (Fig. 6). The ability of plantderived CTB to bind GMi-ganglioside indicates that the specific protein-ganglioside
binding interactions between amino acid residues forming the Gmi binding sites and the
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oligosaccharide moiety of GMi-ganglioside are conserved. Unlike the heat-labile
enterotoxin of enterotoxigenic E. coli, cholera toxin does not bind to CrM2-ganglioside,
which lacks the terminal galactose found in Gmi (Fukuta et ai, 1988). However, plantderived CTB, bacterial CTB and CTX showed a weak but significant binding affinity for
GjvLz-monosialoganglioside (possibly due to Gmi contamination of the commercial Gm2
preparation). Based on DNA sequence analysis of the CTB gene present in our plant
expression vector, plant-synthesized CTB should contain tryptophan at position 88 of the
protein. Tryptophan at this location is essential for both pentamerization of the B
monomer as well as binding of the pentamer to the oligosaccharide moiety of Gmi
(de Wolf et al., 1981a,b). Boiling the plant and bacterial CTB prior to Gmi-ELISA
abolished anti-CTB antibody detection (result not shown). This result could be
explained by the fact that monomeric CTB is unable to bind to GMi-ganglioside, and/or
that monomers are weaker in antigenicity in comparison with oligomeric CTB. The
strong binding efficiencies of plant and bacterial CTB for Gmi indicate that plant-derived
CTB subunit binding to Gmi is cooperative (Schon and Freire, 1989; Merritt et ai, 1994).
The apparent cooperativity exhibited by plant CTB-GMi-ganglioside binding reinforces
the probability that monomeric B subunits accumulate within the lumen of the ER of
plant cells where self-assembly into oligomeric, possibly pentameric, Gmi binding forms
occur.
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The mas promoter system for expression of multiple genes
Auxin induction of the mas PI and P2 promoters (Langridge et al., 1989) results in
expression of foreign proteins in plants at levels equivalent to or greater than strong
constitutive promoters such as the cauliflower mosaic virus (CaMV) 35S promoter
(Mason et al., 1992; Haq et al., 1995; Mason et al, 1996). Auxin induction provides a
substantial contribution to CTB gene expression. Approximately 100-fold lower amounts
of CTB protein and luciferase activity were detected in leaf and tuber tissues without
induction by this plant hormone (results not shown). While in potato transformation
experiments, exogenous auxin addition was required to stimulate CTB gene expression
from the mas promoter in leaf and microtuber tissues, food plants like tomato which
make large amounts of auxin during fruit ripening may not require auxin induction for
maximum gene induction.
The combination of a convenient method for screening large numbers of
transformants via the bacterial luciferase reporter gene and the hormone-inducible mas
promoter system provides us with the potential for rapid screening of large numbers of
transgenic plants to select those with the highest transgene expression levels. In our
potato transformation experiments, the luciferase reporter gene was not essential for
identification of transformants as only six kanamycin-resistant plants were regenerated
and all of them were observed to contain CTB gene sequence. However, when plant
transformation efficiency is low, presence of the luciferase gene on the mas PI promoter
can be extremely useful for selection of transformed plants. The results of our
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experiment indicate that the mas dual promoter system can serve as a model system for
simultaneous expression of two desired gene products in food plant tissues. The mas dual
promoter system provides a distinct advantage when two proteins are expected to be
produced in the plant, for example, when two recombinant protein antigens are desired
for construction of a vaccine against multiple pathogens.

Future perspectives for food plant-derived recombinant CTB
The production of oligomeric CTB protein in edible plants may induce mucosal and
systemic anti-cholera toxin antibodies in mammals at levels sufficient to provide
protective immunity against cholera toxin challenge upon feeding transgenic plant tissues.
Although, it has been reported that a production of enterotoxigenic Escherichia coli heatlabile enterotoxin B subunit (LT-B) in transgenic potato tubers of 0.01% of total soluble
protein is sufficient to elicit production of both systemic and mucosal antibodies in mice
with in vitro toxin neutralization capabilities upon oral immunization (Haq et al., 1995),
it may be desirable to increase antigen expression levels to create more effective food
plant-based oral vaccines for larger animals and humans. Earlier reports indicate that
cost-effective plant-based oral vaccines for developing countries will require increased
amounts of recombinant proteins made in plants before they can be used as economically
feasible production and delivery systems capable of replacing traditional bacterial
fermentation systems (Mason and Amtzen, 1995). Minimum levels of recombinant
protein antigen must be determined in food plants for each vaccine target, as individual
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protein antigens may vary in their ability to stimulate the immune response. In addition,
palatable food plant species of tropical and semi-tropical origin that can be consumed
without cooking, such as bananas, tomatoes and avocados, must be evaluated for their
abilities to produce vaccine antigens. These food plants would be more practical
alternatives for production of heat-labile recombinant protein antigens like LT-B or CTB,
and due to their palatability, they would be particularly useful as oral vaccines for
children. Development of edible transgenic plants with high expression levels of
multimeric CTB, which can function both as an immunogen as well as a carrier peptide
for other antigen epitopes, will move us closer to a low-cost, convenient, effective, and
safe strategy for the prevention of infectious and autoimmune diseases in man, especially
in regions of the developing world where the resources of modem medical technology are
largely unavailable.

78
Acknowledgments
We would like to thank Dr. J. Mekalanos of Harvard University for providing us
with the CTB gene and Dr. G. Larson of the DNA Core Facility of the Center for
Molecular Biology and Gene Therapy, Loma Linda University, for assisting in DNA
sequence analyses and oligonucleotide synthesis. We thank Dr. S. Hilliker for critical
reading of the manuscript. This work was supported in part by startup funds and a Basic
Science Research Grant awarded to Dr. William H.R. Langridge from the Loma Linda
University, School of Medicine.

79
References
Chong, D.K.X., Roberts, W., Arakawa, T., Hies, K., Bagi, G., Slattery, C.W., and
Langridge, W.H.R. Expression of the human milk protein, p-casein in transgenic
potato plants. Transgenic Res. 6, 289-96.
Czerkinsky, C., Russell, M.W., Lycke, N., Lindblad, M., and Holmgren, J. (1989) Oral
administration of a streptococcal antigen coupled to cholera toxin B subunit evokes
strong antibody responses in salivary glands and extramucosal tissues. Infect.
Immun. 57, 1072-7.
de Block, M. (1988) Genotype-independent leaf disc transformation of potato (Solanum
tuberosum) using Agrobacterium tumefaciens. Theor. Appl. Genet. 76,161-1 A.
Dertzbaugh, M.T., and Elson, C.O. (1993) Comparative effectiveness of the cholera toxin
B subunit and alkaline phosphatase as carriers for oral vaccines. Infect. Immun. 61,
48-55.
Doyle, J.J., and Doyle, J.L. (1992) Isolation of plant DNA from fresh tissue. Focus 12,
13-5.
Elson, C.O. and Ealding,W. (1984) Generalized systemic and mucosal immunity in mice
after mucosal stimulation with cholera toxin. J. Immunol. 132, 2736-41.
Escher, A., O’Kane, D.J., Lee, J., and Szalay, A.A. (1989) Bacterial luciferase alpha-beta
fusion protein is fully active as a monomer and highly sensitive in vivo to elevated
temperature. Proc. Natl. Acad. Sci. USA 86, 6528-32.
Fuhrman, J.A., and Cebra, J.J. (1981) Special features of the priming process for a
secretory IgA response: B-cell priming with cholera toxin. J. Exp. Med. 153,
534-44.
Fujita, K. and Finkelstein, R.A. (1972) Antitoxic immunity in experimental cholera:
comparison of immunity induced perorally and parenterally in mice. J. Infect. Dis.
125,647-55.
Fukuta, S., Magnani, J.L., Twiddy, E.M., Holmes, R.K., and Ginsburg, V. (1988)
Comparison of the carbohydrate-binding specificities of cholera toxin and
Escherichia coli heat-labile enterotoxins LTh-1, LT-IIa, and LT-IIb. Infect. Immun.
56, 1748-53.

80
Gill, D.M. (1976) The arrangement of subunits in cholera toxin. Biochemistry 15,
1242-8.
Gill, D.M. and Meren, R. (1978) ADP-ribosylation of membrane proteins catalyzed by
cholera toxin: Basis of the activation of adenylate cyclase. Proc. Natl. Acad. Sci.
USA 75, 3050-54.
Hancock, W.W., Sayegh, M.H., Kwok, C.A., Weiner, H.L., and Carpenter, C.B. (1993)
Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by
selective intragraft Th2 cell activation. Transplantation 55, 1112-8.
Haq, T.A., Mason, H.S., Clements, J.D., and Amtzen, CJ. (1995) Oral immunization
with a recombinant bacterial antigen produced in transgenic plants. Science 268,
714-6.
Hardy, S.J.S., Holmgren, J., Johansson, S., Sanchez, J., and Hirst, T.R. (1988)
Coordinated assembly of multisubunit proteins: Oligomerization of bacterial
enterotoxins in vivo and in vitro. Proc. Natl. Acad. Sci. USA 85, 7109-13.
Hirst, T.R. and Holmgren, J. (1987) Conformation of protein secreted across bacterial
outer membranes: a study of enterotoxin translocation from Vibrio cholerae. Proc.
Natl. Acad. Sci. USA 84, 7418-22.
Holmgren, J., Lycke, N., and Czerkinsky, C. (1993) Cholera toxin and cholera B subunit
as oral-mucosal adjuvant and antigen vector systems. Vaccine 11, 1179-84.
Jackson, R.J., Fujihashi, K., Xu-Amano, J., Kiyono, H., Elson, C.O., and McGhee, J.R.
(1993) Optimizing oral vaccines: induction of systemic and mucosal B-cell and
antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect.
Immun. 61, 4272-9.
Khoury, S.J., Lider, O., Al-Sabbagh, A., and Weiner, H.L. (1990) Suppression of
experimental autoimmune encephalomyelitis by oral administration of myelin basic
protein. Cellular Immunology 131,302-10.
Koncz, C., Olsson, O., Langridge, W.H.R., Schell, J., and Szalay, A.A. (1987) Expression
and assembly of functional bacterial luciferase in plants. Proc. Natl. Acad. Sci. USA
84, 131-5.
Kozak, M. (1981) Possible role of flanking nucleotides in recognition of the AUG
initiator codon by eukaryotic ribosomes. Nucleic Acid Res. 9, 5233-52.

81
Langridge, W.H.R., Escher, A., and Szalay, A. A. (1991) Measurement of bacterial
luciferase as a reporter enzyme in vivo in transformed bacteria, yeast, plant cells and
in transgenic plants. Technique 3, 99-108.
Langridge, W.H.R., Fitzgerald, K.L., Koncz, C., Schell, J., and Szalay, A.A. (1989) Dual
promoter of Agrobacterium tumefaciens mannopine synthase gene is regulated by
plant growth hormones. Proc. Natl Acad. Sci. USA 86, 3219-23.
Lycke, N. and Holmgren, J. (1986) Strong adjuvant properties of cholera toxin on gut
mucosal immune responses to orally presented antigens. Immunology 59, 301-8.
Lycke, N., Lindholm, L., and Holmgren, J. (1983) IgA isotype restriction in the mucosal
but not in the extramucosal immune response after oral immunizations with cholera
toxin or cholera B subunit. Int. Arch. Allergy Appl. Immunol. 72, 119-27.
Lycke, N., Lindholm, L., and Holmgren, J. (1985) Cholera antibody production in vitro
by peripheral blood lymphocytes following oral immunization of humans and mice.
Clin. Exp. Immunol. 62, 39-47.
Ma, J.K.-C., Hiatt, A., Hein, M., Vine, N.D., Wang, F., Stabila, P., van Dolleweerd, C.,
Mostov, K., and Lehner, T. (1995) Generation and assembly of secretory antibodies
in plants. Science 268, 716-9.
Mason, H.S. and Amtzen, C.J. (1995) Transgenic plants as vaccine production systems.
Tibtech. 13, 388-92.
Mason, H.S., Ball, J.M., Shi, J.-J., Jiang, X., Estes, M.K., and Amtzen, C.J. (1996)
Expression of Norwalk vims capsid protein in transgenic tobacco and potato and its
oral immunogenicity in mice. Proc. Natl. Acad. Sci. USA 93, 5335-40.
Mason, H.S., Lam, D.M.-K., and Amtzen, C.J. (1992) Expression of hepatitis B surface
antigen in transgenic plants. Proc. Natl. Acad. Sci. USA 89, 11745-9.
McKenzie, S.J. and Halsey, J.F. (1984) Cholera toxin B subunit as a carrier protein to
stimulate a mucosal immune response. J. Immunol. 133, 1818-24.
Merritt, E.A., Sarfaty, S., Akker, F.V.-D., L’Hoir, C., Martial, J.A., and Hoi, W.G.J.
(1994) Crystal structure of cholera toxin B-pentamer bound to receptor Gmi
pentasaccharide. Protein Sci. 3, 166-75.

82
Miller, A., Lider, O., Roberts, A.B., Spom, M.B., and Weiner, H.L. (1992) Suppressor T
cells generated by oral tolerization to myelin basic protein suppress both in vitro
and in vivo immune responses by the release of transforming growth factor after
antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89, 421-5.
Munro, S. and Pelham, H.R.B. (1987) A C-terminal signal prevents secretion of luminal
ER proteins. Cell 48, 899-907.
Sayegh, M.H., Khoury, S.J., Hancock, W.W., Weiner, H.L., and Carpenter, C.B. (1992)
Induction of immunity and oral tolerance with polymorphic class II major
histocompatibility complex allopeptides in the rat. Proc. Natl. Acad. Sci. USA 89,
7762-6.
Schell, J. (1987) Transgenic plants as tools to study the molecular organization of plant
genes. Science 231, 1116-S3.
Schon, A. and Freire, E. (1989) Thermodynamics of intersubunit interactions in cholera
toxin upon binding to the oligosaccharide portion of its cell surface receptor,
ganglioside Gmi- Biochemistry 28, 5019-24.
Sun, J.-B., Holmgren, J., and Czerkinsky, C. (1994) Cholera toxin B subunit: An efficient
transmucosal carrier-delivery system for induction of peripheral immunological
tolerance. Proc. Natl. Acad. Sci. USA 91, 10795-9.
Sun, J.-B., Rask, C., Olsson, T., Holmgren, J., and Czerkinsky, C. (1996) Treatment of
experimental autoimmune encephalomyelitis by feeding myelin basic protein
conjugated to cholera toxin B subunit. Proc. Natl. Acad. Sci. USA 93, 7196-201.
Svennerholm, L. (1976) Interaction of cholera toxin and ganglioside G(M1). Adv. Exp.
Med. Biol. 71, 191-204.
Thanavala, Y., Yang, Y.-F., Lyons, P., Mason, H.S., and Amtzen, C.J. (1995)
Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proc. Natl.
Acad. Sci. USA 92, 3358-61.
Trentham, D.E., Dynesius-Trentham, R.A., Orav, E.J., Combitchi, D., Lorenzo, C.,
Sewell, K.L., Hafler, D.A., and Weiner, H.L. (1993) Effects of oral administration
of type II collagen on rheumatoid arthritis. Science 261, 1727-30.

83
Wandelt, C.L, Khan,
Craig, S., Schroeder, H.E., Spencer, D. and Higgins, T.J.V.
(1992) Vicilin with carboxy-terminal KDEL is retained in the endoplasmic
reticulum and accumulates to high levels in the leaves of transgenic plants. Plant J.
2, 181-92.
Weiner, H.L., Mackin, G.A., Matsui, M, Orav, E.J., Khoury, S J., Dawson, D.M., and
Hafler, D.A. (1993) Double-blind pilot trial of oral tolerization with myelin antigens
in multiple sclerosis. Science 259, 1321-4.
de Wolf, M.J.S., Fridkin, M., Epstein, M. and Kohn, L.D. (1981a) Structure-function
studies of cholera toxin and its A and B protomers: modification of tryptophan
residues. J. Biol. Chem. 256, 5481-8.
de Wolf, M.J.S., Fridkin, M., and Kohn, L.D. (1981b) Tryptophan residues of cholera
toxin and its A and B protomers: intrinsic fluorescence and solute quenching upon
interacting with the ganglioside Gmi, oligo-GMi, or dansylated oligo-GMi- J. Biol.
Chem. 256, 5489-96.
Zhang, R.-G., Scott, D.L., Westbrook, M.L., Nance, S., Spangler, B.D., Shipley, G.G.,
and Westbrook, E.M. (1995) The three-dimensional crystal structure of cholera
toxin. J. Mol. Biol. 251, 563-73.
Zhang, Z.J., Davidson, L., Eisenbarth, G., and Weiner, H.L. (1991) Suppression of
diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc.
Natl. Acad. Sci. USA 88, 10252-6.

84
Sac I

Xba 1
393 bp

<

o

CD

H

<
I— 63 bp —h

309 bp

leader

CTB

-t-18 bpH
SEKDEL -

Xba 1
Sma I
- Spe I
r Sac I

h

Srf I
Bam H I

cn

or

£

p,

mas
^ g7pA

Bla

luxF
T-DNA

OcspA
Pnos

Ori
pBR322

PPCV701 FM4-CTB:SEKDEL
(12 kb)

NPTII

g4pA

LB

RB

Ori V
OriT

Figure 1. Structure of the plant expression vector pPCV701FM4-CTB:SEKDEL. The
following four genes are located within the T-DNA sequence flanked by the right and left
border (RB and LB) 25 bp direct repeats required for integration of the T-DNA into plant
genomic DNA: (1) 393 bp CTB: SEKDEL coding sequence under control of the mas P2
promoter; (2) the bacterial luciferase AB fusion gene (luxF) under control of the mas PI
promoter as a detectable marker; (3) an NPT-II expression cassette for resistance to
kanamycin in plants; (4) a P-lactamase cassette for resistance to ampicillin in E. coli and
carbenicillin in A. tumefaciens. The g7pA polyadenylation signal is from the
A. tumefaciens Tl-DNA gene 7; the OcspA polyadenylation signal is from the octopine
synthase gene; Pnos is the promoter of the nopaline synthase gene; g4pA is the
polyadenylation signal from Tl-DNA gene 4; OriT is the origin of transfer derived from
pRK2; OriV is the wide host range origin of replication for multiplication of the plasmid
in A. tumefaciens derived from pRK2; and Ori pBR322 is the replication origin of
pBR322 for maintenance of the plasmid in E. coli.
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Figure 2. Luciferase activity in transformed potato leaf tissues. Bacterial luciferase
activity was detected in leaves of six kanamycin-resistant potato plants (Nos 1-6) by lowlight image analysis after induction on high auxin medium for 48 h (columns A and B in
duplicate). Arrows indicate leaves with relatively high light intensities. No luciferase
activity was detected in leaves of six untransformed potato plants (Nos 7-12, columns C
and D in duplicate). Photon detection period was 5 min.
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Figure 3. CTB fusion gene detection in genomic DNA of transformed potato leaves.
Lane 1 is a 1 kb DNA ladder (Gibco Life Technologies). DNA templates used for PCR
amplification reaction of the CTB gene were as follows: lane 2, pPCV701FM4CTB:SEKDEL plasmid DNA (10 ng); lane 3, untransformed potato plant genomic DNA
(500 ng); lane 4-6, transformed potato plant genomic DNA (500 ng) from plants No. 1,
No. 3, and No. 4.
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Figure 4. Immunoblot detection of plant CTB protein. Auxin-induced leaf callus tissues
derived from transgenic potato plant No. 4 were analyzed for the expression of
multimeric CTB protein, which dissociated to monomers by heat treatment.
A. Multimeric CTB. Lane 1, 100 ng bacterial CTB; lane 2, 100 ng bacterial CTB mixed
with total protein (100 pg) from untransformed potato plant leaf callus tissue; lane 3, total
protein (100 pg) from untransformed potato plant leaf callus tissue; lane 4, total protein
(100 pg) from No. 4 transgenic potato plant leaf callus tissue. B. Monomeric CTB.
Lane 1, 100 ng bacterial CTB multimer (Mr ~ 45 kDa) partially dissociated to monomer
(Mr ~ 12 kDa); lanes 2 (boiled) and 3 (unboiled), total protein (100 pg) from
untransformed potato plant callus tissue; lanes 4 (boiled) and 5 (unboiled), total protein
(100 pg) from No. 4 transgenic potato plant leaf callus tissue. Arrow indicates the band
(Mr ~ 15 kDa) corresponding to leaf callus CTB monomer. C. CTB in tuber tissues.
Lane 1, 100 ng bacterial CTB (boiled); lane 2, total protein (150 pg) from No. 4
transgenic potato plant microtuber tissue (boiled); lane 3, total protein (150 pg) from
untransformed potato plant microtuber tissue (boiled); lanes 4-6, identical to lanes 1-3,
respectively, except samples were not boiled prior to SDS-PAGE. Arrow indicates
microtuber CTB monomer (Mr ~15 kDa).
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Figure 5. Determination of CTB protein levels in transgenic potato plants. The GmiELISA detection of plant-synthesized CTB using a variety of transgenic plant protein
concentrations indicates that CTB protein levels in induced leaf tissues from transgenic
potato plant No. 4 is approximately 0.3% of total soluble plant protein. CTB protein
levels (% CTB) were plotted against dilutions of plant homogenate. Error bars indicate
SE.
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Figure 6. Gmi binding ability of plant-derived CTB, bacterial CTB, and bacterial CTX.
The ELISA assay was performed by coating microtiter plates with either Gmimonosialoganglioside, sucrose, galactose, or BSA as CTB or CTX receptor molecules
(300 ng/well). For binding the plant-derived CTB (A), a transformed plant tissue
homogenate containing approximately 30 ng of recombinant CTB in 10 pg of total
soluble protein was used per well. For binding bacterial CTB (B) and CTX (C), 30 ng of
each molecule was mixed with untransformed plant homogenate containing 10 pg of total
soluble protein per well. Relative binding affinity of plant CTB, bacterial CTB, and CTX
for receptor molecules was expressed as relative light units (RLU).
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Abstract
Transgenic potato tissues synthesized a cholera toxin B subunit (CTB) pentamer
with a strong affinity for GMi-ganglioside. Both serum and intestinal CTB-specific
antibodies were induced in orally immunized mice. Mucosal antibody titers declined
gradually after the last immunization but were restored following an oral booster of
transgenic potato. The cytopathic effect of cholera holotoxin (CT) on Vero cells was
neutralized by serum from mice immunized with transgenic potato tissues. Following
intra-ileal injection with CT, the plant-immunized mice showed up to a 60% reduction in
diarrheal fluid accumulation in the small intestine. Protection against CT was based on
inhibition of enterotoxin binding to the cell surface receptor GMi-ganglioside. The
experimental results demonstrate the ability of transgenic food plants to generate
protective immunity in mice against a bacterial enterotoxin, which opens the way for
development of food plants as production and delivery systems for mucosal
immunization.
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Introduction
Cholera is a devastating infectious diarrheal disease which has caused recurrent
pandemics throughout the emerging world since 1871. The total number of annual
cholera cases and deaths around the globe exceeds 5 million and 200,000 respectively1.
Effective prevention of cholera dissemination depends on safe water sources and
improved sanitation in countries where cholera is endemic. Poor economic situations in
these countries make the cost of building large-scale water treatment and sanitation
systems prohibitive. Thus, the ultimate challenge for cholera prevention lies in
establishment of low-cost alternatives, including effective oral vaccines which provide
lasting protection after a single immunization, or convenient and readily available
vaccines for frequent administration to people living in regions where cholera is endemic.
Based on the fact that cholera is controlled more effectively through mucosal rather than
parenteral immunization, both killed whole-cell and recombinant live-attenuated oral
cholera vaccine candidates have been extensively tested in field trials1'4.
Microbial antigens expressed in food plants and have been successfully used for
r o

oral immunization in mammals ' . Construction of tropical and semi-tropical food plantbased oral immunization methods for microbial enteropathogens could be an inexpensive
alternative to conventional fermentation systems for vaccine production, as food plants
can be grown inexpensively in large quantities using only sunlight energy and indigenous
agricultural technologies for vaccine harvest. In addition, edible plant-based recombinant
vaccines are safe, provide nutrition, and are easy to administer. Although oral
administration of CT and the nontoxic CTB subunit are known to induce both systemic
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and mucosal antibody production in animals and humans9 n, it is currently unknown
whether food plant-synthesized CTB subunits: retain their native antigenicity, pentameric
structure and GMi-ganglioside receptor binding capacity; or if they can stimulate a
significant protective immune response against the biological effects of cholera holotoxin
following oral administration.
We have investigated transgenic food plants for the production and delivery of
oral vaccine against microbial enteropathogens and their toxins, using cholera toxin (the
prototypical diarrhea-inducing enterotoxin), as a model system. We report here, oral
immunization of CD-I mice by transgenic potato plants transformed with the CTB gene.
We determine the levels of serum and mucosal anti-cholera toxin antibodies and evaluate
the efficacy of the edible vaccine against V. cholerae enterotoxin in mammalian cell
culture and in mouse intestine.

Results
Transgenic potato plants producing pentameric CTB. The oligonucleotide sequence
encoding the endoplasmic reticulum (ER) retention signal (SEKDEL) was fused to the 3 ’
end of the CTB gene and cloned into the plant expression vector pPCV701FM4
(Fig. 1A). Following yfgroZjtfcrmwm-mediated potato leaf transformation, the CTB
fusion gene was expressed in both microtuber and leaf tissues up to 0.3% of total soluble
19

protein . In addition, the chimeric protein monomers assembled into pentamers which
exhibited native antigenicity with a small molecular weight increase in comparison with
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the bacterial CTB pentamer (45 kDa vs. 50 kDa). The increase in molecular weight is
presumably due to the extra six amino acids present at the C-terminus and possible
retention of the 21-amino acid leader peptide at the N-terminus (Fig. IB, compare
lanes 1 and 3). This chimeric CTB molecule bound specifically to GMi-ganglioside and
thus retained the native biological activity of CTB12. Both ELISA and low-light image
analysis methods indicated that 1 g of transgenic potato microtuber or leaf callus tissue
produced approximately 30 pg of pentameric CTB, and that the amount of CTB was
uniform in the transformed potato tissues. Humans, unlike mice, eat only cooked
potatoes, therefore we determined the effect of boiling on pentameric CTB levels in
potato tuber tissues. After cooking the transgenic potato tubers in boiling water until the
tissue became soft, we were able to detected approximately 50% of CTB as the
pentameric GMi-ganglioside binding form (Fig. 1C).

Induction of serum and mucosal anti-CTB antibodies. Potato tissues were orally
administered to mice four times at weekly intervals for a month with a final booster
feeding. Systemic and mucosal CTB-specific antibody titers were determined in both
serum and feces collected from immunized mice by the class-specific chemiluminescent
1T

ELISA (CL-ELISA) method and expressed as endpoint (E) titers . Essentially, the
E titers for the three antibody isotypes (IgM, IgG, and IgA) were determined in serum
and fecal samples as shown in Fig. 2A. Following subtraction of the background signal
from mice fed untransformed potato tissues, relative light units (RLU) were plotted in log
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scale against two-fold dilutions (log2) of serum or fecal samples to generate a titration
curve. The curves were extrapolated for the three groups of mice to the level of 0.5 RLU,
which was the value of the signal generated from the enzyme-substrate reaction alone in
this assay system. Since the baseline RLU value determines the E titer, any fluctuation in
RLU baseline affects the E titer value. Thus, errors in E titer estimations were calculated
based on the deviation of RLU baseline values from 0.5 RLU, which was found to be in
the range of 0.3 to 0.7. Regression coefficients are indicated for all three samples.
The E titers of the three serum anti-CTB antibody isotypes (IgG, IgA and IgM)
were determined and the results expressed for days 35 and 70 (Fig. 2B). Anti-CTB titers
for IgG and IgA slightly increased from day 35 to day 70, while the IgM titer decreased.
The E titers of fecal (intestinal) anti-CTB antibody isotypes (IgA and IgG) were
determined in a similar fashion, and the results expressed for each day of sample
collection (Fig. 2C). Both fecal IgA and IgG titers reached the highest level around day
28, four days after the 4th feeding, and gradually decreased over the next 40 days until
the booster feeding on day 65. In all three groups of CTB immunized mice, fecal IgA
and IgG titers increased after the booster dose. For mice fed 3 g of transformed potato, a
single booster feeding increased the IgA titer to approximately the highest titer observed
on day 28. In general, fecal IgA titers were higher than IgG titers for three groups of
immunized mice for each day of fecal sample collection. Mice immunized with 30 pg of
bacterial CTB and 3 g of transformed potato tissues showed similar mucosal IgA
antibody titers on day 70 of the ileal loop ligation experiment.
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Neutralization of CT by anti-CTB antiserum. Normal Vero cell morphology detected
by light microscopy is presented in Fig. 3A. Vero cells affected by cholera toxin
appeared reffactile, thick-walled, and possessed filamentous tendrils (Fig. 3B). The
neutralization titer was defined as the highest serum dilution providing complete
neutralization of CT cytotoxicity. Serum derived from mice fed 1 g of untransformed
potato tissues showed no protection against CT-induced cytotoxicity, and addition of
immune serum alone to the cell monolayers did not adversely affect cell morphology,
indicating that mouse serum contains no factors which abrogate the toxin effect, nor
factors which alter Vero cell morphology. Mice orally immunized four times followed
with a final booster of 30 pg bacterial CTB showed a titer of 1:32 for complete
protection, in comparison with a titer of 1:8 for mice fed with 3 g of transformed potato
tissues and a titer of 1:2 for mice fed with 1 g of transformed potato tissues (Table 1).

Reduction of CT-induced diarrhea in immunized mice. Representative ileal loops
from a mouse fed untransformed potato tissues and a plant-CTB immunized mouse are
shown in Figs. 4A and B, respectively. To evaluate the protective efficacy of oral
immunization, the volume of fluid accumulated in ileal loops from immunized and nonimmunized animals was measured and expressed as the ratio of volume (V) to loop
length (L) [V/L (pl/cm)] (Fig. 4C). Mice orally immunized with bacterial or plantderived CTB showed significantly less fluid accumulation in comparison with mice fed
untransformed potato tissues. Mean values of V/L for each group of mice were:

99
157.1 ± 12.5 SEM (standard error of the mean) for untransformed potato-immunized
mice; 71.0 ± 7.7 SEM for 30 pg bacterial CTB-immunized mice; 91.0 ± 8.6 SEM for 1 g
transgenic potato-fed mice; and 59.9 ± 10.0 SEM for 3 g transgenic potato-fed mice.
Student’s /-test revealed significant fluid reduction between the unimmunized mouse
groups and the bacterial CTB-immunized mice {p < 0.05), and the transgenic potatoimmunized mice [both 1-g and 3-g groups (p < 0.05)]. Considering reduction in
intestinal-fluid accumulation as a measure of protective efficacy of oral immunization,
approximately 55% protection was observed for mice immunized with 30 pg of bacterial
CTB, 42% protection for mice immunized with 1 g of transformed potato tissues, and
62% protection for mice immunized with 3 g of transgenic potato tissues. Ileal loops
injected with saline did not accumulate significant amounts of fluid (1.5-3.5 pl/cm),
suggesting that mechanical disturbances during loop ligation do not cause an
inflammatory response.

Antiserum-mediated inhibition of cholera toxin-GMi-ganglioside binding. Plantsynthesized CTB was shown to specifically bind to GMi-ganglioside, but not to mono- or
19

di-saccharides such as galactose and sucrose . A Gmi-ELISA was performed to
determine if CT neutralization in Vero cell cultures and mouse ileal loops was due to
anti-CTB antibody-mediated prevention of CT binding to GMi-ganglioside. Incubation of
CT with pooled antiserum from mice fed 1 g of transgenic potato tissues resulted in 36%
less RLU signal in comparison with the same amount of CT incubated with pooled
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antiserum derived from mice fed 1 g of untransformed potato tissues (Fig. 5). When CT
was incubated with either immune or non-immune serum, and the mixture bound to the
microtiter plate surface not coated with (jMi-ganglioside, similar RLU signal levels were
detected for both mixtures (Fig. 5).

Discussion
The 21 -amino acid leader peptide of the CTB protein, absent from secreted
V. cholerae CT molecules, is thought to function as a leader peptide in eukaryotic cells
for translocation of nascent CTB polypeptides into the lumen of the plant ER14. The ER
retention signal (SEKDEL) fused to the C-terminus of the plant CTB may sequester the
protein within the plant ER and may increase stability of the protein 6,15 . The plant ER
may function similarly to the periplasmic space of gram-negative bacteria in providing an
intracellular environment in which CTB monomers accumulate and assemble into
pentamers. We previously demonstrated that the disassembled plant-synthesized CTB
monomer was approximately 3 kDa larger than the bacterial CTB monomer (15 kDa vs.
12 kDa), which may be due to the presence of the hexapeptide ER retention signal and
io

(or) the 21-amino acid leader peptide on the CTB molecule .
Many infectious agents which invade through mucosal surfaces can be effectively
controlled by parenteral immunization, however, oral immunization is more effective for
certain enteric diseases, resulting from V. cholerae and salmonellae infections. In the
present study, oral immunization of CD-I mice with pentameric CTB synthesized in
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potato plants induced generation of both mucosal and systemic anti-CT antibodies at
levels sufficient to generate protective immunity against the biological effects of CT.
The extent of cholera toxin neutralization in both Vero cell and ileal loop
experiments suggests that anti-CTB antibodies prevent CT binding to cellular
GMi-ganglioside. The reduction in RLU signal detected when CT is mixed with immune
serum in comparison with mixtures of CT and nonimmune serum (Fig. 5, GM1+), is
unlikely to result from competition between mouse anti-CTB antibody and primary rabbit
anti-CTB antibody for binding sites on the CT molecule, as there was no significant
difference in RLU signal levels when CT was mixed with either immune or nonimmune
serum prior to addition to microtiter plate wells not coated with GMi-ganglioside (Fig. 5,
GM1-). Thus, immunological protection against CT may be due predominantly to antiCTB antibody-mediated specific prevention of CT binding to cellular GMi-ganglioside.
The molecular mechanism responsible for inhibition of CT binding to GMi-ganglioside
may rely on conformational changes induced in the B subunit of cholera holotoxin by
CTB-specific antibodies. These results are consistent with in vivo experiments in which
anti-CT antibodies prevented CT from binding to the cell surface16.
Secretory IgA is more abundant than IgG in the intestinal lumen (~ 10:1);
however, we observed that in fecal samples, differences in IgA and IgG titers were
smaller than might have been expected (Fig. 2C). This result may have been dependent
on the 10-fold reduction in protease activity detected in fecal extracts in comparison with
intestinal secretions17. The relatively protease free environment in feces may protect the
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IgG antibodies from proteolytic degradation. Secretory IgA is more stable than IgG
against proteolytic attack due to the presence of the secretory component gained during
transcytosis.
Reduction in fluid secretion into intestinal loops of plant-CTB immunized mice
clearly indicated that plant-based oral immunization was as effective as oral
immunization with bacterial CTB for protection of the intestine against cholera toxin.
Mice fed 3 g of transgenic potato tissues and mice gavaged with 30 pg of bacterial CTB
exhibited similar intestinal protection levels, but mice fed 1 g potato showed slightly
lower levels of protection (Fig. 4C). One gram of potato tissues was estimated to deliver
about 30 jug of CTB, which is equivalent to the bacterial CTB dose, thus these two
groups of mice were expected to show similar antibody titers and intestinal protection
levels. However, mice fed 1 g of potato tissue exhibited detectably lower systemic and
mucosal antibody titers, Vero cell neutralization titers and intestinal protection from
cholera toxin in comparison with mice gavaged with 30 pg of bacterial CTB. Thus, it
may be that plant-delivered CTB is less effective in immune stimulation than the same
amount of bacterial CTB, which could be due to differences in antigen delivery; i.e.,
gavage versus chewing and prolonged digestion of plant tissues consumed intermittently
over a several hour period. Further, plant tissues may contain factors which interfere
with antigen presentation to gut-associated lymphoid tissue (GALT)6. In addition, the
sodium bicarbonate buffer used for bacterial CTB gavage to neutralize stomach acid
might have contributed to reduction in CTB pentamer disassembly, or possibly the
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presence of trace amounts of holotoxin in commercial CTB preparations may have
enhanced immune response. An additional explanation for the differences in
immunogenicity in mice, without apparent differences in antigenicity in vitro between
bacterial CTB and plant CTB, may be the differences in amino acid sequences between
the two CTB forms, especially presence of the hexapeptide sequestration sequence at the
C-terminus and possible retention of the 21-amino acid leader peptide at the N-terminus
of the plant CTB molecule. It was reported earlier that amino acid addition at the
N-terminus of the CTB molecule resulted in minor changes in the net conformation,
which resulted in a decrease in GMi-ganglioside affinity and oral immunogenicity 18 .
We observed an apparent discrepancy between serum and mucosal anti-cholera
toxin titers and toxin neutralizing assays in the intestine and in cell culture (Figs. 2 and 4;
Table 1). These apparent internal inconsistencies between antibody titers and protection
against enterotoxin suggest that antibody titer is not always the most reliable marker for
protective efficacy, possibly because not all antibodies are equally neutralizing16. An
apparent dissociation between antibody titers and vaccine efficacy was observed both in
mouse models as well as clinical vaccine trials in the field6,11,19 22. Therefore, our
observations combined with those of other investigators imply that antibody titers may
not always be the best predictable markers for protection against V. cholerae and its
toxin, which emphasize the importance of efficacy studies for in vivo protection. We
should emphasize here that the protection we refer to is protection of tissues (i.e.,
intestine) of immunized animals rather than protection of the animal itself from a lethal
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dose of cholera toxin, which could also be a useful alternative food plant-based vaccine
efficacy study in the mouse model23 .
The increased protective efficacy of a killed-whole cell vaccine strain mixed with
CTB (BS-WC) in comparison with the killed-cell vaccine strain alone (WC) in a largescale field trial in Bangladesh clearly demonstrated the significant protective
immunogenicity of the CTB subunit22,24. Induction of antitoxic immunity alone does not
provide protection against pathological effects caused by the live V. cholerae. The
antibacterial (vibriocidal; i.e., anti-lipopolysaccharide and anti-outer membrane protein
antigens) immune mechanism is critical for prevention of V. cholerae infection25,26.
Thus, it will be desirable in the future to produce edible vaccine plants containing, in
addition to enterotoxin antigens, neutralizing epitopes of structural antigens such as
pilus-associated adhesins for induction of antibacterial immunity27.
While CTB is not a strong adjuvant for co-administered antigens, due to its ability
to bind to GMi-ganglioside on the surface of mammalian intestinal epithelial cells
especially M cells of the GALT, it can function as an effective carrier for induction of an
increased mucosal immune response to polypeptides to which CTB is chemically or
genetically conjugated28 31. Thus, production of pentameric CTB in food plants is not
necessarily confined to development of an anti-diarrheal vaccine against cholera
enterotoxin; CTB may be even more useful for providing safe and cost-effective mucosal
immunization against other enteric pathogens which can be effectively controlled by
recombinant subunit vaccines. Increased immunogen concentration at the mucosal
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lymphoid tissues may reduce the requirement for high levels of antigen biosynthesis in
food plants. In addition, CTB has recently been shown to function as a carrier molecule
for conjugated peptides for induction of immunological tolerance

32-34

. Thus, food plant

CTB-based oral vaccines may open the way for a novel food plant-based therapeutic
32

approach for prevention of autoimmune diseases such as type I diabetes and
encephalomyelitis33 .
Our animal immunization experiments demonstrate that antibody titers can be
boosted by oral administration of additional vaccine food plant tissues when the
protective titer declines. Thus, food plants grown in tropical and semi-tropical regions of
the world can provide a continuous source of oral vaccine for the consequent booster
dose. Application of the CTB pentamer as an effective carrier for conjugated peptides in
food plants will move us closer to achievement of a low-cost, convenient, effective, and
safe strategy for prevention of infectious enteric diseases as well as autoimmune diseases
in animals and in man, especially in regions of the economically emerging world where
conventional vaccines are unaffordable as well as unavailable.

Experimental Protocol
Construction of transgenic potato plants producing CTB:SEKDEL fusion peptide.
The CTB coding sequence including its putative leader peptide (which is absent in
mature cholera toxin B subunit in V. cholerae), was PCR amplified from the ctxAB
operon in the plasmid pRT42 (provided by J. Mekalanos). The 3 ’ PCR primer contained
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an oligonucleotide sequence encoding a hexapeptide endoplasmic reticulum (ER)
retention signal (SEKDEL) in frame with the CTB gene. The amplified DNA fragment
containing the CTB:SEKDEL fusion gene was cloned into plant transformation vector
pPCV701FM435. The resultant plasmid was introduced into Agrobacterium tumefaciens
strain GV3101 pMP90RK by electroporation35. Potato plants {Solarium tuberosum cv.
Bintje) were transformed with agrobacteria harboring pPCV701FM4-CTB:SEKDEL as
previously described112 .

Immunization Antigens. Purified cholera holotoxin and its B subunit were purchased
from Sigma Chemical Co., St. Louis, MO. Immunization was performed with CTB.
Cholera holotoxin was used in mouse ileal loop ligation and in vitro toxin neutralization
assay experiments. Potato tuber and leaf callus tissues producing approximately 0.3% of
total soluble protein as CTB pentamers were used for oral immunization of CD-I mice.

Laboratory Mice and Cell Lines. Adult female CD-I mice were purchased from
Charles River Co., (Charles River, MA) and were maintained in the University animal
care facility. Sex and age-matched, untransformed potato placebo-immunized control
animals were used. African Green Monkey kidney cells (Vero cells) were purchased
from the American Type Culture Collection (Rockville, MD) and grown as monolayers at
37 °C in Dulbecco’s Modified Eagle’s Medium (DMEM) (Sigma) supplemented with 5%
fetal calf serum (FCS) in a 5% CO2 atmosphere.
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Oral immunization with CTB. Mice were fed ad libitum transgenic (microtuber or leaf
callus) potato tissues containing approximately 30 pg CTB/g fresh weight, previously
determined by CL-ELISA and immunoblot experiments with transformed plant tissue
homogenates12. Mice were fed four times on days 0, 6, 17, 24 with a final booster dose
on day 65. A group of 10 mice were fed with 1 g of transgenic potato tissues, and a
group of 8 mice were fed with 3 g of transgenic potato tissues. Using the same feeding
schedule, 1 g of untransformed potato plant tissues were fed to 5 mice as a negative
control; a group of 8 mice were given 30 pg of bacterial CTB in sodium bicarbonate
buffer (350 mM), pH 8.5 by oral feeding tube (gavage) as a positive control.

Serum and fecal sample preparation. For serum antibody titer determinations, animals
were bled on days 35 and 70 of the experiment. Fecal pellets were collected on days 25,
28, 31, 38, 45, 65, and 70 of the experiment to determine the presence of mucosal
antibodies (IgA and IgG) secreted in response to CTB ingestion. Fecal antibodies were
detected according to the coproantibody isolation method described by de Vos and
Dick17.

Chemiluminescent ELISA. One hundred microliters of bacterial CTB diluted in
bicarbonate buffer (pH 9.6) to 5.0 pg/ml was absorbed onto Microlite™ 2 microtiter plate
wells (Dynatech Laboratories, Burlington, MA) overnight at 4 °C. The plates were
washed with PBS-0.05% Tween-20 and blocked with 1% BSA in PBS for 2 h at 37 °C.
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Serial dilutions of serum or fecal extract were added to the wells (100 jil/well) and
incubated overnight at 4 °C. Alkaline-phosphatase conjugated anti-mouse antibody
[1:20,000 dilution of anti-mouse IgG (Sigma A-3688), 1:20,000 IgA (Sigma A-4937), or
1:30,000 IgM (Sigma A-9688)] diluted in PBS containing 0.5% BSA was added (100
pl/well), and incubated for 2 h at 37 °C. The wells were washed and incubated with the
chemiluminescent substrate, Lumi-Phos Plus (100 pl/well; Lumigen, Southfield, MI.) for
20 min at 37 °C. The plates were read in a Microlite™ ML3000 Microtiter® Plate
Luminometer (Dynatech Laboratories).

Endpoint titer measurement. Serum and fecal endpoint titers were determined as
described by Jackson et al.13. Briefly, serial dilutions of serum or fecal extracts from
immunized or unimmunized mice were transferred in duplicate into microtiter plates for
CL-ELISA. Background RLU from the fecal or serum sample of unimmunized mice was
subtracted from the RLU of samples from immunized mice. The resultant RLU was
plotted on a logio scale against twofold dilutions (log2) of the samples. The graphic data
were extrapolated for three groups of immunized mice to the level of 0.5 RLU, which
was the nonspecific background signal generated from the enzyme-substrate reaction
alone in this assay system.

Vero-cell based CT neutralization assay. Vero cells were grown at 37 °C in DMEM
supplemented with 5% PCS in a 5% CO2 atmosphere. The concentrations of CT required
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for a cytotoxic response were determined initially by adding serial dilutions of CT to
Vero cell monolayers36. The changes in cellular morphology (retractile, thick-walled
with several filamentous tendrils) were scored as 0, 1, 2, 3, 4, or 5, corresponding roughly
to 0, < 25, 25-50, 50-75, 75-90, or > 90% cells affected. A final concentration of
25-30 ng CT/ml, was found to give scores above 3 and was used for toxin neutralization
assays. The relative efficacy of toxin neutralization of antisera was assayed by
incubating 100 pi of twofold dilutions of pooled serum in PBS prepared from immunized
or unimmunized mice with 25 ng CT for 1 h at 35 °C. Prior to addition of the toxinantiserum mixture to confluent monolayers, the growth medium was replaced with 1 ml
of fresh medium containing 5% PCS, followed by 1 h incubation at 37 °C in a 5% CO2
atmosphere. The toxin-antiserum mixture was added to the cell monolayers and
cytotoxic responses were observed after 20 h incubation at 37 °C.

Mouse ileal loop ligation assay. A mouse ileal loop ligation experiment was conducted
essentially as described by Punyashthiti and Finkelstein on day 70 of the CTB oral
immunization experiment. Briefly, animals were starved for 48 h and three equal loops 2
to 3 cm in length were ligated. Cholera toxin (125 ng in 30 pi physiological saline) was
injected into each of the two loops, and the third loop was injected with saline only.
After 24 h incubation the three consecutive ileal loops excised and were punctured to
measure the fluid volume and the length of the empty loops. Student’s /-test was used to
determine the significance of fluid reduction between control mice and immunized mice.
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Antiserum-mediated inhibition of CT binding to GMi-ganglioside by Gmi-ELISA.
A 96-well microtiter plate was coated with 100 jil/well of GMi-ganglioside (3.0 pg/ml;
Sigma G-7641) in bicarbonate buffer, pH 9.6, and incubated at 4 °C overnight. Pooled
serum (100 pi) from mice fed 1 g of transgenic potato tissues, or from mice fed 1 g of
untransformed potato tissues was mixed with 2.5 ng of CT and incubated at 35 °C for 1 h.
The serum-CT mixture was loaded into the GMi-ganglioside-coated or uncoated wells and
the plate was incubated at 4 °C overnight. Washing, blocking, and chemiluminescent
substrate addition steps were described in the section for chemiluminescent ELISA.
Rabbit anti-CT antibody (1:5,000 dilution; Sigma C-3602) and anti-rabbit IgG antibody
(1:50,000 dilution; Sigma A-2556) were used as primary and secondary antibodies,
respectively.
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Figure 1. (A) The CTB plant expression vector pPCV701FM4-CTB:SEKDEL. The
T-DNA sequence, flanked by right and left borders (RB and LB), contains the
/wxF/CTB: SEKDEL expression cassette containing the bi-directional mannopine
synthase {mas) PI and P2 promoters35. The luxF gene is a detectable marker for
agrobacteria and plants38,3 . The NPTII expression cassette, containing the nopaline
synthase promoter, provides kanamycin resistance in plants; and the P-lactamase (Bla)
expression cassette provides ampicillin resistance in Escherichia coli and carbenicillin
resistance in Agrobacterium tumefaciens. The CTB fusion gene contains the DNA
sequence encoding the CTB leader peptide at the 5’ end and an ER retention signal
(SEKDEL) at the 3’ end. The g7pA, g4pA, and OcspA sequences are polyadenylation
signals from A. tumefaciens Tl-DNA gene 7, gene 4, and the octopine synthase gene,
respectively. Ori pBR is the origin of replication from plasmid pBR322.
(B) Immunoblot detection of CTB protein in a transgenic potato plant.
Lane 1: Bacterial CTB pentamer; lane 2: untransformed potato tuber; lane 3: chimeric
CTB pentamer. (C) Effects of boiling tuber tissues on CTB pentamer dissociation.
Potato tuber tissue slices (approximately 300 mg) were boiled for increasing time
intervals in a plant extraction buffer (v:w = 1:1.5) and the amount of CTB (Gmiganglioside binding form) was determined by Gmi-ELISA. The amount of CTB in the
tuber homogenate prior to boiling (time 0) was considered to be 100%. The increase in
CTB amount detected after 0.5 min boiling may indicate enhanced extraction of plant
soluble protein due to tissue softening. Transgenic potato tissues became soft after 3 min
boiling, which corresponded to CTB levels of 50%. Data are indicated as the average of
four separate measurements.
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Figure 2. (A) Anti-CTB antibody endpoint titer determination. An example of an
endpoint (E) titer measurement using a fecal IgA on day 38. The same general method
was used for both fecal and serum E titer determination for all isotypes of antibody in
serum and fecal samples. Baseline RLU: background signal from the enzyme-substrate
reaction alone. R2: regression coefficient. The thin line is an extrapolation of the sample
value to the baseline for determination of the E titer. (B) Serum anti-CTB antibody
titers. The E titers of three isotypes (IgG, IgA, IgM) of serum anti-CTB antibody are
expressed for days 35 and 70. Bacterial CTB: is the serum sample obtained from mice
orally immunized with 30 pg of bacterial CTB. Potato (Ig) and (3g): are serum samples
obtained from mice orally immunized with 1 g and 3 g of transgenic potato tissues,
respectively. Negative control: serum sample derived from mice orally immunized with
1 g of untransformed potato tissues. Error bars were determined based on the
fluctuations of RLU baseline values which affect the E titer. (C) Mucosal anti-CTB
antibody titers. The E titers of mucosal (fecal) anti-CTB isotypes (IgA, IgG) were
expressed for each day of fecal sample collection. Legends in the box and error bar
determination are the same as in serum antibody titers except the samples are fecal
pellets.
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Figure 3. Cholera toxin neutralization assay in cell culture. Serum samples from
orally immunized mice prepared on day 70 neutralize cholera toxin as demonstrated by
reduction in cytotoxic effects. (A) Normal Vero cell morphology. (B) Cholera toxin
effect on Vero cells. Affected cells appeared refractile, with thick-membranes, and
possessed filamentous tendrils. Untreated normal cells and cells protected from CT
toxicity by addition of antitoxin antibody prior to cholera toxin challenge were
morphologically indistinguishable. Scale bar represents 50 pm. Microscope
magnification is x320.
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Figure 4. Ileal loop ligation assay. Oral immunization with bacterial or plant CTB
protected the small intestine against CT-induced diarrhea. Ileal loops were excised from
unimmunized (A) and an orally immunized (B) mice. The middle and right loops were
challenged with CT (125 ng/loop). The left loop was injected with physiological saline
as a negative control for internal comparison. Oral immunization with bacterial or plant
CTB provides protection against cholera CT-induced diarrhea (C). The intestinal fluid
accumulation per unit length of ligated ileal loops from unimmunized and immunized
mice was determined. The bars represent mean values of intestinal fluid volume
(pl)/intestinal loop length (cm) ± standard error. The reduction in fluid secretion into the
ileal loop in the immunized mice in comparison with unimmunized mice (*) is expressed
as % protection above each bar. A significant difference in reduction of fluid
accumulation in mice orally immunized with plant or bacterial CTB was observed in
comparison with mice fed untransformed potato tissues (P < 0.05).
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Figure 5. Gmi-ELISA assay of CT binding to Givii-ganglioside. The Gmi-ELISA was
used to elucidate the protective mechanism of anti-CTB antibody. Approximately 35%
less RLU signal was detected from GMi-ganglioside-coated microtiter wells [GM1(+)]
when CT was incubated with immune serum prior to assay than when CT was incubated
with non-immune serum. In the absence of GMi-ganglioside [GM1(-)], CT incubated
with either immune or non-immune serum resulted in similar RLU levels. The RLU
levels in GMi-ganglioside coated and in uncoated wells can not be compared directly as
affinities of CT to GMi-ganglioside and the microtiter-plate plastic surface differ. Data
represent mean values of RLU of four individual samples.
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Serum samples
Mice gavaged
bacterial CTB (30 pg)

Titer
32

Mice fed transformed
potato tissue (1 g)

2

Mice fed transformed
potato tissue (3 g)

8

Table 1. Neutralization of CT activity by immune serum. Cholera toxin
neutralization titers are expressed as the highest dilutions of 100 pi of pooled immune
serum which conferred complete protection against cholera toxin (25 ng/ml final)
cytotoxic effects in Vero cells.
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ABSTRACT
Oral administration of disease-specific autoantigens can prevent or delay the onset
of autoimmune diseases. We have generated transgenic potato plants synthesizing human
insulin, a major insulin-dependent diabetes mellitus (IDDM) autoantigen, at levels up to
0.05% of total soluble protein. Insulin was linked to the C-terminus of the cholera toxin
B subunit (CTB) to direct delivery of plant-synthesized insulin to the gut-associated
lymphoid tissues (GALT). Transgenic potato tubers produced 0.1% of total soluble
protein as the pentameric CTB-INS fusion protein which retained GMi-ganglioside
binding affinity and displayed native antigenicity of both CTB and insulin.
Nonobese diabetic (NOD) mice fed transformed potato tuber tissues containing
microgram levels of the CTB-INS fusion protein showed a substantial reduction in
pancreatic islet inflammation (insulitis), and a delay in the progression of clinical
diabetes. The feeding of transgenic potato tissues producing insulin or CTB protein alone
provided no significant reduction in insulitis or diabetic symptoms. The experimental
results indicate that food plants are feasible production and convenient delivery systems
for CTB-autoantigen conjugates for immunotolerization against a T cell-mediated
autoimmune disease.
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Introduction
Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease in which
immunological events lead to the destruction of the insulin-producing pancreatic
P cells1,2. Both humoral and cellular mechanisms of immunity are involved in disease
pathogenesis, although destruction of pancreatic (3 cells appears to be mediated
predominantly by the activity of CD4+ and CD8+ T-cells. While there are several
autoantigens recognized by the T-cell repertoire, insulin appears to have a critical role in
the diabetogenic response and it has been demonstrated that a major subset of T-cells
infiltrating the islet respond to insulin in the nonobese diabetic (NOD) mouse1.
Oral administration of pancreatic tissue-specific autoantigens may provide a
convenient and safe clinical approach for prevention of spontaneous autoimmune
diabetes3-7. However, the therapeutic potential of this approach is limited by the
requirement for repeated administration of large amounts of autoantigen, and tolerization
'j

is usually less efficient in previously sensitized hosts . The nontoxic B subunit of cholera
toxin (CTB) was employed to overcome such limitations by serving as a carrier molecule
for chemically conjugated autoantigens for the induction of oral tolerance . Therapeutic
application of the CTB carrier has been demonstrated for prevention and treatment of
autoimmune diseases in animals9,10. Conjugation with CTB may greatly facilitate antigen
delivery and presentation to the gut-associated lymphoid tissues (GALT) due to its
affinity for the cell surface receptor GMi-ganglioside located on cells of the GALT
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including the membranous (M) cells as well as enterocytes for increased uptake and
immunological recognition8,11.
Recent advances in the production of recombinant proteins in plants has permitted
the exploitation of genetically modified edible plants for the production and delivery of
vaccine antigens 12-14 . Here we report that transgenic potato plants synthesizing human
insulin and its CTB conjugate suppress insulitis and clinical symptoms of diabetes in
NOD mice.

Results
Construction of transgenic potato plants. Potato plants (Solarium tuberosum var.
Bintje) transformed with the plant expression vector pPCV7011uxF containing either the
human insulin cDNA (INS) or with the CTB-INS fusion gene were generated by an
Agrobacterium tumefaciens-mcdiated transformation method (Fig. 1). Regenerated
kanamycin-resistant putative transformants displayed the luxF marker gene activity
detected by low light image analysis method (data not shown). Transformed plants were
analyzed for the presence of the human insulin gene, its mRNA and protein product.
Presence of the human insulin gene was confirmed in transformed plant genomic DNA
(Fig. 2a). A full-length preproinsulin mRNA was detected in total RNA preparations by
RT-PCR amplification using the insulin gene-specific DNA primers (Fig. 2b). Direct
PCR amplification of total RNA preparations without the reverse transcription step
indicated no amplification of this fragment, confirming that amplification product was
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not due to DNA contamination of the RNA preparation. Untransformed potato plants did
not show the presence of the insulin gene or its mRNA. The amount of insulin protein
synthesized in transformed tuber tissue was measured by chemiluminescent ELISA
methods, and was found to be approximately 0.05% of the total soluble tuber protein
(data not shown).
Immunoblot analysis of transgenic potato plants transformed with the CTB-INS
fusion gene revealed an oligomeric CTB-INS fusion protein with higher molecular
weight than either bacterial CTB or plant-synthesized CTB pentamer15 (Fig. 3a). The
oligomeric fusion protein which dissociated into their monomers by boiling transgenic
plant homogenates for 5 min showed an apparent molecular weight of 30 kDa (Fig. 3b).
The oligomeric CTB-INS fusion protein retained specific affinity for GMi-ganglioside
and both CTB and insulin native antigenicity. The amount of total CTB-INS fusion
protein construct was estimated to be approximately 0.1% of the total soluble protein
based on the relative light units (RLU) generated from known amounts of bacterial
pentameric CTB used as a standard (Fig. 3 c). A concentration-dependent increase in the
RLU signal was observed only when GMi-ganglioside was used as the capture molecule,
indicating that the fusion protein exists as a pentamer because only pentameric CTB can
bind the GMi-ganglioside. Similar to bacterial CTB and plant-synthesized CTB, the
pentameric form of the CTB-INS protein dissociated to the monomers by heat treatment,
and completely lost its affinity for GMi-ganglioside (Fig. 3d). The CTB-INS fusion
protein derived from potato leaf tissues exhibited identical biochemical and antigenic
properties to the tuber-derived fusion protein.
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Humoral immune response in mice fed CTB-INS potato tissues. We have previously
demonstrated that feeding plant tissues synthesizing CTB induced both mucosal and
serum antibody responses14. Feeding CTB-INS potato tuber tissues to NOD mice
induced both serum and intestinal anti-CTB antibodies (Fig. 4a). In addition, serum anti
insulin IgG levels were substantially elevated in animals fed CTB-INS potato tissues in
comparison to animals fed potato tissues synthesizing insulin or untransformed potato
tissues (Fig. 4b). Since Th2 lymphocyte-mediated oral tolerance results in predominantly
an IgGl rather than IgG2a isotype induction, we measured the serum anti-insulin IgGl
and IgG2a antibodies as described by Ma et al. (1998). The results of these experiments
showed a significant increase in serum IgGl anti-insulin antibody titers in NOD mice fed
transgenic potatoes producing the CTB-INS fusion protein in comparison with antibody
titers detected in the serum of mice fed either untransformed potatoes or transgenic
potatoes producing insulin alone (Fig. 4b). All three groups of mice showed similar
levels of serum anti-insulin IgG2a.

Suppression of insulitis. To determine the effects of feeding transgenic potato tissues
producing insulin and CTB-INS on the reduction of insulitis, female NOD mice were fed
autoantigen containing potato tuber tissues once per week for five weeks starting at
5 weeks of age. The mice were sacrificed at 10 weeks of age for histopathological
analysis of pancreatic tissues. At the moment of sacrifice, all the mice including the
animals fed untransformed potato tissues had not yet developed any diabetic symptoms as
determined by urine and blood glucose analysis. A normal pancreatic islet showed no
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signs of lymphocyte infiltration (insulitis score = 0) (Fig. 5a). Representative pancreatic
islets from an animal fed CTB-INS potatoes (insulitis score = 2) and from an animal fed
untransformed potato tissues (insulitis score = 4) are shown in Figures 5b and c. A
heavily infiltrated islet from mice fed untransformed potato tissues (insulitis score = 5) is
shown in Figure 5d. The Student’s t test revealed a significant reduction in insulitis in
mice fed CTB-INS potato tissues in comparison with those fed untransformed potato
tissues (1.9 ± 0.5 s.e.m. vs. 3.9 ± 0.4 s.e.m., P = 0.001) (Fig. 5e). Although there was a
detectable reduction in insulitis severity in NOD mice fed transformed potato tissues
containing 30 pg of insulin (3.8 ± 0.4 s.e.m.) in comparison with animals fed
untransformed potato tissues, the difference was statistically insignificant.

Suppression of diabetes. The CTB-INS producing plants which provided effective
suppression in insulitis were further analyzed by testing their effects on the suppression
of diabetic symptoms using Kaplan-Meier procedure (Fig. 6). For the time interval
between 16 and 24 weeks of age, the incidence of diabetes was substantially lower in the
CTB-INS-fed group than in the control group fed transgenic potato tubers producing only
CTB (P <0.01, logrank test).

Discussion
Oral immunotolerization against autoimmune diseases require repeated
administration of substantial amounts (milligram levels) of autoantigen proteins3,5,16.
Although, stable transformation of food plants may provide an opportunity for cost-
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effective, safe and convenient methods for production and delivery of recombinant
proteins, the use of edible plants for this purpose has been limited primarily due to low
antigen protein production levels in plants.
Cholera toxin B subunit has been shown to function as an effective mucosal
carrier for conjugated proteins for enhanced immunological tolerance . The pentameric
structure of the CTB fusion protein complex not only facilitates site-specific delivery and
presentation of conjugated proteins to the gut-associated lymphoid tissues (GALT), it
also increases the molar concentration of the antigen per molecule of CTB pentamer.
This increase in antigen concentration at the GALT may reduce the traditional
requirement for high levels of antigen biosynthesis in food plants.
The proinsulin (preproinsulin without the leader peptide), was conjugated with
CTB via the flexible hinge peptide which may reduce steric hindrance between the CTB
17

and insulin moieties facilitating CTB subunit assembly in plant cells . The application
of less frequently used codons in plants within the hinge peptide may promote
translational arrest during the protein elongation process, facilitating CTB subunit folding
prior to translation of the insulin message18. The CTB leader peptide and the microsomal
retention signal permit sequestration of recombinant proteins in the plant endoplasmic
reticulum, increasing protein concentration for more effective subunit interactions i.e.,
CTB fusion protein pentamerization 12,15,19,20 . The fusion protein retaining Gmiganglioside binding affinity indicates that it exists predominantly as a pentamer since
only the pentameric CTB configuration can bind to the receptor. The presence of the
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pentameric CTB-INS chimera as the predominant protein species in plant tissues suggests
efficient pentamerization within plant cells.
Induction of both systemic and intestinal anti-CTB antibodies in NOD mice fed
transformed potato tubers synthesizing the CTB-INS fusion protein suggests that the
fusion protein was effectively delivered to the intestinal immune system. This finding
was further reinforced by the detection of increased serum anti-insulin IgG antibody titer
in mice fed transformed potato tissues. The humoral response mounted against both CTB
and insulin proteins may be a collateral effect occurring in response to stimulation of
Th2 cells by the oral tolerance. Since there is a decreasing gradient of sensitivity to the
induction of oral tolerance with Thl cells being the most susceptible to tolerization
followed sequentially by Th2 cells and B cells, it is possible that induction of systemic
T cell tolerance may occur simultaneously with systemic and mucosal B cell priming21-24
A reduction in insulitis and subsequent prevention of diabetic symptoms can be
mediated by oral tolerance mechanisms such as bystander suppression, peripheral
deletion, and induction of clonal anergy6,25. Induction of predominantly serum
anti-insulin IgGl rather than IgG2a antibody in mice fed transgenic potato tissues
synthesizing the CTB-INS fusion protein suggests that the immune response was biased
towards an insulin-specific Th2 lymphocyte response. Feeding autoantigens which
stimulate the GALT is known to preferentially generate a Th2-lymphocyte response
including secretion of lymphokines such as interleukin (IL)-4, IL-10, and transforming
growth factor (TGF)-p 6,7,16 . In addition, recombinant CTB subunits without the CTA
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subunit was recently shown to induce mucosal antibody production mediated by TGF-p,
a major inducer of oral tolerance6,26. Therefore, it is possible that plant-synthesized CTBINS fusion protein delivered to the GALT preferentially generates insulin-specific
Th2 lymphocytes for induction of systemic tolerance i.e., reduction in pancreatic
lymphocyte infiltration and subsequent diabetic symptoms, as well as concurrent
induction of both mucosal and systemic humoral responses against CTB and insulin. The
lack of serum IgGl antibody increase and the reduction in insulitis levels in NOD mice
fed transgenic potato tissues synthesizing insulin only supports the hypothesis that CTB
protein significantly increases the tolerogenicity of fused autoantigens for induction of
oral tolerance.
This study demonstrates that feeding microgram amounts of food plant-produced
insulin conjugated with CTB subunit can effectively suppress the development of
autoimmune diabetes in NOD mice. The plant-synthesized CTB-INS fusion protein is
effective at doses at least 100 fold less than generally reported for unconjugated
autoantigens. Feeding transgenic potato tissues synthesizing 30 jug of insulin on a
weekly basis did not provide oral tolerance (Fig. 5). This finding reinforces the
importance of oral antigen dose and the effect of CTB on oral tolerance induction10.
Genetic conjugation of autoantigens with CTB may be a useful method for food plantbased oral tolerization therapy, as antigen protein production levels in stably transformed
plants are often limited.
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The experimental results described in this study indicate that transgenic food
plants are feasible production and mucosal delivery systems for disease-specific CTBautoantigen fusion proteins for suppression of autoimmune diseases. Transgenic food
plants may provide a cost-effective and convenient production systems especially useful
in economically emerging nations, as cultivation of antigen-producing food plants
requires only sunlight energy, water, and conventional or indigenous agricultural
technology. This novel CTB-autoantigen conjugate induced oral tolerization method
may provide food plant-based prevention of various T cell-mediated autoimmune
diseases.

Materials and Methods
Plant expression vector. The genes encoding human insulin and its CTB conjugate
97

were inserted into the plant expression vector pPCVTOlluxF . Human preproinsulin
cDNA was inserted within the multiple cloning site immediately downstream of the
mannopine synthase {mas) P2 promoter28.
Prior to construction of the CTB-INS fusion gene, the olionucleotide sequence
encoding a flexible hinge tetrapeptide (GPGP) was fused at the 3’ end of the CTB gene17.
The CTB-hinge fusion was inserted downstream of the mas P2 promoter. Less frequently
used codons for potato plants were used in the hinge encoding sequence to permit the
translation apparatus to reduce the rate of protein elongation which may facilitate CTB
1R

subunit folding . The oligonucleotide sequence flanking the CTB translation start codon
9Q

was modified for efficient translation in eukaryotic cells . The 21-amino acid leader
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peptide of the CTB subunit which presumably functions to translocate the fusion proteins
into the plant endoplasmic reticulum was conserved19. The human proinsulin gene was
PCR amplified with DNA primers containing the microsomal retention signal (SEKDEL)
encoding sequence 12,20,30 . Amplified proinsulin:SEKDEL encoding sequence was
inserted into the Sad site at the 3’ end of CTB-hinge sequence. Following confirmation
of the DNA sequences, the plant expression vector was transferred into
Agrobacterium tumefaciens strain GV3101 pMP90RK, and potato leaf explant
transformation was performed as previously described15.

Plant genomic DNA and total RNA isolation for PCR and RT-PCR analysis.
Genomic DNA was isolated from both untransformed and transformed potato leaf tissues
as described by Doyle and Doyle31. The presence of the insulin gene was determined by
PCR analysis using oligonucleotide primers specific for both the pPCV7011uxF vector
and the insulin gene. Transformed plant genomic DNA (500 ng) was used as a template
for detection of the insulin gene under the following PCR conditions: 94 °C for 45 s,
55 °C for 60 s, and 72 °C for 60 s for a total of 30 cycles. Plant total RNA was isolated
using a plant RNA isolation kit (Boehringer Mannheim). RT-PCR analysis was
performed to detect the presence of full length insulin mRNA using an insulin genespecific oligonucleotide primer set.

139
Immunoblot analysis. Approximately 1 g of tuber tissue was homogenized on ice in
1 ml of extraction buffer (200 mM Tris-HCl, pH 8.0, 100 mM NaCl, 400 mM sucrose,
10 mM EDTA, 14 mM 2-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride, 0.05%
Tween-20). The tissue homogenates were centrifuged at 17,000 x g for 15 minutes at
4 °C to remove insoluble debris. A 10-20 pi aliquot of supernatant, containing 50 to
100 pg of total soluble protein, as determined by protein assay (Bio-Rad, Inc.), was
analyzed by 10-15% SDS-PAGE. Samples of the plant homogenate were either boiled
for 5 minutes prior to electrophoresis or loaded directly on the gel without heat treatment.
Plant homogenates were evaluated for the presence of monomeric or pentameric CTBINS protein using a rabbit anti-cholera toxin antiserum and an alkaline phosphataseconjugated anti-rabbit IgG (1:5,000 and 1:10,000 dilutions respectively, Sigma).

Chemiluminescent ELISA. Production levels of recombinant insulin and its CTB
conjugate in transgenic potato tissues were determined by chemiluminescent ELISA. For
quantitation of human insulin in the potato homogenate, a 96-well microtiter plate
(Dynatech Laboratories) was loaded with serial dilutions of induced leaf or microtuber
tissue homogenate in bicarbonate buffer, pH 9.6 and incubated overnight at 4 °C. The
wells were blocked by 1% bovine serum albumin (BSA) in PBS. The plate was
incubated in a 1:7,000 dilution of anti-pig insulin antibody (Sigma) in 0.5% BSA in PBS
overnight at 4 °C, followed by incubation with alkaline phosphatase-conjugated
secondary antibodies (Sigma) for 2 hours at 37 °C. The wells were washed twice with

140
PBST (PBS containing 0.05% Tween-20) and once with PBS after each step.
Chemiluminescent substrate Lumi-Phos® Plus (Lumigen, Inc., MI) was added to wells
and the plate was incubated for 30 minutes at 37 °C. Chemiluminescence was measured
in a Microlite™ ML3000 Microtiter® Plate Luminometer (Dynatech Laboratories).
For quantitation of CTB-INS fusion protein, the microtiter plate was coated with
3.0 pg/ml of GMi-monosaialoganglioside (Sigma) in bicarbonate buffer (pH 9.6) and
incubated overnight at 4 °C. The wells were loaded with various dilutions of plant tissue
homogenates diluted in PBS (pH 7.2), and incubated overnight at 4 °C. For detection of
the CTB moiety of the fusion protein, a rabbit anti-cholera toxin primary antibody and an
alkaline phosphatase-conjugated anti-rabbit IgG secondary antibody (1:5,000 and
1:50,000 dilution respectively, Sigma) were added15. For detection of the insulin moiety
of the CTB-INS fusion protein, the same set of primary and secondary antibodies
previously used for insulin detection was used.

Induction of oral tolerance. Four-week old female NOD mice were purchased from
Jackson Laboratory (Bar Harbor, Maine) and maintained in the Loma Linda University
animal facility. The mice were divided into the following groups: group 1, fed
untransformed potato; group 2, fed transgenic potato synthesizing insulin; group 3, fed
transgenic potato synthesizing CTB-INS fusion protein. At 5 weeks of age, each mouse
was fed 3 g of potato tubers once per week until they reached 9 weeks of age (a total of
five feedings). Each feeding of transgenic potato tuber tissues was found to deliver
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approximately 30 p.g of insulin or 20 pg of insulin as the CTB-INS conjugate. The
animals were either sacrificed at 10 weeks of age for antibody titer assay and
histopathological analysis of pancreatic tissues, or monitored for 6 months for diabetes
development.

Antibody titer. The serum and intestinal washings (5 animals in each group) were
assayed for anti-CTB and ant-insulin antibody isotypes using a chemiluminescent ELISA
method. Human insulin or CTB (Sigma) were used for the well coating antigens
(500 ng/well), and serial dilutions of pooled serum or intestinal washings were added to
the coated microtiter plate wells. Alkaline phosphatase-conjugated anti-mouse IgGl,
IgG2a or IgA antibodies (Zymed, Inc.) were used as the secondary antibodies. The
microtiter plate wells were washed twice with PBST and once with PBS after each step.
Chemiluminescence relative light units (RLU) was measured in the Microlite™ MLB000
Microtiter® Plate Luminometer. The titer was defined as the reciprocal of the highest
dilution of the sample to give a RLU signal above background RLU levels which were
individually determined for each sample.

Histopathological analysis of pancreatic islets. Insulitis levels were arbitrarily
measured based on the extent of lymphocyte infiltration of the islets of Langerhans. Each
group consisted of 5 mice. At 10 weeks of age the mice were sacrificed and the pancreas
removed. Pancreatic tissues were fixed in Bouin’s fixative and stained with hematoxylin

142
and counterstained with eosin. The degree of insulitis was scored based on a 7-level
semiquantitative scale ranging from 0 to 6, where score 0 is normal islet morphology
with no sign of T-cell infiltration and scores 1-3 and 4-6 indicate increasing levels of
peri-insulitis and intra-insulitis, respectively3. At least 10 islets were scored for each
animal. The Student’s t test was used for statistical analysis of the data.

Assessment of diabetic symptoms. The incidence of diabetic symptoms was compared
among mice fed transgenic potatoes synthesizing CTB and potatoes synthesizing CTBINS fusion protein. The feeding schedule was the same as described above. Each group
consisted of 10 mice. Starting at 10 weeks of age the mice were monitored on a weekly
basis with urinary glucose test strips (Clinistix® and Diastix®, Bayer) for development of
diabetes. Glycosuric mice were bled from the tail vein to check for glycemia using a
glucose analyzer (Boehringer Mannheim). Diabetes was confirmed by hyperglycemia
(> 250 mg/dl) for two consecutive weeks3,16. The Cox-Mantel logrank test was
performed for comparison between the life table (Kaplan-Meier analysis) of two groups.
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Figure 1. Plant expression vector pPCVTOlluxF. The T-DNA sequence flanked by
the right and left borders (RB and LB) for insertion into the plant genome contains the
bacterial luciferase (/wxF)/IDDM autoantigen gene expression cassette transcriptionally
regulated by the bi-directional mannopine synthase (mas) PI and P2 promoter
respectively. The luxF is a detectable marker gene for transformed agrobacteria and
plants32. The P-lactamase (Bla) expression cassette is included to confer for ampicillin
resistance in Escherichia coli and carbenicillin resistance in Agrobacterium tumefaciens.
The NPT II expression cassette linked to the nopaline synthase promoter (pNOS)
generates kanamycin resistance in plants. The g7pA, g4pA and OcspA polyadenylation
signals are from the A. tumefaciens Tl-DNA, gene 7 and gene 4, the octopine synthase
gene, respectively. Ori pBR is the origin of replication from plasmid pBR322. (1) The
human preproinsulin cDNA (leader, B, C, and A chains), or (2) the CTB-INS (proinsulin)
fusion gene was inserted between the Xbal and Sacl cloning sites downstream from the
mas P2 promoter. The CTB-INS fusion gene is flanked at the 5’ end by the bacterial
CTB leader sequence. A DNA sequence encoding a flexible hinge tetrapeptide GPGP
with less frequently used codons in plants, was inserted between the CTB and the
proinsulin gene. An 18-bp DNA sequence encoding the hexapeptide SEKDEL
microsomal retention signal was fused to the 3’ end of the proinsulin gene.
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350 bp

Figure 2. Human insulin biosynthesis in potato tuber tissue, (a) PCR detection of
insulin cDNA in potato genomic DNA: lane 1, 1 kb molecular weight marker; lane 2,
amplified preproinsulin cDNA from plant expression vector pPCV7011uxF-INS; lane 3,
amplification reaction without the plant expression vector; lane 4, genomic DNA from
untransformed potato leaf tissues; lane 5, genomic DNA potato leaf tissues transformed
with preproinsulin cDNA. (b) RT-PCR detection of insulin mRNA: lane 1, 1 kb
molecular weight marker; lanes 2 and 3, total RNA preparations from untransformed
potato leaf tissues; lanes 4 and 5, total RNA preparations from preproinsulin gene
transformed potato leaf tissues. Lanes 2 and 4, the PCR reaction only, without the
reverse transcription step.
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Figure 3. Synthesis of CTB-INS fusion protein in potato tuber and leaf tissues, (a)
Immunoblot detection of the pentameric CTB-INS fusion protein in transformed potato
leaf and tuber tissues: lane 1, bacterial CTB pentamer (45 kDa); lane 2, total soluble leaf
protein from a potato plant transformed with vector without CTB-INS fusion gene; lane
3, CTB-INS pentamer from leaf tissues; lane 4, total soluble tuber protein from a vectoronly transformed potato plant; lane 5, CTB-INS pentamer from tuber tissues. In lanes 2
through 5, 100 pg of total soluble potato protein was loaded per lane, (b) Immunoblot
detection of the monomeric CTB-INS fusion protein from leaf and tuber tissues: lane 1,
bacterial CTB monomer (11.6 kDa); lane 2, total soluble tuber protein from a potato plant
transformed with vector without CTB-INS gene; lanes 3 and 4, CTB-INS monomers
from transgenic potato leaf and tuber tissues, respectively (arrow). In lanes 2 through 4,
100 pg of total soluble protein was loaded per lane, (c) Quantitative analysis of the
pentameric CTB-INS fusion protein exhibiting specific binding affinity for Gmiganglioside by chemiluminescent Gmi-ELISA. The fusion protein made up
approximately 0.1% of total soluble tuber protein, (d) Heat-induced pentamer
dissociation into monomers, resulting in loss of GMi-ganglioside affinity. Approximately
identical amounts of three different CTB constructs (bacterial CTB, plant CTB, and plant
CTB-INS) were used to provide similar RLU signal levels for unheated samples for a
better comparison between samples.
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Figure 4. Anti-CTB and anti-insulin antibody titers in mice fed transgenic potato
tissues. Prediabetic 5-week-old NOD mice were fed transgenic potato tissues containing
insulin, CTB-INS, or untransformed tuber tissues once per week until 10 weeks of age.
The mice were sacrificed and serum and intestinal washings were examined for (a) CTBspecific serum and intestinal antibodies, and (b) serum anti-insulin IgGl and IgG2a
antibodies by chemiluminescent ELISA method. Serum and intestinal washings were
pooled from five individual animals within the same group. The titer was defined as the
reciprocal of the highest dilution of the sample to give a RLU signal above the
background RLU levels. Data are expressed as an average of six measurements.
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Figure 5. Reduction of insulitis in NOD mice. Five-week-old female NOD mice were
fed 3 g of untransformed or transformed potato tuber tissues. The animals were
sacrificed at 10 weeks of age for histopathological examination of pancreatic islet tissues.
Approximately 10 islets from each animal were scored, (a) Representative normal
pancreatic islet from an animal fed CTB-INS potato tissues (histopathologic score 0). (b)
An islet representing an average score of insulitis from an animal fed CTB-INS potato
tissues (histopathologic score 2). (c) An islet representing an average score of insulitis
from an animal fed untransformed potato tissues (histopathologic score 4). (d)
Representative heavily infiltrated islet from an animal fed untransformed potato tissues
(histopathologic score 5). Open arrows indicate areas of lymphocyte infiltration, (e)
Insulitis score with semiquantitative scales. Data are expressed as the mean score of each
group ± s.e.m. {P = 0.001 for a group fed CTB-INS potato tubers in comparison with a
group fed untransformed potato tubers). No statistically significant difference was
observed between groups fed transgenic potato tubers synthesizing insulin only and
untransformed potato tuber tissues. Scores were compared by Student’s t test for
unpaired samples.
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Figure 6. Suppression of diabetes in NOD mice by feeding CTB-INS potato tuber
tissues. Five-week old female NOD mice (10 animals per group) were fed with either
transgenic potato tuber tissue producing CTB or CTB-INS once per week for a total of
five weeks until animals reached 10 weeks of age. Animals were monitored weekly for
diabetes (> 250 mg/dl blood glucose) beginning at 10 weeks of age. The results were
expressed based on Kaplan-Meier analysis of the control group fed transgenic potatoes
producing CTB, and a group fed transgenic potatoes synthesizing CTB-INS (P <0.01,
Cox-Mantel logrank statistics).
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ABSTRACT
We have generated transgenic potato plants synthesizing glutamate decarboxylase
(GAD65), a major autoantigen of insulin-dependent diabetes mellitus (IDDM). The
GAD protein was synthesized up to 0.01% of total soluble potato tuber protein. To target
the gut-associated lymphoid tissues (GALT), the GAD peptide was linked to the
C-terminus of the cholera toxin B subunit (CTB) to produce a chimeric fusion protein.
To facilitate sequestration and pentamerization of the fusion peptide within the plant
endoplasmic reticulum, a microsomal retention signal (SEKDEL) was linked to the CTB
C-terminus and a flexible hinge peptide (GPGP) was inserted between the CTB and the
GAD moieties of the fusion peptide. The fusion protein displayed the predicted
molecular weight, pentameric structural conformation possessing GMi-ganglioside
binding affinity, and native antigenicities of both CTB and GAD65.
Oral administration of transgenic potato tissues containing the CTB-GAD fusion
peptide induced intestinal IgA and serum IgG anti-CTB antibodies in nonobese diabetic
(NOD) mice. A substantial reduction in pancreatic islet lymphocyte infiltration (insulitis)
and clinical diabetes was detected in mice fed CTB-GAD containing potato tissues. In
contrast, mice fed transgenic potato tubers synthesizing GAD or CTB protein alone did
not show a significant reduction in insulitis or diabetic symptoms. The experimental
results suggest that food plants are effective production and delivery systems of
CTB-autoantigen fusion peptides for oral tolerization against development of
autoimmune diseases.
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INTRODUCTION
Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease
characterized by lymphocyte infiltration of the pancreatic islets (insulitis) leading to
destruction of the insulin-secreting p cells (1,2). Several P-cell autoantigens are
recognized by the T-cell repertoire, including insulin and glutamic acid decarboxylase
(GAD) (3, 4).
Oral administration of p cell-specific autoantigens may provide a safe and
convenient clinical approach for the prevention of IDDM (2, 5-10). However, the
therapeutic potential of this approach may be seriously limited by the requirement for
repeated administration of large amounts of tolerogens, and tolerization is usually less
efficient in a systematically sensitized host than in a naive host. The nontoxic cholera
toxin B subunit (CTB) has been used to increase the tolerogenic nature of orally
administered antigens based on its affinity for GMi-ganglioside, a cell surface receptor
located on the M cells in gut-associated lymphoid tissues (GALT) and enterocytes in the
intestinal villi (8, 11). The application of CTB has been demonstrated for prevention of
autoimmune diseases in animals (12, 13).
Recently plants have been used for the production of vaccine antigens such as
viral capsid proteins and bacterial enterotoxins (14-17). Production of autoantigens in
food plants for the induction of oral tolerance is particularly attractive, as plants can
synthesize proteins at low cost and protein intake can be achieved through direct
consumption of the edible plant tissues. Here we report that feeding transgenic potato
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tuber tissues synthesizing a CTB-human GAD65 fusion protein to nonobese diabetic
(NOD) mice reduces the severity of insulitis and significantly delays the onset of clinical
IDDM symptoms.

Materials and Methods
Generation of transgenic potato plants producing human GAD65. The 1.8-kb human
GAD cDNA was cloned into the plant expression vector pPCV7011uxF. Prior to
construction of the CTB-GAD fusion gene, the CTB gene was linked to a oligonucleotide
sequence encoding a putative flexible hinge oligopeptide (GPGP) (18), and was inserted
into the vector pPCV7011uxF. Less frequently used codons in plants were selected to
allow the translation apparatus to arrest peptide elongation to facilitate CTB subunit
folding (19). The oligonucleotide sequence flanking the CTB translation start codon was
modified for efficient translation in eukaryotic cells (20). The 21-amino acid leader
peptide of the CTB subunit which presumably functions to translocate the fusion proteins
into the endoplasmic reticulum (ER) of potato cells was conserved (21). To facilitate
accumulation for pentamerization of the CTB-GAD fusion peptide monomers within the
plant cell, a DNA fragment encoding the hexapeptide (SEKDEL) ER retention signal was
linked to the 3’ end of the CTB-GAD fusion gene (14, 22, 23). After PCR amplification
of the GAD-SEKDEL fragment, it was cloned into a Sac\ site at the 3’ end of the CTBhinge sequence. The fusion construct was subjected to DNA sequence analysis.
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The plant expression vectors pPCV7011uxF-GAD and pPCV7011uxF-CTB-GAD
were transferred into the Agrobacterium tumefaciens recipient strain GV3101 pMP90RK,
and potato leaf was transformed as described previously (16).

Immunoblot Analysis. Transgenic potato tissues were assayed for the presence of GAD
and CTB-GAD peptides by immunoblot analysis. Potato leaf and tuber tissues were
incubated for up to 5 weeks on the high auxin MS solid medium. Plant tissues (~ 1 g
fresh weight) were homogenized by grinding in a mortar and pestle on ice in 1 ml of
extraction buffer (16). The tissue homogenate was centrifuged at 17,000 x g for
15 minutes at 4 °C to remove insoluble debris. A 10-20 pi aliquot of supernatant,
containing 100 pg of total soluble protein, as determined by protein assay (Bio-Rad,
Inc.), was analyzed by 10-15% sodium dodecylsulfate polyacrylamide gel
electrophoresis (SDS-PAGE) as described previously (16). Samples of the plant
homogenate were boiled for 5 minutes prior to electrophoresis. For detection of
mammalian and plant GAD65 proteins, a 1:5,000 dilution of mouse monoclonal IgG anti
human GAD65 antibody and a 1:10,000 dilution of alkaline phosphatase-conjugated anti
mouse IgG antibody (Sigma) were used. For detection of CTB-GAD fusion protein a
1:5,000 dilution of rabbit anti-cholera toxin antiserum (Sigma) and a 1:10,000 dilution of
alkaline phosphatase-conjugated mouse anti-rabbit IgG (Sigma) were used.
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Chemiluminescent Gmi-ELISA. The amount of CTB-GAD protein in transgenic potato
tissues was determined by chemiluminescent Gmi-ELISA. The wells of microtiter plate
(Dynatech Laboratories) were coated with 3.0 pg/ml Gmi-monosaialoganglioside
(100 pl/well) in bicarbonate buffer, pH 9.6 and incubated overnight at 4 °C. Serial
dilutions of leaf or microtuber tissue homogenate in phosphate buffered saline (PBS),
pH 7.2, were incubated overnight at 4 °C. The wells were blocked with 1% bovine serum
albumin (BSA) in PBS at 37 °C for 2 hours. For detection of the CTB moiety of the
fusion protein, a 1:5,000 dilution of rabbit anti-cholera toxin antibody (Sigma) in
antibody buffer (0.5% BSA in PBS) was added and the plate was incubated for 2 hours at
37 °C followed by incubation with a 1:50,000 dilution of anti-rabbit IgG conjugated with
alkaline phosphatase (Sigma). For each step, the wells were washed two times with
PBST (PBS containing 0.05% Tween-20) and once with PBS. The alkaline phosphatase
substrate Lumi-Phos® Plus (Lumigen, Inc., MI) was added to each well (100 pl/well) and
incubated for 30 minutes at 37 °C. The chemiluminescence was measured in a
Microlite™ ML3000 Microtiter® Plate Luminometer (Dynatech Laboratories).
For detection of the GAD moiety of the fusion peptide, fresh aliquots of plant
homogenate (100 pi each time) were repeatedly added three to four times to the
Gmi-coated wells to sequester the fusion protein on the well surface to increase assay
sensitivity. A 1:10,000 dilution of mouse monoclonal IgG anti-GAD65 antibody and a
1:10,000 dilution of anti-mouse IgG antibody were used as the primary and secondary
antibodies.
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Induction of Oral Tolerance. Four-week old female NOD mice were obtained from the
Jackson Laboratory (Bar Harbor, Maine) and maintained in the Loma Linda University
animal care facility. At 5 weeks of age, each mouse was fed 3 g of potato tubers on a
weekly basis until they reached 9 weeks of age (a total of five feedings). Potato tissues
fed to the experimental groups of mice were as follows: group 1, untransformed potato
tubers; group 2, GAD potato tubers; group 3, CTB-GAD potato tubers; group 4, a
mixture of CTB-GAD and CTB-INS potato tubers. Each group contained 5 mice. In
group 4, mice were fed a mixture of CTB-GAD and CTB-INS, 1.5 g each per week for
5 weeks. Based on the expression levels of each recombinant protein measured by
chemiluminescent ELISA and Gmi-ELISA methods, each gram of transgenic potato tuber
tissue contained approximately 1 pg of GAD65, 0.7 pg of GAD65 as CTB-GAD, and
7 pg of insulin as CTB-INS.

Histopathological Analysis of Pancreatic Islets. Insulitis levels were measured based
on the extent of lymphocyte infiltration into the pancreatic islets of Langerhans. At
10 weeks of age, the animals were sacrificed for histopathological analysis of pancreatic
tissues. Tissues were fixed with Bouin’s fixative and stained with hematoxylin and
counterstained with eosin. The degree of insulitis was scored using a 7-level
semiquantitative scale ranging from 0 to 6: 0, normal islets with no sign of T-cell
infiltration: 1, focal peri-islet T-cell infiltration but with lymphocytes occupying less than
one-third of the peri-islet area; 2, more extensive peri-islet T-cell infiltration but with
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lymphocytes occupying less than two-thirds of the peri-islet area; 3, peri-islet T-cell
infiltration with lymphocytes occupying more than two-thirds of the peri-islet area;
4, intra-islet T-cell infiltration with lymphocytes occupying less than one-third of the islet
area; 5, more extensive intra-islet T-cell infiltration but lymphocytes occupying less than
two-thirds of the islet area; 6, massive T-cell infiltration involving more than two-third of
the islet area. Scores 1-3 and 4-6 indicate increasing levels of peri-insulitis and
intra-insulitis, respectively.

Assessment of Diabetic Symptoms. The incidence of diabetes was compared among
mice fed potato tissues producing CTB and mice fed potatoes synthesizing CTB-GAD.
The feeding schedule was the same as described above. The mice were monitored
weekly with Diastix® and Clinistix® urinary glucose test strips (Bayer) starting at
10 weeks of age, for development of diabetes. Glycosuric mice were bled from the tail
vein and the blood assayed for glycemia using a glucose analyzer (Boehringer
Mannheim). Clinical diabetes was confirmed by detection of hyperglycemia (> 13.8 mM
blood glucose) for two consecutive weeks (5).

Results
Construction of transgenic potato plants. A physical map of the plant transformation
vectors containing GAD65 cDNA and the CTB-GAD conjugate genes is presented in
Figure 1. Kanamycin-resistant putative potato transformants were analyzed for
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bioluminescence from the luxF marker gene product using a Argus-100 single photon
imaging camera (24, 25) (data not shown).

Transgenic potato plants producing autoantigens. The presence of the autoantigen
transgenes within potato chromosomal DNA was confirmed by PCR analysis (data now
shown). Potato plants produced GAD protein with an approximate molecular weight of
60 kDa (Fig. 2a). The CTB-GAD fusion peptide was detected in transformed plant
tissues by anti-cholera toxin antibodies and its molecular weight (75 kDa), corresponded
to the sum of the plant-produced monomeric CTB (15 kDa) and GAD (60 kDa) (Fig. 2b).

Quantitation and characterization of the CTB-GAD fusion peptide. The CTB-GAD
fusion peptide exhibited a specific binding affinity for GMi-ganglioside, and a
concentration-dependent increase in relative light units (RLU) signal was observed only
when GMi-ganglioside was used as the capture molecule (Fig. 2c). The Gmi binding form
of pentameric CTB-GAD peptide was detected in transformed potato tuber tissues at
0.001% of total soluble protein based on the RLU generated from known amounts of the
pentameric bacterial CTB standard (Fig. 2c). The fusion peptide retained both CTB and
GAD65 antigenicity as the peptide was recognized by both anti-CTB and anti-GAD65
antibodies. Untransformed potato tissues did not show a concentration-dependent
increase in RLU signal in the presence or absence of the Gmi receptor (Fig. 2c). Similar
to bacterial and plant-synthesized CTB, the monomeric CTB-GAD chimeric protein
disassociated from the pentameric form by heat treatment and lost the affinity for
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GMi-ganglioside (Fig. 2d). The fusion protein extracted from leaf tissues exhibited
identical biochemical and antigenic properties to the tuber-derived fusion peptide
(data not shown).

Humoral immune response in mice fed potato tissues producing CTB-GAD
peptides. In contrast to feeding untransformed potato tuber tissues and transgenic potato
tuber tissues producing human GAD alone, the feeding CTB-GAD potato tuber tissues
induced CTB-specific serum and intestinal antibodies in NOD mice (Fig. 3). In addition,
approximately two-fold higher anti-GAD65 IgG antibody levels were detected in the
serum of animals fed GAD or CTB-GAD potato plant tissues in comparison with animals
fed untransformed potato tissues (data not shown).

Suppression of insulitis. To determine whether the feeding of transgenic potato tissues
producing GAD autoantigen reduces lymphocyte infiltration in pancreatic islets, juvenile
female NOD mice were fed transgenic potato tissues producing IDDM autoantigens once
per week for five weeks beginning at 5 weeks of age. The pancreatic tissues were
histologically examined at 10 weeks of age (5). At the time of sacrifice none of the mice
including those fed untransformed potato tissues had developed diabetic symptoms as
analyzed by urine and blood glucose analyses. Representative islets from control animals
and animals fed transgenic potato tissues are shown in Figure 4a and b, respectively. A
significant reduction in insulitis severity in mice fed CTB-GAD potato tissues was
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detected in comparison with mice fed untransformed potato tissues (2.44 ±0.28 SEM vs.
3.92 ± 0.41 SEM, P = 0.003) (Fig. 4c). The GAD potato-fed mice did not show a
statistically significant reduction in insulitis score (3.67 ± 0.38 SEM). To evaluate
whether simultaneous oral administration of two major IDDM autoantigens conjugated
with the CTB carrier molecule can increase the anti-inflammatory response in pancreatic
tissues, mice were fed a mixture of CTB-GAD and CTB-INS potato tissues.
A substantial reduction in insulitis was detected in comparison with mice fed
untransformed potato tissues (1.65 ± 0.33 SEM, P < 0.0001).

Suppression of diabetic symptoms. The onset of diabetes, as determined by
hyperglycemia, was delayed in mice fed the CTB-GAD potato tissues in comparison with
animals fed transgenic potato tissues producing CTB alone (Kaplan-Meier analysis,
Fig. 5). For the period between 16 and 26 weeks of age, the incidence of diabetes was
significantly lower in the CTB-GAD-fed animal group in comparison to the CTB-fed
group (P <0.01, logrank test).

Discussion
Food plant-induced oral tolerance for the prevention of autoimmune could be
especially useful in economically emerging countries as food plants provide a less
expensive source of tolerogen supplementation in comparison with traditional
recombinant protein preparation methods. In addition, treatment can be palatable and
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convenient since transgenic food plants can be included as part of the daily diet.
Although, oral tolerance for prevention of autoimmune diseases is generally considered
to be effective and safe due to its lack of toxicity, it usually requires repeated oral
administration of substantial amounts (milligrams) of tolerogen (5, 7, 26). Therefore, use
of food plants for the production and oral delivery of recombinant proteins against
autoimmune diseases can be limited in practicality due to insufficient amounts of the
antigen in plant tissues.
The CTB molecule has been shown to function as a mucosal carrier for
conjugated peptides to provide enhanced induction of immunological tolerance (11-13).
The pentameric structure of the CTB fusion peptide not only facilitates site-specific
delivery and presentation of conjugated polypeptides to the gut-associated lymphoid
tissues (GALT), it also increases the molar concentration of conjugated polypeptides per
molecule of CTB pentamer. Thus, increases in tolerogen concentrations targeted to the
GALT due to CTB’s Gmi binding affinity and the pentameric structure may significantly
offset the requirement for higher levels of antigen biosynthesis in the plant.
The fusion peptide between CTB and GAD was produced in food plants to
enhance immunological activity of the autoantigen. The GAD peptide was fused to the
C-terminus of the CTB molecule to avoid severe steric hindrance effects on
GMi-ganglioside affinity possibly created by large peptide addition to the N-terminus. In
addition, a flexible hinge peptide containing two glycine and proline residues may
function to reduce steric hindrance between CTB and GAD moieties by permitting
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maximal molecular flexibility. Codons less frequently used in plants located within the
hinge peptide may slow peptide elongation, thereby facilitating CTB subunit folding prior
to GAD message translation (19). Presence of the only full length CTB-GAD fusion
peptide with an expected molecular weight (75 kDa) in plant tissues suggests that
application of less frequently used codons in the hinge peptide did not cause a problem in
peptide translation. The endoplasmic reticulum (ER) retention signal linked to the
C-terminus of the fusion protein has been previously documented to sequester proteins in
the ER, increasing protein amounts and thus facilitating enterotoxin pentamerization (14).
Presence of the GMi-ganglioside binding form of the fusion peptide in plant tissues
confirms its pentameric structure, suggesting subunit assembly in the plant ER is an
efficient process even with a large peptide fusion to the CTB molecule.
Induction of systemic and intestinal anti-CTB antibodies in mice fed CTB-GAD
potato tubers indicates that the fusion protein was effectively delivered to the intestinal
immune system. The increase in serum anti-GAD65 IgG and intestinal IgA antibodies in
NOD mice fed GAD or CTB-GAD plant tissues in comparison with mice fed
untransformed potato tissues may be due to humoral immune responses raised against the
plant-delivered GAD peptide. This humoral response, which may play no significant role
in oral tolerance, may have resulted from preferential stimulation of Th2 cells and resting
B cells in the GALT (8, 26). There is a gradient of sensitivity to induction of oral
tolerance in which the Thl cells are the most susceptible, followed by the Th2 and B cells
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(27). Thus, it may be possible to induce systemic T cell tolerance simultaneously with
systemic and mucosal B cell priming (28-30).
The T cell-mediated destruction of pancreatic p cells is mainly responsible for
diabetogenesis in NOD mice. Thus, reduction in pancreatic lymphocyte infiltration and
subsequent prevention of diabetes due to oral tolerance mechanisms like bystander
suppression, peripheral deletion, and clonal anergy (9, 31) are direct histological and
clinical evidence of induction of oral tolerance. From our experimental results we are
unable to confirm the exact mechanism of oral tolerance responsible for the observed
suppression of insulitis and diabetic symptoms. However, reports from several
laboratories indicate that a subset of protective T cells generated by feeding autoantigens
migrate to the pancreatic lymph nodes where they interfere with the migration of
diabetogenic T lymphocytes (13), and secret anti-inflammatory cytokines. For example,
it has been reported that feeding autoantigens which stimulate the GALT preferentially
generate a Th2-type of response including secretion of lymphokines e.g., interleukin
(IL)-4, IL-10, and transforming growth factor (TGF)-p but suppress production of
Thl-mediated lymphokines such as IL-2 and interferon-y in pancreatic tissues of NOD
mice (9, 10, 26).
Recombinant CTB subunits (without the CTA subunit) were recently shown to
induce mucosal antibody through induction of TGF-p, a major mediator of oral tolerance
(9, 32). Therefore, it is possible that the plant-synthesized CTB-GAD fusion peptide
delivered to the GALT stimulates lymphoid cells to secrete TGF-p, which in turn,
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mediates concurrent induction of observed systemic tolerance (i.e., suppression of
insulitis and subsequent diabetic symptoms) as well as induction of both mucosal and
systemic humoral responses towards CTB and GAD peptide.
The experimental results demonstrate that feeding microgram amounts of food
plant-produced GAD conjugated with CTB effectively suppresses diabetes in NOD mice.
Oral administration of CTB-GAD was effective at doses 1000 fold less than generally
reported for unconjugated autoantigens. In contrast, feeding GAD peptide alone did not
provide significant levels of oral tolerance (Fig. 4c). This finding reinforces the
importance of oral antigen dose and the effect of CTB on oral tolerance induction.
Conjugation of autoantigens with CTB suggests a generally useful method for food plantbased oral tolerization therapy against a variety of T-cell mediated autoimmune diseases,
alleviating the need for high levels of protein antigen production in stably transformed
plants required for achievement of comparable levels of tolerance induction previously
observed by other investigators (5, 26). Further, as suggested by several investigators,
concurrent oral administration of two major pancreatic autoantigens as CTB conjugate,
significantly increased the efficacy of insulitis reduction in NOD mice (5) (Fig. 4c).
The production of edible transgenic plants which synthesize multiple diseasespecific autoantigens as CTB fusion proteins may provide convenient, effective,
affordable and palatable method for prevention of autoimmune diseases especially in
economically emerging countries. The cultivation of transgenic food plants is costeffective requiring few dedicated resources, e.g., sunlight energy, water, and conventional
agricultural technology for cultivation and harvest. Vegetables and fruits endogenous to
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developing countries can provide inexpensive and continuous supply of transgenic plants.
The results of these experiments in combination with additional research findings will
contribute to edible plant-based prevention of a variety of autoimmune diseases of
animals and man.
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Figure 1. Plant expression vector pPCV7011uxF containing the human GAD65 and
CTB-GAD65 autoantigen genes. The T-DNA sequence flanked by the right and left
borders (RB and LB) contains the /wxF/autoantigen gene expression cassette driven by
the bi-directional mannopine synthase (mas) PI and P2 promoters. The 2.2-kb luxF gene
(bacterial luciferase AB fusion gene) was linked to the mas PI promoter as a detectable
marker gene for identification of transformed agrobacteria and plants. The p-lactamase
(Bla) expression cassette is included for ampicillin resistance in Escherichia coli and
carbenicillin resistance in Agrobacterium tumefaciens. The NPTII gene fused to the
nopaline synthase promoter (pNOS) is included for kanamycin resistance in plants. (1)
The human GAD65 cDNA (1.8 kb) or (2) the CTB-GAD65 fusion gene was inserted
between Xbal and Sacl sites of the mas P2 promoter. The oligonucleotide sequence
encoding the putative leader peptide of CTB protein (63 bp) was retained for
transportation of the chimeric protein into the lumen of the plant ER. The DNA sequence
encoding a tetrapeptide hinge (GPGP) was inserted between the 3’ end of the CTB and 5’
end of the GAD65 gene. The DNA sequence encoding the hexapeptide microsomal
retention signal (SEKDEL) was fused to the 3’ end of the GAD65 gene. The g7pA,
g4pA and OcspA polyadenylation signals from A. tumefaciens Tl-DNA gene 7, gene 4,
and octopine synthase gene respectively, were included for gene expression in plant cells.
Ori pBR is the origin of replication from plasmid pBR322.
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Figure 2. Immunological detection of the GAD peptide in transgenic potato tubers,
(a) Production of human GAD65 protein in potato plants: lane 1, truncated human
GAD65 proteins synthesized in E. coli (~ 55 and ~ 45 kDa); lane 2, transgenic potato
tuber tissue transformed with the plant expression vector without the GrAD65 gene; lane
3, transgenic potato tuber tissue transformed with human GAD65 gene producing a 60kDa GAD protein (arrow), (b) Immunoblot detection of a 75-kDa CTB-GAD fusion
protein in potato plants: lane 1, potato CTB-GAD fusion peptide (arrow); lane 2,
transgenic potato plants transformed with plant expression vector pPCV7011uxF without
the CTB-GAD fusion gene, (c) Binding specificity of the CTB-GAD fusion peptide for
GMi-ganglioside and quantitative analysis of Gmi-binding pentameric fusion molecule
determined by Gmi-ELISA. The fusion protein was produced at approximately 0.001%
of total soluble tuber protein. Bacteria-derived CTB protein mixed with soluble potato
tuber protein from an untransformed potato plant was used as a standard, (d) The GmiELISA assay of untransformed and transformed (CTB-GAD) potato homogenates in
response to heat treatment (5 min). Heat induces dissociation of pentamers into
monomers, resulting in loss of GMi-ganglioside binding affinity.
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Figure 3. Anti-CTB antibody titers in mice fed transgenic potato plants producing
the CTB-GAD peptide. Prediabetic mice five weeks old were fed transgenic potato
tissues containing GAD, CTB-GAD, or untransformed tuber (control) once per week for
a total of five weeks. The mice were sacrificed and serum and intestinal washings were
assayed for CTB-specific serum and intestinal antibodies by chemiluminescent ELISA.
Titers is defined as the reciprocal of the highest dilution of the sample to give a
chemiluminescent relative light units (RLU) signal above background RLU generated in
the absence of the sample. Serum and intestinal washings were pooled from five
individual animals within the same group.
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Figure 4. Reduction of insulitis in NOD mice fed transgenic potato tissues. Fiveweek-old prediabetic female NOD mice were fed untransformed or transformed potato
microtuber tissues once per week for five weeks. Each transgenic potato tuber tissue
feeding delivered per mouse approximately 3 pg of GAD65, 2 pg of GAD65 as CTBGAD, and 20 pg of insulin as CTB-INS. The animals were sacrificed at 10 weeks of age
for pancreatic islet histopathological examination. Approximately 10 islets were scored
from each animal. Representative pancreatic islets from (a), an animal fed untransformed
potato tissues (score 5) (b), an animal fed CTB-GAD potato tissues (score 2). (c)
Insulitis score based on the semiquantitative scale. Data are expressed as the mean score
of each group ± SEM (P = 0.003 for a group fed CTB-GAD, and P < 0.0001 for the
group fed CTB-GAD + CTB-INS in comparison with the group fed untransformed potato
tuber tissues). No statistically significant differences were observed between the groups
fed GAD and untransformed potato tissues. Insulitis scores were compared by the
Student’s t test for unpaired samples.
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Figure 5. Suppression of diabetes in NOD mice. Five-week old female prediabetic
NOD mice (10 animals per group) were fed transgenic potato tuber tissue producing
either CTB or CTB-GAD once per week, for a total of five weeks. The animals were
checked weekly for diabetes (>250 mg/dl blood glucose level for two consecutive
weeks) beginning at 10 weeks of age. The results were expressed using the KaplanMeier analysis method for the control group fed transgenic potato tissues synthesizing
CTB and the group fed transgenic potatoes synthesizing CTB-GAD (P <0.01, logrank
statistics).
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Abstract
A fusion gene encoding the cholera toxin B subunit (CTB) linked to the 22-amino
acid neutralizing epitope (114-135) of the human rotavirus nonstructural protein (NSP4)
enterotoxin was inserted adjacent to the bi-directional mannopine synthase {mas) P2
promoter in a plant expression vector which contains a bacterial luciferase reporter gene
{luxF) linked to the mas PI promoter. To permit accumulation and pentamerization of
the fusion gene product within the plant endoplasmic reticulum (ER), the CTB leader
peptide encoding sequence was retained, and an oligonucleotide sequence encoding a
microsomal retention signal (SEKDEL) was added to the 3’ end of the fusion gene. To
permit flexibility between the CTB and NSP4 protein moieties, a DNA sequence
encoding a tetrapeptide hinge was inserted between the CTB and NSP4 DNA sequences.
Transgenic potato plants carrying the plant expression vector were generated by an
Agrobacterium tumefaciens-mediated in vivo plant transformation method. Immunoblot
analysis of regenerated potato tuber tissue proteins indicated that the molecular size of
the CTB-NSP4 fusion protein was slightly larger than the CTB pentamer and that the
pentameric CTB-NSP4 fusion protein was the predominant molecular species. The CTBNSP4 fusion protein retained specific binding affinity for GMi-ganglioside, a cell surface
receptor for CTB protein, and was synthesized in amounts up to 0.1% of total soluble
potato protein. Pentameric CTB molecules linked to antigens in food plants may provide
edible subunit mucosal vaccines for protection against infectious diseases.
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Introduction
Human rotavirus is one of the most important etiological agents responsible for
infantile gastroenteritis. Nearly every child becomes infected with this virus in the first
few years of life (Kapikian et al., 1985). World wide, rotavirus infection is responsible
for 18 million hospitalizations and approximately 1 million deaths each year. The
incidence of acute gastroenteritis is second only to acute respiratory disease in the United
States, although mortality rates in the US are relatively low (75 to 125 deaths each year)
in comparison with mortality in developing countries (Jawetz et al., 1989). Rotavirus has
a substantial economic impact in the US; direct medical expenses exceed $500 million
and total related costs exceed $1 billion annually (Glass et al., 1994). While palliative
medical treatment for rotavirus gastroenteritis is routine in hospitals in the US, early
epidemiological studies conducted in Finland indicated that rotavirus might best be
controlled through vaccination (Vesikari et al., 1986). Natural passive immunity
generally protects children under 2 years of age. Reinfection with the same rotavirus
occurs infrequently, and repeated illness tends to be less severe or even asymptomatic.
While immunity against rotavirus is not fully protective against reinfection, neonatal
rotavirus infection confers protection from the development of clinically severe disease
later in life (Bishop et al., 1983).
Human rotavirus belongs to the family Reoviridae, genus rotavirus which
contains 11 segments of double-stranded RNA, each encoding a viral protein. The two
most important rotavirus-neutralizing capsid glycoproteins are VP7 and VP4. There are
four serologically common types of VP7 glycoprotein (G1 through G4) and two common
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VP4 serotypes (P4 and P8) found in children with diarrhea (Glass et al., 1994).
Protection against rotavirus gastroenteritis is generally serotype specific and is related to
levels of antibodies against the homotypic virus (Chiba et al., 1993). Thus, an effective
rotavirus vaccine should protect against all common viral serotypes.
Recent discovery of the rotavirus enterotoxin, NSP4 and its 22-amino acid
derivative peptide may provide new insights into the development of effective rotavirus
subunit vaccines. Immunity against NSP4 alone may confer cross-protection from
clinical disease without the need for induction of anti-capsid protein antibodies (Ball et
al., 1996; Conner et al., 1996). The induction of antibodies against NSP4 or its 22-amino
acid peptide moiety was found to confer passive immunity to mouse pups bom to
immunized dams, and decreased the incidence and severity of diarrhea (Ball et al., 1996).
Cholera toxin B subunit (CTB), which functions as an effective carrier for foreign
epitopes for mucosal vaccines (Dertzbaugh and Elson, 1993a), was recently synthesized
in transgenic food plants and its efficacy as a vaccine demonstrated in a mammalian
animal model (Arakawa et al., 1997, 1998). Here we have generated potato plants that
synthesize a pentameric CTB-NSP4 fusion protein which retains GMi-ganglioside
binding affinity. The transformed food plants may provide a cost-effective and
convenient source of recombinant vaccines against rotavims infection which may be
especially useful in countries unable to afford conventional rotavims reassortant
vaccmes.
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Materials and Methods
Construction of plant expression vector pPCV7011uxF-CTB:NSP4 (114135):SEKDEL. The oligonucleotide 5’ primer (5’-GCTCTAGAGCCACCATGATTAA
ATTAAAATTTGGTG-3’) and the 3’ primer tS’-CTGGAGCTCGGGCCCCGGCCCAT
TTGCCATACTAATTGCGG-3’) were used for amplification and cloning the CTBhinge (CTBh) fusion DNA sequence from plasmid pRT42 containing the ctxAB operon
(provided by Dr. J. Mekalanos, Harvard Medical School). The PCR amplified DNA
fragment was cloned into plant expression vector pPCV7011uxF. The oligonucleotide
sequence surrounding the translation initiation codon of the CTB gene was converted to a
preferred nucleotide context for efficient translation in plant cells (Kozak, 1981). The
3’ primer was designed to contain a nucleotide sequence encoding the tetrapeptide hinge
(Gly-Pro-Gly-Pro), with less frequently used codons in plants (underlined) to reduce the
rate of translation to enhance proper folding of the CTB protein moiety prior to
translation of the downstream NSP4 message (Purvis et ai, 1987; Lipscombe et al.,
1991). The Gly-Pro box was inserted to function as a flexible hinge between CTB and
the conjugated protein (Clements, 1990; Lipscombe et al., 1991). The CTBh fusion
sequence was cloned between the Xbal/Sacl restriction endonuclease sequences within
the multiple cloning site adjacent to the mas P2 promoter. After 30 cycles of PCR
amplification of the CTBh sequence from plasmid pRT42 (94 °C 45 s: 55 °C for 60 s:
72 °C for 45 s), the amplified CTBh fragment was ligated into plasmid pPCV7011uxF
with T4 DNA ligase for 20 hrs. at 16 °C. The recombinant plasmid was transferred into

190
Escherichia coli strain HB101 by electroporation at 250 pFD, 200 Q, and 2,500 volts.
Ampicillin resistant colonies were isolated following overnight incubation at 37 °C. The
CTBh fusion gene was subjected to DNA sequence analysis with the forward primer
(5’-ACCAATACA TTACACTAGCATCTG-B’) specific for the mas P2 promoter and
the reverse primer (5’-GACTGAGTGCGATATTATGTGTAATAC-3’) specific for the
A. tumefaciens gene 7 poly(A) signal. This plant expression vector was designated
pPC V701 luxF-CTBh.
To synthesize DNA fragments encoding the rotavirus enterotoxin NSP4
(114-135) epitope, two overlapping primer sequences were synthesized and equimolar
amounts of both single-stranded DNAs were subjected to PCR amplification (94 °C for
45 s: 55 °C for 60 s: 72 °C for 60 s: 30 cycles total) to create a double-stranded 103 bp
length synthetic gene fragment. The 60 base 5’ oligonucleotide (5’-GCCGAGCTCGA
TAAGTTGACTACTAGGGAGATTGAGCAAGTTGAGTTGTTGAAGAGGATT-3 ’)
and the 60 base 3’ oligonucleotide (5 ’-GCCGAGCTCACAACTCATCCTTCTCAGAA
GTCAACTTATCGTAAATCCTCTTCAACAACT-3’1 were designed to contain a 17 bp
complementary sequence (underlined) for the Vent DNA polymerase (New England
Biolabs) attachment site to permit initiation of the first cycle of the PCR reaction. The
3’ oligonucleotide contained a DNA sequence encoding a microsomal retention signal
(SEKDEL) (Arakawa et al., 1997). Codons frequently found in potato plants were used
for this synthetic gene. Both oligonucleotides contained Sad recognition sites (bold) to
clone the synthetic gene fragment into the Sad site immediately downstream of the
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CTBh sequence to create vector pPCV7011uxF-CTBh-NSP4:SEKDEL. Following
confirmation of the DNA sequences, the plant expression vector was transferred by
electroporation into Agrobacterium tumefaciens strain GV3101 pMP90RK and restriction
endonuclease analysis of the plant expression vector was performed prior to plant cell
transformation. Potato leaf explant transformation was performed followed by selection
of transformed plants by luciferase marker gene activity by low-light image analysis as
previously described (Langridge et al., 1991; Arakawa et al., 1997).

Immunoblot detection of pentameric CTB-NSP4 fusion protein. Transgenic potato
leaf and microtuber tissues were analyzed for CTB fusion gene expression by
immunoblot analysis. Callus tissues were derived from leaf or tuber tissues incubated for
4 weeks on Murashige and Skoog (MS) solid medium containing 5 pg/ml NAA and
6 pg/ml 2,4-D. Transformed and untransformed plant tissues were homogenized by
grinding a mortar and pestle at 4 °C in extraction buffer (1:1 w/v) (200 mM Tris-Cl,
pH 8.0, 100 mM NaCl, 400 mM sucrose, 10 mM EDTA, 14 mM 2-mercaptoethanol,
1 mM phenylmethylsulfonyl fluoride, 0.05% Tween-20). The tissue homogenate was
centrifuged at 17,000 x g in a Beckman GS-15R centrifuge for 15 min at 4 °C to remove
insoluble cell debris. An aliquot of supernatant containing 100 pg of total soluble
protein, as determined by Bradford protein assay (Bio-Rad, Inc.), was separated by 15%
sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) at 125 volts for
30 to 45 min in Tris-glycine buffer (25 mM Tris, 250 mM glycine, pH 8.3, 0.1% SDS).
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Samples were either loaded directly on the gel or boiled for 5 min prior to
electrophoresis.
The separated protein bands were transferred to an approximately 80 cm ImmunLite membrane (Bio-Rad, Inc.) by electroblotting in a semi-dry blotter (Labconco) for
60 min at 15 V and 100 niA. The membrane was incubated for 1 h with gentle agitation
on a rotary shaker (40 rpm) in TBS buffer (20 mM Tris, pH 7.5, 500 mM NaCl)
containing 5% non-fat dry milk. Following the blocking step, the membrane was washed
with TBS buffer for 5 min. After washing, the membrane was incubated overnight at
room temperature with gentle agitation in a 1:5,000 dilution of rabbit anti-cholera
antiserum (Sigma C-3062) in an antibody buffer (TBS with 0.05% Tween 20 and 1%
non-fat dry milk) followed by washing three times in TBST buffer (TBS with 0.05%
Tween 20). The membrane was then incubated for 1 h at room temperature with gentle
agitation in a 1:10,000 dilution of mouse anti-rabbit IgG conjugated with alkaline
phosphatase (Sigma A-2556) in the antibody buffer. Following incubation in the
secondary antibody solution, the membrane was washed three times in TBST buffer as
before and once with TBS buffer to remove Tween-20, followed by incubation with
lx chemiluminescent substrate CSPD™ (Bio-Rad) for 5 min at room temperature in a
plastic container with gentle agitation. The membrane wrapped in a transparent plastic
bag was exposed to Kodak X-OMAT for 1 - 10 min at room temperature. Finally the
film was developed in a Kodak M3 5A X-OMAT X-ray film Processor.
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Quantitation of CTB-NSP4 chimeric protein synthesis in transgenic potato tissues.
The amount of plant-synthesized pentameric CTB-NSP4 fusion protein exhibiting Gmiganglioside affinity was measured by chemiluminescent Gmi-ELISA detection methods.
A 96-well microtiter plate (Dynatech Laboratories) was coated with 100 pi volume of
monosialoganglioside Gmi (3.0 pg/ml) (Sigma G-7641) in bicarbonate buffer, pH 9.6
(15 mM Na2CG3, 35mM NaHCOs) and incubated at 4 °C overnight. The wells were
loaded with serial dilutions of total soluble potato leaf or tuber protein in phosphate
buffered saline (PBS) and the mixture incubated overnight at 4 °C. The wells were
blocked by 1% bovine serum albumin (BSA) in PBS. The wells were loaded with
100 pl/well of a 1:5,000 dilution of rabbit anti-cholera toxin antibody (Sigma C-3062)
diluted in PBS containing 0.5% BSA and incubated plate overnight at 4 °C.
Alternatively, for detection of the NSP4 epitope, anti-NSP4 antibody generated in rabbits
(provided by Dr. M. Estes, Baylor College of Medicine) was used for binding. The
microtiter plate was incubated with a 1:50,000 dilution of alkaline phosphataseconjugated anti-rabbit IgG (Sigma A-2556) diluted in PBS containing 0.5% BSA for 2 h
at 37 °C. The plate was washed twice with PBST (PBS with 0.05% Tween 20) and once
with PBS following each step. The plate was incubated with 100 pl/well of Lumi-Phos
Plus (Lumigen, Inc.) for 30 min at 37 °C and the enzyme-substrate reaction measured in a
Microlite™ ML3000 Microtiter® Plate Luminometer (Dynatech Laboratories).
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Results
Generation of transgenic potato plants synthesizing the CTB-NSP4 fusion protein.
Agrobacterium-mQ&\dXQ<\ transformation of potato leaf explants with plant expression
vector pPCV7011uxF-CTBh:NSP4:SEKDEL (Fig. 1), generated kanamycin-resistant
plants that expressed detectable luciferase activity (results not shown).
Three transformed plants expressing the highest luciferase activities were
analyzed further for the presence of the chimeric CTB-NSP4 protein (Fig. 2).
Transformed potato tuber tissues contained a protein band that reacted strongly with anti
cholera toxin antibody made against the pentameric form of the cholera toxin B subunit.
Potato plant #1 produced a substantially higher chimeric protein level than the other two
plants. The potato-synthesized CTB-NSP4 fusion protein was slightly higher in
molecular weight than either pentameric bacterial CTB (45 kDa, lane 1) or potatosynthesized CTB (50 kDa, lane 5).

Quantitative analysis of CTB-NSP4 protein in transformed potato plants. The
amount of pentameric CTB-NSP4 chimeric protein retaining GMi-ganglioside binding
affinity was determined by chemiluminescent Gmi-ELISA in transgenic tuber tissues in
comparison with the chemiluminescent intensities of known amounts of bacterial CTB
protein-antibody complex (Fig. 3). Two standard curves (0.1% and 0.01%) were
generated based on chemiluminescent signals generated from pentameric bacterial CTB.
The relative light units (RLU) obtained from serial dilutions of transgenic potato plant
homogenates were plotted on the graph. Plant #1 produced approximately 0.1% of total
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soluble protein as the chimeric CTB-NSP4 protein (Fig. 3). The other two transformed
plants contained several fold less amounts of the chimeric protein (data not shown).
The amounts of CTB-NSP4 protein reactive with anti-cholera toxin antibody was
quantitated by a chemiluminescent immunoblot assay method. The light intensities of
bacterial CTB and the plant chimeric CTB-NSP4 protein on Immun-Lite membranes
were measured and compared in the Data Analysis Program of the Argus-100 low-light
imager (Hamamatsu Photonics, Japan). The number of photons emitted from either
bacterial CTB, plant CTB, or the plant CTB-NSP4 fusion protein bands was quantified
and the percent of plant CTB-NSP4 fusion protein determined to be approximately 0.1%
of total soluble plant protein, a value in close agreement with measurements made by the
chemiluminescent Gmi-ELISA method. These experimental results suggest that
essentially all the CTB-NSP4 fusion protein produced in plant cells was assembled into
the pentameric molecular form with GMi-ganglioside binding affinity. The CTB-NSP4
fusion protein also contained NSP4 antigenicity as the fusion protein was also detected
by anti-NSP4 antiserum (Fig. 3). Based on the quantitative luminescence measurements,
1.0 g of callus tissues (fresh weight) from potato #1 tubers contained approximately
10 pg of recombinant CTB-NSP4 fusion protein.

Discussion
Addition of polypeptides to the N-terminus of the CTB subunit reduces
GMi-ganglioside binding affinity. This result is probably due to steric hindrance or
conformational changes induced within the CTB molecule (Dertzbaugh and Elson,
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1993b). In contrast, the C-terminus of the CTB subunit can tolerate addition of relatively
large polypeptides (up to 15 kDa) without disrupting CTB’s affinity for its ligand
(Arakawa et al., unpublished results). The leader peptide of this fusion protein required
for translocation of the conjugate into the lumen of the ER was provided by the original
CTB leader peptide. The presence of the Gly-Pro box between CTB and NSP4 (114-135)
peptide may function as a flexible hinge between the two moieties of the chimera to
reduce steric hindrance (Jagusztyn-Krynicka et al., 1993). In addition, codons relatively
less frequently used in plants were selected for the hinge region to allow the ribosome to
slow the rate of translation to facilitate CTB subunit folding prior to translation of the
downstream message. The C-terminus of the CTB-NSP4 fusion protein contains a
hexapeptide microsomal retention signal for sequestration of the chimeric protein in the
lumen of the ER, which may help to facilitate the pentamerization process. Presence of
the SEKDEL hexapeptide at the C-terminus of proteins has been shown to significantly
increase protein accumulation within plant tissues such as potato leaves and tubers,
tobacco and alfalfa leaves as well as in COS cells (Munro and Pelham, 1987; Wandelt et
al., 1992; Haq et al., 1995), thereby facilitating protein subunit oligomerization.
Production of the pentameric CTB chimeric protein in transgenic potato tissues suggests
that the plant endoplasmic reticulum, similar to the periplasmic space of gram-negative
bacteria (Hirst and Holmgren, 1987), may provide an intracellular environment in which
the CTB-NSP4 chimeric protein monomers can accumulate and assemble into pentameric
fusion proteins.
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The production in edible plants of pentameric CTB protein conjugated with
neutralizing epitopes from microbial pathogens may provide protective mucosal
immunity through ingestion of transgenic plant tissues. To further broaden the
application of mucosal vaccines, a variety of palatable food plant species of tropical and
semi-tropical origin such as bananas and tomatoes which can be consumed without
cooking can now be evaluated for their ability to produce CTB-fixsion proteins. These
food plants would have the practical application for production of heat-labile CTBconjugated vaccine proteins. In addition, due to the high palatability of fruits they would
be particularly advantageous for use as oral vaccines for children. Development of food
plants capable of producing CTB fusion proteins carrying microbial neutralizing epitopes
may provide low-cost and convenient recombinant mucosal vaccines for prevention of a
variety of infectious diseases in regions of the economically emerging world where
conventional vaccines are difficult to supply and maintain.
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Figure 1. Plant transformation vector pPCV701FM4-CTBH:NSP4:SEKDEL. Four
genes located within the T-DNA sequence flanked by the right and left border (RB and
LB), 25 bp direct repeats required for integration of the T-DNA into plant genomic DNA:
1.) CTBH:NSP4 (114-135):SEKDEL coding sequence under control of the mas P2
promoter; 2.) the bacterial luciferase AB fusion gene {luxF) under control of the mas PI
promoter as a detectable marker; 3.) an NPTII expression cassette for resistance to
kanamycin in plants; 4.) a (3 -lactamase cassette for resistance to ampicillin in E. coli and
carbenicillin in A. tumefaciens. The g7pA polyadenylation signal is from the A.
tumefaciens Tl-DNA gene 7; the OcspA polyadenylation signal is from the octopine
synthase gene; Pnos is the promoter of the nopaline synthase gene; g4pA is the
polyadenylation signal from Tl-DNA gene 4; OriT is the origin of transfer derived from
plasmid pRK2; OriV is the wide host range origin of replication for multiplication of the
plasmid in A. tumefaciens derived from plasmid pRK2; and Ori pBR322 is the replication
origin of pBR322 for maintenance of the plasmid in E. coli.
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Figure 2. Immunoblot detection of the CTB-NSP4 chimeric protein in potato
tissues. Auxin induced microtuber tissues derived from transgenic potato plant #1 were
analyzed for expression of the multimeric CTB-NSP4 fusion protein. Lane 1, 100 ng
bacterial CTB (arrow); lanes 2-4, total protein (100 pg) from tuber tissues of individual
transgenic potato plants #1 - #3, respectively; lane 5, total protein (100 pg) from CTB
transformed potato tuber tissue.
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Figure 3. Gmi-ELISA detection of CTB-NSP4 fusion protein levels in transgenic
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ABSTRACT
Advances in plant molecular biology during the past decade have facilitated the
introduction of a wide variety of novel genes into food plant species for the improvement
of human nutrition and health. Plant biotechnology research efforts in the Loma Linda
University School of Medicine have been instrumental in development of food plants
producing human milk proteins for infant formulas and baby foods for improved nutrition
of malnourished people of all age groups especially in developing nations. This review:
(1) describes the composition and health benefits of human milk; (2) identifies
differences between human milk and bovine milk, discusses the disadvantages of cow's
milk and soy-based formulas for certain populations; (3) defines the health benefits of
specific human milk proteins; (4) describes initial efforts to engineer the production of
human milk proteins in food plants; (5) presents calculations to support the feasibility of
replacing cow's milk with plant-produced human milk proteins; and (6) outlines strategies
for increasing production levels and enhancement of the biological activity of plantsynthesized human milk proteins. Development of infant, child and adult foods with
higher protein quality for those at risk of health complications due to cow's milk or soy
proteins, will depend upon the organization of research partnerships among concerned
government agencies, private foundations and technology transfer to companies who can
manufacture those novel plant-based infant formulas, baby foods and health foods.
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Advances in agriculture through biotechnology
The practice of agriculture is a uniquely important human activity which began in
antiquity. It has allowed us to escape from our nomadic existence to develop civilization.
Until recently, however, the selection for desirable plant traits required years, even
decades, to achieve because it depended upon traditional methods of crossing and
inbreeding of plant species. Modem molecular biology-based techniques make possible
the identification, isolation, analysis, transfer, and expression of genes which confer
desirable traits from one life form into another. Through biotechnology, transgenic plants
(i.e., plant recipients of novel genes) are being developed at an unprecedented rate.
During the past decade alone, transgenic plants have been generated which will
not only increase crop climate range and resistance to insect and pathogen damage
(Table 1), but will also enhance human nutrition and health (Table 2). This latter role for
transgenic plants recognizes their attractiveness as bioreactors for the production (and
possibly delivery) of proteins destined for human consumption or disease prevention.
Due to their photoautotrophic nature, plants require only water, CO2, soil minerals,
nitrogen, and sunlight for growth; moreover, plants do not harbor the disease-causing
vimses, microbes, and prions of animal and animal cell origin.
Our group started to develop edible plants with traits that will improve human
nutrition and health. One of the first research problems undertaken was to develop edible
plants which produce human milk proteins for non-breast fed infants. Thus far, p-casein
and lactoferrin have been synthesized in potato and tomato, and experiments are
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underway to introduce genes encoding human a-lactalbumin and p-lactoglobulin into
food plants. In this review we: (1) describe the composition and health benefits of human
milk; (2) identify differences between human milk and bovine milk, and discuss the
disadvantages of cow's milk and soy-based formulas; (3) define the health benefits of
specific human milk proteins; (4) describe initial efforts to genetically engineer the
production of human milk proteins in food plants; (5) offer calculations to support the
feasibility of replacing cow's milk with plant-produced human milk proteins; and
(6) outline strategies which can be employed to increase milk protein production levels
and the enhancement of biological activity.

Composition and health benefits of human milk
Milk is a biochemically complex mixture of proteins, lipids, carbohydrates,
vitamins and minerals, designed to nurture mammalian newborns. Human milk has long
been recognized as a well-balanced diet for human infants, supplying high nutritional
value in both casein phosphoproteins and whey proteins, as well as a source of
antimicrobial proteins, such as lysozyme. There are at least three types of casein
phosphoprotein subclasses: a-, (3-, and K-caseins. The whey proteins include lactoferrin,
a-lactalbumin, P-lactoglobulin, and serum albumin (Miller et al., 1990).
The casein proteins comprise about 0.3 - 0.35% (3 - 3.5 g/1) of human milk, or
about 30 - 35% of total milk protein (Miller et al., 1990). There are two major
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subclasses of human casein: P-casein the most abundant form (70%) and K-casein which
accounts for about 27% of the total casein in human milk (Kunz and Lonnerdal, 1990).
Human P-casein is a 25-kDa protein that exists in several isoforms depending on
its phosphorylation state. Up to five phosphate groups can be attached to serine and
threonine residues located within the first 10 amino acids of the polypeptide (Greenberg
et al., 1984; Hansson et al., 1993). The amphipathic structure of the casein molecule is
due to uneven distribution of its hydrophilic and hydrophobic amino acid residues as well
as phosphorylation of the molecule. Binding calcium, magnesium, and phosphate ions
facilitates formation of large casein aggregates (micelles) which give milk its white color
(Dickson and Perkins, 1971; Blakeborough et al., 1983; Hansson et al., 1993). In
addition to its excellent emulsification properties, human p-casein has diverse biological
effects e.g., enhancement of absorption of calcium and other minerals (Naito and Suzuki,
1974; Mykkanen and Wasserman, 1980), inhibition of angiotensin I-converting enzymes
(Kohmura et al., 1989), opiate agonist effects (P-casomorphin peptides) (Brantl, 1984),
immunostimulating and modulating effects (Migliori-Samour and Jolles, 1988), and
antibacterial functions (lactoferrin, caseciden and isracidin) (Mitra and Zhang, 1994;
Lahov and Regelson, 1996).
Lactoferrin, one of the major whey proteins in human milk, is an iron-binding
glycoprotein. High levels of lactoferrin have been identified in neutrophils (Mason et al..
1969) and in lactating mammary glands (Green and Pastewka, 1978). Although, little is
known about the function of milk lactoferrin in vivo, functions ascribed to lactoferrin in
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vitro include promotion of cell growth, regulation of hematopoiesis, antimicrobial
activity and immune-modulating properties. Antibacterial as well as antiviral activities of
lactoferrin have also been reported (Arnold et al., 1977; Lu et al., 1987).

Differences between human milk and bovine milk
It is generally accepted that human milk is superior to all other milk substitutes
for nutrition of the growing infant. However, there remains a large market for milk
substitutes because not all mothers are able to supply their infants with breast milk due to
adverse physical, psychological or socio-economic restraints. Baby formulas based on
cow's milk or soybean have, until recently, been the traditional substitutes for mother’s
milk. However, bovine milk is designed by nature to promote rapid growth of a 100 lb
calf, and is substantially different from human milk in both protein content and
composition (Table 3). Cow’s milk contains 3.5g/dl of total protein in comparison with
only 0.9g/dl total protein in human milk (Miller et al., 1990). The predominant casein
subclass of bovine milk, a-casein, is found in only trace amounts in human milk (Miller
et al., 1990). The casein/whey ratio in bovine milk is 80/20 in comparison with 40/60 in
human milk.
Although, cow’s milk has been recognized as an excellent source of protein,
vitamins and minerals, there are significant amino acid differences between human and
cow’s milk that can present physiological problems in feeding cow’s milk formulas to
infants (Packard, 1982). Human milk has a higher cysteine:methionine ratio than cow’s
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milk and also contains a substantial amount of taurine, a nonprotein nitrogen constituent
essentially absent from cow’s milk. The liver and brain of the human fetus and pre-term
infant are completely lacking cystathionase, an enzyme which converts methionine to
cysteine which is essential for central nervous system development. Taurine, derived
from cysteine through the action of cysteinesulfonic acid decarboxylase, is essential for
infant’s brain and retinal development as well as the function and conjugation of bile
salts. Optimum levels of cysteine and taurine required for infants cannot be obtained
from cow’s milk. The higher levels of phenylalanine and tyrosine in cow’s milk versus
mother’s milk may present an additional problem. Lower levels of phenylalanine and
tyrosine in human milk match the infant’s limited ability to metabolize these amino acids,
which at higher levels in the diet, can accumulate to cause phenylketonuria (PKU) and
subsequent brain damage.
The milk caseins are responsible not only for binding essential minerals
(especially calcium, phosphate, iron and zinc) to maintain them in an easily ingestible
suspension, but also for aiding in their absorption. The Ca:P ratio is higher in human
milk than in cow’s milk so that formulas need to be adjusted to the appropriate Ca:P ratio
for optimal mineral absorption. The fact that minerals are more efficiently absorbed from
human milk due to structural and functional differences between bovine and human
casein proteins, must be taken into consideration for determining the appropriate mineral
ratio (Lonnerdal, 1985).
Bovine milk consumption is often related to excessive weight gain and cow’s
milk protein allergy and intolerance (CMPA/CMPI) which may effect the gastrointestinal
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tract, respiratory tract, skin and blood (Johansson et al., 1994; Wilson and Hamburger,
1988). The CMPA is a disease of infancy and usually appears in the first few months of
life. Prenatal or early neonatal exposure to cow's milk protein increases the risk, not only
of adverse reactions to this milk but also of developing allergies to other foods, especially
soy and egg (Host, 1991; Host et al., 1995). Over 25 protein fractions in bovine milk
have been demonstrated to induce an allergic response in humans, and many are capable
of inducing IgE-mediated (type I) reactions. Most clinical cases of infant food allergy
induced by consumption of cow’s milk or its products are believed to be related to bovine
casein (Perkin, 1990; Karjalainen et al., 1992).
Soy-based infant formulas have often been recommended as hypoallergic
alternatives for nonbreast-fed infants. However, many infants with food allergy to bovine
milk are also allergic to soy proteins. Therefore, soy formulas are not considered to be
adequate substitutes for cow’s milk formulas under such conditions. Although soybean
allergenic proteins have not been fully identified, the globulin components (2S, 7S and
11S) and hemagglutinin (soybean trypsin inhibitor) have been implicated as allergens
(Perkin, 1990).
There are also a number of reports indicating a possible link between
consumption of cow’s milk and development of insulin-dependent diabetes mellitus
(IDDM) (Daneman, et al., 1987; Savilahti, et al., 1988; Karjalainen et al., 1992). Animal
experiments have indicated that development of diabetes can be prevented in diabetesprone rodents if the animals are given a bovine milk-free diet in early life (Elliott and
Martin, 1984; Daneman et al., 1987). Short duration of breast-feeding and early
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introduction of dairy products were found to be associated with an increased risk of
IDDM in Finnish and Brazilian children (Virtanen et al., 1991, 1994; Gimeno and de
Souza, 1997). Patients with IDDM have elevated levels of serum IgG and IgA anti-BSA
antibodies which cross react with p69, one of the target p-cell antigens in IDDM patients
(Karjalainen et al., 1992).

Production of a human milk casein (P-casein) in transgenic plants
The recent report of human p-casein production in potato (Solarium tuberosum cv.
Bintje) is the first account of stable genomic integration of a human milk protein gene in
a food plant (Chong et al., 1997). Human P-casein cDNA was inserted into a multiple
cloning site under control of the Agrobacterium tumefaciens mannopine synthase (mas)
P2 promoter in the plant transformation vector, pPCV701FM4 (Fig. 1). The bacterial
luciferase fusion gene (Escher et al., 1989), a reporter gene for identification of
transgenic plants and estimation of novel gene expression level, was placed under control
of the mas PI promoter. (The auxin-inducible bi-directional mas promoters function not
only in potato but also in other edible plants, thus it permits the same vector to be used in
a variety of plant species.)
The P-casein cDNA was introduced into potato leaf tissue cells by
Agrobacterium tumefaciens-mediated transformation methods (Horsch et al., 1985),
which resulted in stable integration of human P-casein cDNA into the plant chromosome.
This method of stable plant transformation has the advantage of rapid generation of a
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large number of homogeneous transgenic plants through vegetative means and provides
an opportunity to introduce several genes simultaneously into an individual edible plant.
Putative antibiotic-resistant transformants were examined for luciferase expression by
low light video image analysis (Fig. 2) (Langridge et al., 1991) to identify those
transgenic plants with the greatest potential for maximal p-casein gene expression.
Full length P-casein mRNA was detected by RT-PCR; and the p-casein protein
was identified in transformed potato tissue homogenates by immunoblot analysis (data
not shown, see Chong et al., 1997). The p-casein protein was present in potato and leaf
tuber tissues at an estimated level of 0.01% of total soluble protein. Plant-synthesized
P-casein appears to be a single protein of approximately 24 kDa, approximately 1.0 - 1.5
kDa smaller in molecular weight than the human P-casein isoform phosphorylated at two
sites. The reason for this is not yet understood. Immunoaffinity column purification
experiments are in progress to obtain amounts of protein sufficient for N-terminal amino
acid sequence and phosphorylation pattern analyses. We are currently evaluating how
much the yield of P-casein can be increased by using the tuber-specific patatin promoter.
This tissue specific promoter is reported to express genes at levels of 2% of soluble tuber
protein (Spychalla et al., 1994). Further, we have recently introduced human p-casein
cDNA into tomato (Lycopersicon esculentum cv. Tiny Tim). The presence of p-casein
cDNA, mRNA, and protein were confirmed in transformed tomato tissues (Sovyanhadi et
al., unpublished data).
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Production of a human milk whey protein (lactoferrin) in transgenic plants
The human lactoferrin gene encodes a mature protein with molecular weight of
approximately 80 kDa. Mitra and Zhang (1994) were the first to report attempts to
express human lactoferrin in plants. Produced in tobacco plants under control of the
CaMV 35S promoter, the recombinant human lactoferrin had a molecular weight of
48 kDa. This result suggested the possibility of incorrect protein folding and degradation
of the unfolded protein. The extent of protein glycosylation in tobacco was not reported.
However, when the antibacterial properties of transgenic calli extracts were compared
with untransformed tobacco control extracts and native lactoferrin, they concluded that
the smaller recombinant protein exhibited substantially greater antibacterial activity than
native lactoferrin. Colony-forming unit reduction assays were performed against four
different phytopathogenic bacterial strains: Xanthomonas campestris pv. phaseoli,
Pseudomonas syringae pv. phaseolicola, Pseudomonas syringae pv. syringae, and
Clavibacter flaccumfaciens pv. flaccumfaciens.
Recently, our laboratory successfully regenerated transgenic potato plants
containing the lactoferrin cDNA stably integrated into the plant genome. Leaf and tuber
tissues have been shown to contain a recombinant human lactoferrin of about 80 kDa
which is the size of the naturally-occurring mature milk protein. Experiments are now in
progress to test the potato-derived recombinant lactoferrin for antimicrobial activity.
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How feasible are transgenic potatoes for human milk protein production?
One cup (250 ml) of human milk contains about 0.225 g of p-casein (Miller et ai,
1990). The average-sized potato (300 g), contains approximately 7 g of total soluble
protein (2.3% soluble tuber protein) (Pennington, 1993). Thus, a P-casein expression
level of 3.2 % of total soluble tuber protein would be necessary to produce 0.225 g of
human P-casein in one average-sized potato [i.e. (0.225 g of p-casein / 7 g of total soluble
tuber protein) H 100%]. At the initial (mas promoter) expression level of 0.01% total
soluble tuber protein, 320 potatoes would be required to supply the amount of p-casein in
a cup of milk. At the expression level we can now expect (about 2% of total soluble
tuber protein under the control of the patatin promoter), the number potatoes/cup of milk
drops to a more reasonable 1.6 potatoes. The amounts of other major milk proteins found
in one cup of human milk and their potato equivalents estimated on the basis of the
patatin promoter are provided in Table 4.
Assuming that a woman produces 100 liters of milk during a year (one lactation),
we can also estimate how many acres of transgenic potatoes would be required to obtain
the amounts of several major human milk proteins produced during breast-feeding one
infant for a year. Consider the example of p-casein. We have estimated above that
1.6 average-size potatoes (300 g each) would provide the quantity of this milk protein in
250 ml of human milk. Thus, 6.4 potatoes would be equivalent to 1 liter of human milk,
and 640 potatoes (weighing 192 kg) would be equivalent to 100 liters of mother's milk.
At a yield of 15,000 kg potatoes/acre (U.S. Department of Commerce, 1995), only 0.013
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acres of potatoes would be required to satisfy the needs of one infant's entire lactation
intake of p-casein. Looking at the calculation per acre of transgenic potatoes, we could
produce sufficient P-casein (assuming no purification or other losses) to provide for the
entire lactation period of 77 infants. Similar estimates for other important milk proteins
are provided in Table 4.

Enhancement of the production levels and biological effects of human milk proteins
Since retention of the biological activity of recombinant proteins is essential, each
transgenic plant-produced protein must be evaluated in vivo as well as in vitro. Once the
nutritional, protective and therapeutic benefits of the plant-derived milk proteins are
determined, production and delivery systems must be optimized for highest yield and
biological activity. The economic feasibility and physiological/pharmacological activity
of human milk proteins produced in transgenic plants may be improved by at least four
different strategies:
(1) Increase production levels by manipulation ofgene expression. The addition
of transcriptional and translational enhancers, tissue-specific regulatory elements, leader
peptides and/or endoplasmic reticulum retention signals may help to increase the
production levels of milk proteins in food plants. Optimization of human milk protein
codon usage for plants, as well as insertion of plant introns, may also increase expression
levels for these proteins. Lastly, new systems may be constructed in which multiple
proteins can be simultaneously produced in one plant, based on multiple promoter

218
constructs or the use of an internal ribosome entry site (IRES) elements between adjacent
milk protein genes under the control of a single strong promoter.
(2) Assessment of normal post-translational modification or cleavage upon
ingestion. For example, p-casein is normally phosphorylated and some of the important
physiological effects of casein require that it be cleaved into smaller proteins such as
casomorphins in the human gut.
(3) Selection of appropriate plant species. In the case of heat-labile proteins,
production of the protein must be performed in plants which can be consumed in the raw
state. When proteins require frequent consumption, plants must be selected which are a
substantial part of the normal diet and which can be readily grown and harvested using
available agricultural technologies.
(4) Modification of milk protein properties. Methods for site specific mutagenesis
now provide us with the opportunity to alter milk protein genes to further improve milk
protein digestibility, increase protection against microbial pathogens by production
lactoferrin, and increase the feeling of well-being under stress conferred by the
neurotropic casomorphins.

Epilogue
We have taken the first step toward the goal of reconstituting the major human
milk proteins (P-casein, a-lactalbumin, lactoferrin, and P-lactoglobulin) in transgenic
food plants. Ultimately, the goal of developing an alternative nutrition for people of all
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ages world-wide who are living under inadequate nutritional conditions, and who are at
risk of developing allergic reactions from cow's milk or soy-based formulas will depend
upon the efforts of plant biotechnology researchers in laboratories around the world who
continue to expand the role of innovative research in agriculture to improve human
nutrition and health as we enter the twenty-first century.
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Figure 1. Structure of the plant transformation vector pPCV701FM4-Hbca to
produce human p-casein. The human p-casein cDNA (1162 bp) was subcloned from
plasmid pGEMBZ into the multiple cloning sites of plant transformation vector
pPCV701FM4 to create plasmid pPCV701FM4-Hbca. The T-DNA sequence within the
plasmid flanked by the left (LB) and right (RB) borders (25 bp direct repeats) is
randomly incorporated into an actively transcribed region of the plant genome. The P~
casein cDNA was inserted immediately downstream of mannopine synthase P2 promoter
{mas P2) and is followed by the polyadenylation signal of the Tl-DNA gene 7 (g7pA).
Expression of the bacterial luciferase fusion gene (LuxF) is driven by the mas PI
promoter and is terminated by the polyadenylation sequence of the octopine synthase
gene (OcspA). Arrows indicate the direction of transcription. Restriction endonuclease
cleavage sites are indicated. pNOS, promoter of nopaline synthase gene; NPT-II,
neomycin phosphotransferase gene from transposon Tn5; g4pA, polyadenylation
sequences of the Tl-DNA gene 4; OriV, OriT, replication and transfer origin sequences
derived from plasmid pRK2; Pg5, promoter of Tl-DNA gene 5; Ori pBR322, replication
origin of pBR322, Bla, p-lactamase gene for ampicillin resistance.
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Figure 2. Screening for maximal transgene expression in transformed potato plants
by low light image analysis. A longitudinal slice through a potato tuber taken from a
plant transformed with pPCV701FM4-Hbca was subjected to low light image analysis for
10 min at room temperature with a Hamamatsu Argus 100 intensified video camera
(Langridge, et al., 1991). Note the location of luciferase bioluminescence throughout the
tuber tissue, especially in the areas indicated by arrows. Photon imaging technology of
bioluminescent reporter gene products such as luciferase has made it possible to follow
gene expression non-invasively in real time. Large numbers of plants can be rapidly
screened to locate transformants with the highest expression levels of the transferred
genes, p-casein expression from the mas P2 promoter is correlated with the level of
luciferase expression from the mas PI promoter. Thus, in general, a high level of
luciferase expression indicates a correspondingly high level of expression of P-casein.
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Table 1. Improvements in Crop Range and Resistance to Damage
Novel Trait

Novel Gene Transfer

Recipient
Plant

Reference

Increased
resistance to
salinity

yeast halotolerance
gene

melon

Bordas et al., 1997

Improved
drought
resistance

genes from the
resurrection plant
Craterostigma

tobacco

Iturriaga et al.,
1996

Improved frost
resistance

a gene encoding
flounder antifreeze
protein

tobacco

Kenward et al.,
1993

Increased
resistance to
plant pathogens

plant genes of the
phenylpropanoid
pathway

parsley

Logemann et al.,
1995

Greater
resistance to
insect pests

Bacillus thurin-giensis
delta endo-toxin gene

cotton

Sutton

Improved
resistance of
crop plants to
the herbicides
glyphosate and
atrazine

5-enolpyruvylshikimate-3-phosphate
synthase gene and
mutant photosystem B
genes

crop plants

Suh et al., 1993;
Smedaeffl/., 1993

Delayed fruit
ripening

cDNA encoding
galacturonase and
DNA sequence for
antisense RNA to
down-regulate the
ethylene biosynthetic
pathway

improveme
nt of tomato
and melon
storage and
flavor
quality
(Flavr Savr)

Meyer, 1995

1992
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Table 2. Improvements in Human Health and Nutrition
Novel Trait

Novel Gene
Transferred

Recipient
Plant

Reference

Improve wheat
protein quality for
bread-making

Lysine and
methionine
Biosynthesis genes
from bacteria

wheat

Keeler et al., 1997

Considered for
increased
palatability of
vegetables

Thaumatin sweet
protein genes

vegetable
plants

Zemanek et al.,
1995

Prevent cancer and
arterial plaque
formation to reduce
risk of atheroscler
osis and stroke

Genes encoding
omega fatty acids

Arabidopsis

Arondel et al, 1992

Passive mucosal
immunotherapy

Secretory
immunoglobulin A

tobacco

Ma et al., 1995

Edible plant
vaccine

Heat-labile toxin of
E. coll

tobacco,
potato

Haq et al., 1995

Edible plant
vaccine

Cholera toxin B
subunit

potato

Arakawa et al., 1997

Edible plant
vaccine

Hepatitis B surface
antigen

tobacco,
potato

Mason et al., 1992;
Thanavala et al.,
1995

Edible plant
vaccine

Norwalk virus
capsid protein viral
antigens

tobacco,
potato

Mason et al., 1996
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Table 3. Differences in Cow and Human Milk Composition
Characteristic

Cow Milk

uman Milk

eference

Protein content

3.5g/dl

0.9g/dl

Miller

1990

Predominant casein

a-casem

P-casein

Miller eta/., 1990

Ratio of casein/whey

80/20

40/60

Miller eta/., 1990

Ratio of cysteine/methionine

lower

higher

Packard, 1982

Taurine (a nonprotein
nitrogen source) content

trace
amount

ubstantial
mount

Packard, 1982

Phenylalanine and tyrosine

higher

lower

Packard, 1982

Ratio of calcium/
phosphorous

lower

higher

Jenness, 1979
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Table 4. Feasibility of Human Milk Protein production in Transgenic
Potatoes (Under the Control of the Patatin Promoter)

Milk Proteins Protein (g) in a Equivalent Acres of potatoes Number of
lactations (one
required per
cup (250 ml) of number of
lactation (one year duration)
human milk3 potatoes15
year duration)0 provided by one
acre of potatoes
p-casein

0.225

1.6

0.013

77

K-casein

0.090

0.6

0.005

200

Lactoferrin

0.360

2.6

0.020

50

cc-lactalbumin

0.540

3.8

0.030

33

Lysozyme

0.100

0.7

0.006

167

“Amount of milk proteins in a cup (250 ml) of human milk (Miller et al, 1990).
bAverage-sized potato tuber weighs 300 g and contains 7 g of total soluble protein (Pennington,
1993). Assuming patatin promoter expression levels for all milk proteins are 2% of total soluble
tuber protein.

C15,000 kg potatoes/acre (U.S. Department of Commerce, 1995)

IV. DISCUSSION AND FUTURE PERSPECTIVES
A. Food plants as vaccine production and delivery vehicles
Food plants are an attractive source of vaccine antigens for the following reasons;
1) Cost-effectiveness: the biosynthesis of recombinant proteins requires only sunlight
energy, water, and a small amount of soil minerals, eliminating the need for expensive
cell culture media. Regeneration of potato plants is relatively inexpensive in the
laboratory and greenhouse settings. 2) Biologically active protein production: plants
process foreign proteins in ways which retain native biological activity e.g., retention of
native antigenicity and biological activity of proteins, and appropriate post-translational
modifications such as glycosylation and phosphorylation. The vaccine antigens used in
our study, CTB and its antigen conjugate protein, retained both specific CiMi-ganglioside
binding affinity and native antigenicity. 3) Convenience: oral delivery of recombinant
proteins through consumption of edible plant tissues is economically inexpensive and
trained medical personnel are not required. Further, immunization is painless in
comparison with other methods such as vaccine injection. In our animal feeding
experiments, transformed potato tubers were simply placed in the mouse cage for oral
vaccination. Feeding potato tubers to mice was painless even in comparison with oral
gavage. 4) Effectiveness: plant-based oral vaccines could be effective. In our efficacy
studies, oral vaccine using potato tubers delivering CTB antigens were found to be
effective in inducing intestinal as well as systemic immunity in mice, which provides
significant protection against intra-intestinal cholera toxin challenge. Potato tuber-
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delivered cholera toxin-autoantigen conjugate proteins were also found to be effective in
the suppression of autoimmune diabetes in mice. 5) Availability: food plants
endogenous to areas of the world where vaccines are needed may provide a convenient
source of vaccines. In our animal experiments, we demonstrated that when anti-CTB
titers declined approximately 40 days post-vaccination, a simple booster feeding of the
plant material containing the vaccine antigen increased the titers. Thus, the availability
and the efficacy of the vaccines are intimately related, and these two important aspects of
vaccines were provided with our food plant vaccine delivery systems.

B. Oral delivery of recombinant proteins by transgenic plants for preventive
therapy
Oral immunization was found to be more effective than parenteral immunization
against pathogens which come in contact with mucosal surfaces. We demonstrated in our
animal experiments that plant-synthesized recombinant proteins having vaccine (CTB
and CTB-autoantigens) or nutritional (human milk proteins) value were directly delivered
to the body through the ingestion of edible plant tissues. Proteins are generally degraded
and lose significant biological activity in the gastrointestinal tract. However, degradation
is often partial and intact antigens or antigen epitopes are delivered to the intestine and
absorbed directly by the intestinal cells. For example, at least some potato-delivered
CTB antigen and CTB fusion protein were delivered to the intestinal immune system
without a loss of the pentameric structure and GMi-ganglioside binding affinity. This
result was evidenced by the presence of a strong immune response against CTB antigen
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and its conjugated polypeptide, which could not have been achieved without the intact
pentameric CTB structure retaining the GMi-ganglioside binding affinity. Vaccine
antigens accumulated in the intracellular compartment of plant cells are provided with a
natural protective shield against antigen degradation, which may explain why plantdelivered CTB antigens were as immunogenic as bacterial CTB dissolved in stomach
acid-neutralizing bicarbonate buffer. In addition, recombinant proteins encapsulated
within plant tissues may be slowly released into the animal’s digestive tract, facilitating
recombinant protein absorption through the small intestine resulting in increased
immunological recognition.

C. Mechanism of disease prevention and improvements in preventive therapy
1.

Cholera toxin-induced diarrhea

Oral immunization of CD-I mice with pentameric CTB synthesized in potato
plants induced generation of both mucosal and systemic anti-cholera toxin antibodies at
levels sufficient to generate protective immunity against the biological effects of cholera
toxin. These findings suggested that anti-CTB antibodies prevent cholera toxin binding
to cellular GMi-ganglioside. This hypothesis was indirectly confirmed by Gmi-ELISA
experiments in which cholera toxin was mixed with immune or non-immune serum prior
to addition to the GMi-ganglioside coated microtiter plates. Only immune serum
suppressed binding of cholera toxin to the receptor. This result was probably not due to
competition between anti-CTB antibodies in the immune serum and primary antibodies
used for ELISA detection, since we did not observe significant differences in RLU signal
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levels when cholera toxin was mixed with either immune or nonimmune serum prior to
addition to microtiter plate wells not coated with Givirganglioside. Thus, protection
against cholera toxin in Vero cells and in the mouse intestine may be due predominantly
to anti-CTB antibody-mediated specific prevention of cholera toxin binding to cellular
GMi-ganglioside. This result is consistent with in vivo experiments in which anti-cholera
toxin antibodies prevented the cholera toxin from binding to the cell surface (Apter et al.,
1993).
2.

IDDM

In general, oral immunotolerization therapy for autoimmune diseases requires
repeated administration of milligram levels of autoantigen proteins. However, when
insulin or GAD protein was conjugated with CTB, the concentration of fusion protein
was increased in the GALT, requiring only microgram levels of antigen to induce oral
tolerance.
Increased anti-insulin antibody titer in mice fed CTB-INS as compared with mice
fed INS or untransformed potato tissues suggests that the fusion protein was effectively
delivered to the intestinal immune system. Induction of both systemic and intestinal
anti-CTB antibodies in mice fed CTB-INS potato tubers indicates that the conjugate
protein was delivered to the GALT. The humoral response mounted against both CTB
and insulin proteins may be a collateral effect occurring in response to stimulation of
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Th2 cells by oral tolerance. Since there is a decreasing gradient of sensitivity to
induction of oral tolerance with Thl cells being the most susceptible to tolerization
followed sequentially by Th2 cells and B cells, it is possible that induction of systemic
T cell tolerance occurs simultaneously with systemic and mucosal B cell priming (Husby
et al., 1994; Fujihashi et dl., 1996).
In addition, in Peyer’s patches, the target site of CTB-autoantigen conjugates, Th2
responses are generated primarily, as IL-4 secreting T cells are predominantly activated
in contrast to nonmucosal lymphoid organs such as axillary and inguinal lymph nodes
where IL-2 secretion is predominant. The cells of the Peyer’s patches preferentially
mediate Th2-type immune responses which are important for the generation of oral
tolerance and prevention of microbial infections. Humoral responses with secretory IgA
production is a critical factor for disease prevention. Therefore, oral administration of
antigens may induce systemic hyporesponsiveness in the presence of mucosal IgA
responses.
Reduction in insulitis and subsequent suppression of diabetic symptoms provides
a direct histological and clinical evidence of oral tolerance induction. The mechanism of
oral tolerance observed in our animal experiments was not clearly defined. However,
experimental evidence indicated that Th2 cells generated in the GALT secrete suppressor
lymphokines such as interleukin (IL)-4, IL-10, and transforming growth factor (TGF)-(3
when they encounter autoreactive T cells (Weiner et al., 1994; Hancock et al., 1995).
Therefore, bystander suppression mediated through the action of Th2-type anti-
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inflammatory cytokines may be responsible for the oral tolerance observed in our
experiments.
The recombinant CTB subunit induces mucosal antibody production through the
action of TGF-P, a major mediator of oral tolerance (Kim et al., 1998). Therefore, it is
possible that the plant-synthesized CTB-INS fusion protein delivered to the GALT
stimulates lymphoid cells capable of secreting TGF-|3. Secreted TGF-P may mediate
induction of systemic tolerance and concurrent induction of both mucosal and systemic
humoral responses against CTB and insulin.
We observed that anti-CTB antibody was generated in mice fed CTB-autoantigen
synthesizing potato tissues, and this anti-CTB antibody was demonstrated to interfere
with the binding of cholera toxin to the cellular receptor GMi-ganglioside. Therefore,
effectiveness of oral administration of the CTB-autoantigen may decrease with time due
to the presence of anti-CTB antibodies in the intestinal lumen. This possibility is
confirmed by the observation made by Bergerot et al. (1997) that there was no significant
difference between single and multiple feedings of CTB-autoantigen conjugate for the
induction of oral tolerance.
3.

Improvements in efficacy of disease prevention

Since retention of native biological activity and immunogenicity of recombinant
proteins produced in plants is critical for induction of immune responses and consequent
disease prevention, each plant-synthesized protein must be evaluated in vivo as well as
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in vitro, before claims can be asserted that transgenic plant-derived proteins can be used
for improvement of human health. Once the therapeutic benefits of the plant-delivered
proteins have been determined in cell culture and in animals, plant production systems
can be optimized to obtain the highest protein yield and biological activity. The
immunological, physiological and pharmacological activity of recombinant proteins may
be improved by the following methods:
a.

Assessment of biological activity of recombinant proteins

Evaluation of recombinant proteins for their biochemical, immunological, or
physiological activities is critical for production of optimal biological effects. In our
preclinical vaccine trial against autoimmune diabetes in NOD mice, it was essential to
determine whether plant-produced CTB-autoantigen conjugate proteins form pentamers
and retain specificity for GMi-ganglioside as well as native antigenicity for induction of
effective oral tolerization. For antimicrobial protein production in plants, physiological
assessment of the recombinant proteins in cell cultures and animals must be performed.
For the production of milk protein (3-casein in food plants, correct post-translational
modifications of the proteins e.g., phosphorylation, may be required.
b.

Increase recombinant protein amounts by increasing the

transcriptional, translational and post-translational levels
In future experiments, it will be desirable to increase recombinant protein
production in plants at transcriptional or translational levels sufficient to generate
effective food plant-based oral vaccines for humans and larger animals. Genetic
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manipulation of foreign genes will include the addition of transcriptional and
translational enhancers, tissue-specific regulatory elements, leader peptides and/or
endoplasmic reticulum (ER) retention signals (SEKDEL or KDEL). Other factors which
need to be considered include potential polyadenylation signals, mRNA destabilization
sequences, and cryptic introns, which contribute to low levels of mRNA production.
Genetic codons optimal for translation in plant cells may enhance translation efficiency.
Production of synthetic genes using codons optimized for the plant translational
machinery may be desirable if the size of the gene of interest is small. Thus, we
generated a “plant-optimized” synthetic gene encoding the 22-amino acid neutralizing
epitope of rotavirus enterotoxin NSP4 by designed oligonucleotide synthesis.
Introduction of the Kozac sequence flanking the ATG start codon may facilitate
translation initiation of prokaryotic genes in eukaryotic cells (Kozak, 1981). We have
modified the CTB gene start codon according to the Kozak sequence for enhanced
translation in potato cells. Since there are no distinct differences between the prokaryotic
and the eukaryotic leader peptide, the N-terminus leader peptide of recombinant protein
with prokaryotic origin may also function in eukaryotic cells to translocate nascent
polypeptides into the lumen of the plant ER (von Heijne, 1985). We therefore retained
the original CTB leader peptide for translocation of CTB or CTB-conjugate proteins into
the plant ER. In addition, the ER retention signal at the C-terminus of the protein may
help to sequester the protein within the plant tissues (Munro and Pelham, 1987; Wandelt
et al., 1992; Haq et al., 1995). The ER retention signal sequence provides a signal for the
protein to return to the ER from the cis Golgi. The lumen of the plant ER may function

239
similar to the periplasmic space of gram-negative V. cholerae organism (Hirst and
Holmgren, 1987), by providing an intracellular environment permitting recombinant
protein accumulation and assembly into multimeric proteins. In addition, vacuole
targeting signals may enhance sequestration of recombinant proteins in the large plant
cell central vacuole.
c.

Use of cholera toxin as mucosal carrier molecule for enhanced

immunological recognition of fused antigens
While CTB is not a strong adjuvant for co-administered antigens, it functions as
an immunostimulatory molecule for induction of immune response to chemically or
genetically conjugated polypeptides (McKenzie and Halsey, 1984; Czerkinsky et al.,
1989; Dertzbaugh and Elson, 1993a; Holmgren et al., 1994). The carrier property of the
CTB pentamer molecule is due to its affinity for a natural receptor GMi-ganglioside on
the cell surface of the GALT (Svennerholm, 1976). Although, CTB has been extensively
investigated as a mucosal vaccine antigen carrier for enteropathogens, our report on CTB
production in food plants is the first demonstration indicating that plant-derived
pentameric CTB can be used effectively as a mucosal vaccine carrier for the suppression
of infectious as well as autoimmune diseases (Arakawa et al., 1998; Arakawa et al.,
unpublished data).
The cholera toxin B subunit reduces the required amount of antigen molecule
needed for induction of oral tolerization by 100-1000 fold (Sun et al., 1994, 1996;
Bergerot et al., 1997; Arakawa et al., unpublished results). We have demonstrated that
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feeding transgenic potatoes containing 20 pg of insulin conjugated with CTB
significantly reduced pancreatic inflammation as well as development of diabetic
symptoms in NOD mice. The amount of insulin used in our experiments is
approximately 100 fold less than previously reported for insulin alone for the suppression
of diabetes in NOD mice (Zhang et ai, 1991). It was clearly shown that the CTB subunit
functions as an effective mucosal carrier for conjugated proteins for enhanced
immunological recognition. The pentameric structure of the CTB fusion protein complex
not only facilitates site-specific delivery and presentation of conjugated polypeptides to
the GALT, it may also increase the molar concentration of the antigen per molecule of
CTB pentamer. This increase in antigen concentration at the GALT can reduce the
traditional requirement for high levels of antigen biosynthesis in food plants. Therefore,
it is our observation that it is more practical to produce the CTB-antigen conjugate rather
than the antigen alone in plants for food plant-based immunotolerization therapy.

E.

Advantages of using CTB as a plant-delivered carrier molecule
1.

Enhanced immunological detection of CTB conjugates in plant tissues

Conjugation of foreign epitopes with CTB has increased the immunological
detection efficiency in plants. The anti-cholera toxin antibody developed in rabbits used
in our study, specifically recognized both A and B subunits of cholera toxin with a
minimal level of cross reaction with plant proteins. When small foreign antigen epitopes
with weak antigenicity (e.g., self antigens like insulin) are produced in plants, efficient
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immunoblot detection of the CTB moiety of the conjugate by means of anti-cholera toxin
antibody can demonstrate the increased molecular weight of both monomeric and
pentameric CTB fusion proteins in comparison with CTB alone, indirectly indicating the
presence of the fused polypeptide moiety. Further, the Gmi-ELISA method confirms the
presence of the pentameric CTB conjugate which is the only molecule capable of binding
GMi-ganglioside. This ELISA method permits quantification of the amount of only the
biologically active form of the CTB conjugate in plant tissues. Further, immunological
detection of the conjugated polypeptide can be more easily achieved, because pentameric
CTB conjugates can be sequestered on GMi-ganglioside coated microtiter plates by
repeated addition of aliquots of the plant homogenate.
2.

Enhanced immunological recognition by the GALT

Pentameric structure of the CTB fusion proteins facilitates site-specific delivery
and presentation of conjugated polypeptides to the GALT due to the affinity of CTB for
the GMi-ganglioside receptor molecules on cell surface of the enterocyte and the M cells.
Conjugation with CTB also increases the molar concentration of conjugated polypeptides
per molecule of CTB pentamer. Enhanced immunological as well as increased physical
concentrations of CTB conjugate polypeptides at the GALT may facilitate immunological
recognition of conjugated polypeptides for subsequent immune responses. Significantly
higher antigen concentrations in the GALT can compensate for low antigen production
levels in plants. Therefore, establishment of the CTB-mediated oral delivery method may
contribute to significantly improved efficacy of food plant-based immunotherapy in
humans and animals.
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F.

Multiple antigen delivery to the GALT for improved vaccine efficacy
To enhance efficacy of recombinant proteins for protection against infectious as

well as autoimmune diseases, it is desirable to deliver multiple vaccine antigens to
sensitize animals against a broad range of neutralizing epitopes, or to deliver multiple
antimicrobial proteins for the production of synergistic protective effects. The following
conditions must be considered:
1.

Consumption of a mixture of plant tissues

To deliver multiple antigens, a mixture of individual transgenic plant tissues
containing a recombinant protein can be orally administered. For example, feeding a
mixture of two transformed potato plants each producing CTB-INS or CTB-GAD was
found to significantly reduce pancreatic inflammation in comparison with feeding a
single kind of CTB-antigen conjugate. A possible disadvantage of this strategy may be
that since an animal can consume limited amounts of plant tissues, thus, the amount of
each recombinant protein delivered to an animal will be limited.
2.

Sexual crossing between transgenic plants containing different

antigens
One method to achieve multiple antigen gene expression within the same plant
tissue is by generating transgenic plants synthesizing individual antigens and
subsequently making sexual crosses between them to generate a single plant producing
multiple recombinant proteins. Successive sexual crosses between four different
transgenic tobacco plants expressing four individual component of secretory
immunoglobulin (a light chain, a heavy chain, a joining chain, and in addition, a secretory
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component) resulted in an individual plant that expressed all four chains simultaneously.
All the recombinant proteins were assembled into a functional, high molecular weight
secretory IgA molecule that specifically recognized its target, the native streptococcal
antigen I/II cell surface adhesion molecule (Ma et al., 1995, 1998; Arakawa and
Langridge, 1998). This result indicates the possibility that sexual crosses between
multiple plants is a feasible method to generate a plant simultaneously producing multiple
recombinant proteins. A possible disadvantage of this method could be that sexual
crosses are not always easily achieved for certain plant species.
3.

Auxin induction of the mannopine synthase dual promoters

Multiple gene expression systems may provide a distinct advantage when multiple
proteins must be produced in one plant. For example, multiple gene expression systems
are required when two recombinant protein antigens are desired for the construction of a
vaccine against multiple neutralizing epitopes of a single or multiple pathogens. More
than one recombinant protein can be synthesized simultaneously in one plant using the
bi-directional mas PI, P2 promoters (Langridge et al., 1989). The mas promoters can be
induced with auxin to produce foreign proteins at levels greater than obtained by known
strong constitutive promoters such as the cauliflower mosaic virus (CaMV) 35S promoter
(Mason et al., 1992; Haq et al., 1995; Mason et al., 1996). Without auxin induction,
expression levels are so low that no phytotoxicity can be detected, a problem frequently
encountered with the use of constitutive promoters like the CaMV 35S promoter
(Dr. C. Amtzen, personal communication). The results of our experiments indicate that
the mas dual promoter system can serve as an excellent model system for simultaneous
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expression of two desired gene products in food plant tissues. Further, use of plant
hormone-upregulated promoters such as the mas dual promoters may provide a certain
advantage in stimulating gene expression in climacteric food plants like tomato and
banana. Auxin levels are usually elevated during the fruit ripening stage of climacteric
plants, which switches on gene expression from the auxin-inducible mas PI, P2
promoters, achieving highest protein accumulation within the fruit tissues only during the
ripening stage.
4.

Promoter combinations

A number of different plant promoters can be inserted within a single plant
expression vector. For example, the CaMV 35S promoter, the mas PI, P2 promoters, and
potato tuber-specific constitutive patatin promoter or stem-specific gene 5 promoter can
be located within the same plant expression vector for expression of multiple genes of
interest.
5.

Cholera toxin subunit CTA2/CTB double fusion vector

Several CTB fusion proteins have been constructed to carry polypeptides fused
either at the N- or C-terminus of the CTB protein. The N-terminus of the CTB molecule
may be more critical than the C-terminus for the pentamerization process of CTB
monomers as N-terminal addition of amino acids with increasing length gradually
decreased affinity of the chimeric protein for GMl-ganglioside (Dertzbaugh and Elson,
1993b). However, short oligopeptides were fused at the C-terminus without disrupting
the pentamerization of CTB chimeric monomers. Thus, in our experiments, protein
antigens were fused at the C-terminus of the CTB protein and transgenic plants were
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found to produce relatively high levels of pentameric CTB-antigen conjugates. For
example, a transgenic plant produced up to 0.1% of total plant soluble protein as the
pentameric CTB-INS chimera without disrupting the affinity for GMi-ganglioside.
Addition of a flexible hinge region (Gly-Pro-Gly-Pro) between the CTB and insulin may
reduce steric hindrance between the two proteins, facilitating pentamerization of the
CTB-INS chimera. Although CTB is an effective carrier molecule for targeting and
presenting conjugated polypeptides to the GALT, the molecule may be limited in the size
of the polypeptide it can carry. Potato plants transformed with the CTB-GAD fusion
gene, in which the size of the GAD65 cDNA is 1.8 kb, synthesized 100 fold less CTBGAD protein (i.e., 0.001% of total soluble protein) in comparison with CTB-INS. This
significant reduction in production of pentameric CTB-GAD may be due to the large size
of the GAD polypeptide.
In contrast to the CTB subunit, the toxic CTAj moiety (22 kDa) of the dimeric
CTA subunit (29 kDa) can be replaced by a polypeptide with a molecular weight
substantially larger than 22 kDa (Hajishengallis et aL, 1995). The chimeric CTA2conjugated polypeptide assembles into heterohexamers with the CTB pentamer molecule
(Hajishengallis et ai, 1995). Since the CTAi moiety of the CTA protein is exposed at the
surface of the CTB pentamer structure, the protein molecule which replaces the CTAi
moiety will presumably be exposed as well. The exposed protein antigen may also be
effectively presented to the GALT by oral administration of transgenic food plant tissues
producing the chimera. The oligonucleotide encoding the leader peptide of the CTA
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(18 amino acids) was retained to target the fusion CTA2 protein to the endoplasmic
reticulum. Since the original CTA2 molecule has a eukaryotic ER sequestration signal
(KDEL) fused at the C-terminus, the CTA2 chimera may be expected to accumulate in
the ER of plant cells. Since an ER sequestration signal sequence has been added to the
C-terminus of the CTB chimeric proteins, the CTB chimera and the CTA2 chimera may
co-localize in the plant ER microenvironment to facilitate formation of heterohexameric
CTA2/CTB molecules carrying a short oligopeptide attached to the CTB moiety and a
larger protein fused to the CTA2 subunit. This double fusion CTA2/CTB chimeric protein
may then be used for multivalent vaccine delivery by food plants.

G.

Future experiments: application of cholera toxin-antigen fusion proteins

(proposals)
The cholera toxin-antigen fusion protein could be used for multivalent vaccine
production against enteric as well as autoimmune diseases, as inclusion of more than one
pathogen-derived protein or disease-specific autoantigen is often recommended for
increased vaccine efficacy. Two sets of experiments for the prevention of IDDM and the
vaccination against rotavirus infection, using cholera toxin based-vector system for
delivery of multiple antigens, are proposed.
1.

Prevention of IDDM

Oral administration of autoantigens can prevent or delay the onset of autoimmune
diseases. Although, oral tolerance as a therapeutic approach for protection against
autoimmune diseases is considered to be a safe and effective method, repeated
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administration of large doses of autoantigens are required and it is considerably less
effective in systematically sensitized hosts than in naive hosts. We have previously
demonstrated that feeding transgenic potato tissues producing two major EDDM
autoantigens, insulin and glutamic acid decarboxylase (GAD), to juvenile NOD mice
were not effective in the prevention of insulitis, a major cause of the autoimmune
diabetes in both mice and humans. However, oral administration of microgram amounts
of insulin and GAD conjugated with CTB effectively suppressed the onset of
autoimmune diabetes in mice. Further, simultaneous oral administration of two
transgenic potato plant tissues producing CTB-INS and CTB-GAD resulted in an
increased tolerogenic response in comparison with feeding transgenic potato tissue
containing only one autoantigen. Thus, simultaneous presentation of multiple CTBautoantigen conjugates significantly increases the efficacy of disease prevention.
However, fusion of large proteins like GAD65 (64 kDa) with CTB resulted in relatively
inefficient pentamerization of the fusion protein, an essential molecular configuration for
CTB to bind to its cell receptor Givn-ganglioside on intestinal cells. The levels of
pentameric CTB-GAD production in plant tissues was considerably lower than that of
CTB-INS, while the levels of chimeric monomers in boiled plant tissues were similar for
both constructs.
Potato tissues will be engineered to produce both CTB-INS and CTB-GAD
simultaneously in a single plant to provide a mosaic mixture of fusion pentamers to
reduce the problem of steric hindrance. In addition, a fusion between a nontoxic cholera
toxin A2 subunit (CTA2) and GAD (CTA-GAD) will be generated. The CTA2 subunit is
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nontoxic like CTB and unlike CTB it can tolerate the addition of large polypeptide.
Further, simultaneous production of CTB-INS and CTA2-GAD in the same cellular
compartment can presumably result in heterohexameric cholera toxin double fusion
proteins carrying the two IDDM autoantigens. Potato tissues synthesizing CTB-INS,
CTB-GAD, and CTA2-GAD will be fed to prediabetic NOD mice and the extent of
insulitis will be detected histopathologically. The ability of the fusion protein containing
plant tissues to provide protection against diabetes development in NOD mice will be
determined by monitoring urine and blood glucose levels over a 6 month time interval
following oral immunization. The results of these experiments will provide information
whether plant delivered multiple cholera toxin-autoantigen fusion proteins can supply
superior immunological protection against the development of diabetic symptoms in
comparison to an comparable amount of CTB-INS or CTB-GAD alone and whether
transgenic plants can generate levels of immunotolerance sufficient to prevent IDDM in a
susceptible mammalian model system.
The goal of these proposed experiments is to test the hypothesis that
immunotolerization against autoantigens of IDDM depends predominantly upon efficient
delivery and immunological presentation of autoantigens (tolerogens) to the gutassociated lymphoid tissues (GALT). To increase the efficacy of plant-based autoantigen
delivery and presentation to the GALT, we can improve three factors of food plant-based
oral tolerance: (1) We can increase the amount of autoantigen production in transformed
potato tuber tissues by using constitutively expressed enhanced cauliflower mosaic virus
35S promoter (e35S) and the tuber-specific patatin promoter. (2) We can increase the
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kinds of tolerogens produced in plants for simultaneous delivery of multiple autoantigens
to the GALT for synergistic effect on oral tolerization. (3) Finally we can increase the
efficacy of immunological recognition of autoantigens by the GALT through specific
targeting of the mucosal immune system by fusing autoantigen proteins with a mucosal
carrier molecule such as cholera toxin B and/or A2 subunits. To achieve maximal
tolerization with the least amount of potato tissues, a combination of the three approaches
is desirable and is discussed in some detail below.
The feeding of transgenic potato tissues producing human insulin or GAD alone
did not provide a statistically significant reduction in pancreatic inflammation (insulitis).
However, feeding plant tissues containing comparable amounts of insulin or GAD fused
with the nontoxic CTB subunit (CTB-INS or CTB-GAD) provided significant protection
against insulitis and clinical diabetes in NOD mice. In addition, simultaneous oral
delivery of CTB-INS and CTB-GAD plant tissues provided superior protection against
insulitis in the NOD mice.
Reinforced by these successful animal experiments, improvements in food plantbased oral tolerization systems may be achieved (1) by increasing the amount of
autoantigen protein produced in the plant tissues through expression of autoantigen genes
under control of the tuber-specific patatin promoter and the constitutively expressed
enhanced cauliflower mosaic virus 35S (e35S) promoter, and (2) by constructing a plant
expression vector which enables simultaneous expression of the two CTB-autoantigen
conjugates (CTB-INS and CTB-GAD), under control the dual mas PI, P2 promoters or
under a combination of the patatin and the e35S promoter, and finally (3) by
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simultaneous production of CTB-INS and a fusion between CTA2 with GAD
(CTA2-GAD) to generate a heterohexameric cholera toxin double fusion molecule
carrying two different tolerogen polypeptides.
Thus, we propose transformation of potato plants with plant expression vectors
containing CTB-INS or CTB-GAD genes linked to the tuber-specific patatin promoter, or
to the e35S promoter to generate higher levels of the autoantigen production in the tuber
tissues (Fig. 1). One disadvantage in this construction is that since CTB can only tolerate
relatively small polypeptide addition without the loss of pentamerization capability,
fusion of a large GAD polypeptide (in contrast to smaller insulin) could reduce the
production level of the Gmi binding form of pentameric CTB-GAD.
In a second set of experiments, CTB-INS and CTB-GAD will be simultaneously
produced in a single transgenic potato plant by using the mas dual promoters or by the
combination of patatin and the e35S promoters (Fig. 2). The major advantage of these
constructs over those in Fig. 1 is that the amount of potato tissues fed to mice can be
significantly reduced without reducing the amounts of either CTB fusion protein. In
contrast to independent production of CTB-INS and CTB-GAD by different transgenic
potato plants (Fig. 1), we expect a mosaic mixture of CTB-INS and CTB-GAD subunits
in a single pentameric molecule since they are produced within the same cells. The
presence of both CTB-INS and CTB-GAD subunits in an individual pentamer may
reduce steric hindrance caused by the large GAD protein. Therefore, the amount of GAD
protein delivery to the GALT may be increased due to increased CTB-GAD
incorporation efficiency in pentamers (without reducing the amounts of CTB-INS
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delivery). A potential disadvantage is the chance for homologous recombination between
the two copies of identical CTB genes present in the same vector.
In a third set of experimental constructs, we will replace CTB with CTA2 for
GAD linkage to avoid the possibility of recombination between the two copies of the
CTB gene (Fig. 2), while maintaining higher GAD protein incorporation efficiency into
the carrier molecule. The nontoxic subunit of CTA2 can tolerate addition of large
polypeptides like GAD and still retain its ability to interact with pentameric CTB
molecules to form the heterohexameric complex. Therefore, the CTA2-GAD fusion
protein can presumably interact with the CTB-INS pentamer to generate heterohexameric
double fusion molecule carrying both insulin and GAD protein. We will use both the
mas dual promoters and the combination of patatin and the e35S promoters for
expression of CTB-INS and CTA2-GAD (Fig. 3).
Regenerated transformed plants will be assayed for the presence of the fusion
genes and amounts of the two gene products in the leaves and tubers quantified by
immunoblot and chemiluminescent Gmi-ELISA methods. Transgenic plant tuber tissues
will be fed to prediabetic NOD mice and the efficacy of oral tolerization determined by
(1) histological analyses of insulitis and by (2) reduction in the incidence of diabetes
development analyzed through analysis of urine and blood glucose levels.
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Figure 1. Plant expression vector pPCV702 containing IDDM autoantigen genes
(1) pPCV702 Pe35S (or Ppa“m) : CTB-hinge-INS-SEKDEL
(2) pPCV702 Pe35S (or PP“,,n) : CTB-hinge-GAD-SEKDEL

Figure 2. Plant expression vectors pPCV701 and pPCV703 containing CTB-IDDM
autoantigen fusion genes
(1) pPCV701 CTB-hinge-IN S-SEKDEL : P mas : CTB-hinge-GAD-SEKDEL
(2) pPCV703 Pe35S : CTB-hinge-INS-SEKDEL ..........ppatatm . CTB-hinge-GAD-SEKDEL

Figure 3. Plant expression vectors pPCV701 and pPCV703 containing CTB/CTA2IDDM autoantigen fusion genes
(1) pPCVTOl CTB-hinge-INS-SEKDEL : Pmas : CTA2-GAD-KDEL
(2) pPCV703 Pe3SS : CTB-hinge-INS-SEKDEL ........ Ppatatm : CTA2-GAD-kdel

• pe35S: e35S promoter
• Ppatatin: patatin promoter
• Pmas: mas promoters
• Vectors in parenthesis are original vectors from which those constructs will be derived.
• Vector pPCV703 will be constructed from pPCV702 by addition of patatin promoter into the vector.
• KDEL and SKDEL sequences are for sequestration of the fusion protein in the endoplasmic reticulum
(ER) for enhanced pentamer assembly.
• The flexible hinge oligopeptide (Gly-Pro-Gly-Pro) inserted between CTB and autoantigen protein is to
reduce the steric hindrance to facilitate pentamerization.
• Both CTB and CTA2 contain their original leader peptide (18 to 22 amino acids).
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a.

Future experimental plan:

We previously generated transgenic potato plants synthesizing up to 0.1% of
human insulin or human GAD65 by using the auxin-inducible mas promoters in vector
pPCVTOlluxF. Since feeding these transgenic potato plants to prediabetic NOD mice did
not successfully induce oral tolerance, we transformed potato plants with CTB-INS and
CTB-GAD fusion genes to increase the efficacy of autoantigen presentation to the
GALT. We were able to produce a transgenic potato plant synthesizing 0.1%
of CTB-INS fusion protein and a transgenic potato plant synthesizing 0.001% of the
CTB-GAD fusion protein. Feeding mice with transgenic potatoes containing 20 pg CTBINS or 2 pg CTB-GAD a total of five times resulted in the induction of anti-CTB
antibodies indicating that the conjugated proteins were effectively delivered to the
mucosal immune system for immunological recognition. Further, feeding NOD mice
with transgenic potato tissues containing the CTB-autoantigen fusions significantly
reduced the inflammatory response in pancreatic islets (insulitis), while feeding
transgenic potato tissues containing approximately 30 pg of insulin or 3 pg of GAD alone
did not show a statistically significant reduction in insulitis. Feeding transgenic potatoes
containing the CTB-INS and CTB-GAD fusion proteins to NOD mice showed not only a
significant reduction in insulitis scores but a delay in the onset of diabetic symptoms as
well.
To further improve our plant autoantigen expression systems for increased
tolerization capability, the following constructs will be generated:
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(1) To achieve strongly constitutive expression of CTB-autoantigen fusion protein
without the need of auxin induction, we will subclone CTB-INS and CTB-GAD fusion
genes behind the e35S promoter in a plant expression vector pPCV702, and adjacent to
the tuber induced patatin promoter (constructs #1 & #2 in Fig. 1).
(2) For simultaneous expression of two CTB-autoantigen fusion proteins in a
single potato plant, we will subclone CTB-INS and CTB-GAD fusion genes at PI and P2
sites of the dual mas promoters (construct #1 in Fig. 2). Upon completion of an
additional plant expression vector which will contain both the e35S promoter and the
patatin promoter (designated pPCV703), CTB-INS and CTB-GAD fusion genes will
subsequently be subcloned under those constitutively expressed promoters (construct #2
in Fig. 2). The advantage of using a combination of the e35S and the patatin promoter
over the dual mas promoters is that auxin induction of maximum gene expression is not
required.
(3) To simultaneously express both autoantigens without risking the possibility of
recombination between the two identical CTB genes in the same vector (see constructs in
Fig. 2), we will construct a plant expression vector carrying CTB-INS and CTA2-GAD
fusion genes at PI and P2 sites of mas promoters in pPCV701 vector (construct #1 in
Fig. 3). We will also subclone CTB-INS and CTA2-GAD fusion genes into patatin and
e35S promoters in the pPCV703 vector for constitutive expression of two fusion proteins
(construct #2 in Fig. 3).
To generate transgenic potato plants, we will initiate DNA transformation
experiments with potato leaf explants using the Agrobacterium tumefaciens, in vivo
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transformation method established in our laboratory, to introduce the plant expression
vectors carrying the autoantigen fusion genes into potato leaf explants. We will
regenerate kanamycin resistant cells to shoots and roots on plant growth media containing
the appropriate amounts of plant growth hormones auxin and cytokinin and antibiotic
selection to eliminate untransformed cells. The transformed regenerated plantlets will be
transferred to sterile soil and the plants grown in the light room and greenhouse to
maturity for tuber production.
All methods used for the cloning DNA restriction fragments into E. coli
expression vectors, transformation of E. coli strains with plasmid DNA, electrophoretic
separation of DNA fragments, Southern DNA hybridization methods, RNA isolation
methods, electrophoretic separation methods and PCR reactions will be performed
essentially as previously described (Arakawa et al., 1997). Any variations in these
detailed procedures are due to adaptations which we have found to be most suitable for
particularly difficult situations. Animal immunization methods are previously described
(Arakawa et al., 1998). The non-radioactive chemiluminescent immunoblotting
techniques used for the detection of CTB-autoantigen fusion proteins in transformed
plant tissues will be carried out using anti-cholera toxin antibody as well as anti-human
insulin and anti-human GAD65 antibodies. Transformation of potato leaf explants will
be performed as previously described (Arakawa et al., 1997).
The amount of fusion protein products and the fusion gene copy number in
transgenic potato tissues will be determined using Southern hybridization methods in
which a fragment of the fusion gene is used as a digoxigenin labeled probe. Immunoblot
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analyses of transgenic plant leaf and tuber tissues will be performed to determine the
location within the plant of the highest levels of the fusion gene expression, as well as
identification of individual transformants expressing the highest levels of the desired
gene products. The Gmi-ELISA method will be used to accurately determine the
amounts of fusion proteins in potato tissues because this method detects only
immunologically active pentameric fusion molecules.
To test the efficacy of oral tolerization, four-week-old female prediabetic NOD
mice (Charles River Co., MA) will be fed transgenic potato tissues expressing
autoantigen construct mentioned above (Figs. 1-3). Approximately 3 g of transformed
tuber tissues will be fed to a mouse once a week for 5 weeks to attain 2-20 pg of
autoantigen proteins. For the constructs in Fig. 1, a mixture of two transgenic potato
tissues, each producing CTB-INS or CTB-GAD will be fed to mice. Two animal
experiments will be conducted based on assay methods: (A) assessment of reduction in
insulitis as determined by histopathological analysis of pancreatic islets (a 5-week
duration experiment) and (B) assessment of suppression of diabetic symptoms
determined by glycosuria and hyperglycemia (a 7 month duration experiment).
Experiment A: The NOD mice will be fed for 5 weeks. After 5 weeks of feeding
period, animals will be sacrificed by cervical dislocation, and the pancreas removed for
fixation followed by hematoxylin and eosin staining for histopathological examination
with the assistance of Dr. Paul Engen and Mr. John Hough of the Loma Linda University
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Department of Anatomy. The degree of insulitis will be scored using a semiquantitative
scale ranging from 0 to 4, where 0 is a normal islet with no sign of T-cell infiltration;
1 shows focal peri-islet T-cell infiltration; 2, more extensive peri-islet T-cell infiltration
but with lymphocytes occupying less than one-third of the islet area; 3, intraislet T-cell
infiltration in one-third to one-half of the islet area; 4, extensive intraislet inflammation
involving more than half of the islet area (Zhang et al., 1991).
Experiment B: Mice will be monitored for development of diabetes symptoms
weekly, starting at 10-weeks old, by urinary glucose testing with test strips (Bayer) over a
period of 6 months after the initiation of transgenic plant feeding. Glycosuric mice will
be checked for hyperglycemia using a glucose analyzer. Diabetes will be confirmed by
detection of hyperglycemia (>13.8 mM glucose) for two consecutive weeks.
The efficacy of oral tolerization will be judged from the results of the two assay
methods (A and B) compared for each transgenic plant construct, to determine the most
practically feasible construct(s) for food plant-based oral tolerization for prevention of
IDDM in animals. This set of experiments will provide a firm basis for a palatable,
simple and low-cost prevention method for autoimmune diabetes and will establish a
foundation for the development of preventive methods for other autoimmune diseases in
animal and in people at risk.
2.

Prevention of Rotavirus-induced diarrhea

Human rotavirus belongs to the family Reoviridae, genus rotavirus. The
icosahedral virus particles contain 11 segments of double-stranded RNA, each encoding a
viral protein. The two most important virus-neutralizing glycoproteins are the outer
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capsid protein VP7 and VP4 (hemagglutinin) which define the rotavirus serotypes. Four
serologically common types of VP7 glycoprotein (G1 through G4) as well as two
common VP4 serotypes (P4 and P8) are found in children with rotavirus-induced diarrhea
(Glass et al., 1994). Protection against rotavirus gastroenteritis is generally serotype
specific and generally related to levels of antibodies against homotypic virus (Chiba et
al., 1993). Thus, an effective rotavirus vaccine should protect against all of these
common viral serotypes. However, recent experiments with the rotavirus nonstructural
protein NSP4 (formerly called NS28) or its 22-amino acid peptide (amino acid residues
114-135) located in the hydrophilic cytoplasmic domain of NSP4 from group A and B
rotavirus have provided a new insight into generation of an effective rotavirus vaccine.
Discovery of NSP4 and its 22-amino acid protein viral enterotoxin may provide novel,
effective rotavirus recombinant vaccines because NSP4 may provide serotypeindependent protection against heterologous rotavirus strains. The NSP4 protein
increases cytosolic calcium levels in infected insect Spodoptera frugiperda (Sf 9) cells
and is found as a transmembrane glycoprotein in the endoplasmic reticulum (ER) of
infected cells (Tian et al., 1994, 1995). The rotavirus enterotoxin NSP4 was also found
to mobilize intracellular calcium in human intestinal cells by stimulating phospholipase
C-mediated inositol 1,4,5-trisphosphate production (Dong et al., 1997). The NSP4
protein acts as a receptor for newly made subviral particles in the cytoplasm for transient
acquisition of the membrane when the particles bud into the ER (Tian et al., 1996a,b).
During the process of virus maturation in the ER, the viral particles acquire VP4 and
VP7, lose the transient membrane, and nonenveloped virus particles and the NSP4
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protein are released from lysed cells. The Ca2+ ion is important for rotavirus infection
and replication because oligomerization and the specific conformation of proteins such as
VP7, VP4, and NSP4 require Ca2+ during viral maturation in the ER. The molecular
mechanism of rotavirus enterotoxin is not yet known, however, its effect on the small
intestine of animals is similar to bacterial enterotoxins such as heat-labile enterotoxin of
E. coli and cholera toxin. This viral enterotoxin increases intracellular calcium levels
which may trigger chloride ion efflux, inducing diarrhea in animals and humans.
A unique feature of the NSP4 enterotoxin is its age-dependent cytotoxicity: specifically
inducing diarrhea in 6-10 day old CD-I mice (Ball et al., 1996).
Induction of antibodies against NSP4 or its 22-amino acid protein conferred
protection to pups bom from immunized dams, and decreased the incidence and severity
of diarrhea (Ball et al., 1996). Induction of antibody against NSP4 alone may confer
cross protection from clinical disease without the need for induction of antibodies against
viral structural proteins (Ball et al., 1996; Conner et al., 1996). Due to their in vitro
neutralizing capabilities, VP4 and VP7 have been the general targets of vaccine
preparation. However, these glycoproteins generally provide serotype-specific protection
and are thus unable to prevent reinfection with different strains of rotavims. Reduction in
the severity of diarrhea during reinfection with different strains of vims may be explained
by the existence of other neutralizing proteins which confer cross protection against
heterologous strains. The NSP4 protein could be a candidate for this antigen. Other
structural proteins such as inner core proteins VP2 and VP6 may also partially explain the
cross protection. Indeed, VP6 which lacks in vitro neutralizing capability showed
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protection against primary and resolving chronic murine rotavirus infection (Bums et al.,
1996). It was suggested that this protective mechanism was mediated by transcytosis of
IgA molecules from the apical to the luminal side of the small intestine, during which
intracellular viral assembly and replication are inhibited within the cell (Bums et al..
1996). Rotavims exhibits strict tissue tropism in that it only infects the small intestine
where the mucosal immune response presumably provides the most effective prevention
of infection. Therefore, conjugation of rotavims neutralizing antigens such as VP6 and
NSP4 proteins with cholera toxin may effectively immunize animals. Cholera toxin and
its B subunits are particularly suited for vaccine delivery as the toxin molecule would
enhance viral antigen recognition by GALT by its strong GMi-ganglioside affinity
resulting in induction of mucosal secretory IgA antibodies in the small intestine. Since
oral delivery in CD-I mice of cholera toxin B subunits synthesized in potato induced
substantial levels of neutralizing anti-cholera toxin slgA antibodies in the gut (Arakawa
et al., 1998), it is also reasonable to expect that viral antigen epitopes conjugated with
CTB will induce vims-neutralizing slgA antibodies. Here we propose to express
individual rotavims antigen (22-amino acid NSP4 epitope and VP6, constmct #1 & 2 in
Fig. 4), and the simultaneous expression of both antigens (constmct #3 in Fig. 4). We
will also constmct a pPCV703 based plant expression vector carrying CTB-NSP4 and
CTA2-VP6 fusion genes (constmct #4 in Fig. 4). Following regeneration of potato plants
expressing single or double rotavims antigens, animal (mouse) feeding experiments will
be conducted to evaluate the efficacy of the potato plant-based recombinant rotavims
vaccmes.
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Figure 4. Plant expression vectors pPCVTOl and pPCV703 containing CTB/CTA2rotavirus antigen fusion genes
(1) pPCV701 PmaS : Leader-CTB-hinge-NSP4 (114-135)-SEKDEL
(2) pPCV701 Leader-VP6-CTA2-KDEL : PmaS : Leader-CTB-SEKDEL
(3) pPCVTOl Leader-VP6-CTA2-KDEL : PmaS : Leader-CTB-hinge-NSP4 (114-135)-SEKDEL
(4) pPCV703 P'35S : Leader-CTB-hinge-NSP4 (114-135)-SEKDEL
.................... Ppa,a,in : Leader-VP6-CTA2-KDEL
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a.

Future experimental plan:

Diarrhea induced by NSP4 enterotoxin is age dependent (Ball et al., 1996).
Neonatal mice are susceptible to NSP4 induced diarrhea, while adult mice are resistant to
the viral enterotoxin. Further, adult mice can replicate and excrete virus but diarrhea is
usually not observed. Thus, the protective efficacy of NSP4-based rotavirus vaccines can
best be evaluated in the neonatal mouse.
To evaluate the immunogenicity and protective efficacy of VP6 immunization,
adult CD-I mice will be fed transgenic potato tuber tissues producing CTA2-VP6 + CTB
(Fig. 4 and Table 1). Mice will be fed transgenic potato tuber tissues a total of five times
on days 0, 7, 17, 24, and 28 of the feeding experiment. Transgenic potato tissues will be
fed to 10 mice. Mice will be monitored for anti-VP6 antibodies in serum and in fecal
pellets. For vaccine efficacy testing, virus shedding will be monitored in adult mice after
oral and intraperitoneal inoculation of simian rotavirus SA11 (Table 2).
To evaluate the protective efficacy of NSP4 immunization, adult female CD-I
mice will be fed transgenic potato tissues producing CTB-NSP4 (114-135) fusion protein
(construct #1 in Fig. 4). To evaluate whether a synergistic effect is observed during
simultaneous NSP4 and VP6 immunization, adult mice will be fed a mixture of
transgenic potato tissues producing CTB-NSP4 (114-135) (construct #1 in Fig. 4) and
CTA2-VP6 + CTB (construct #2 in Fig. 4), or CTA2-VP6 + CTB-NSP4 (114-135)
(constructs #3 and #4 in Fig. 4). Mice will be fed a total of five times on days 0, 7, 17,
24, and 28 of the experiment. On each feeding day, the mice will be given 3 to 5 g of
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transgenic potato tuber tissues containing approximately 20 to 50 pg of recombinant
rotavirus protein containing fusion protein as previously determined by ELISA and
immunoblot detection experiments. Transgenic potato tissues will be fed to 10 mice.
Untransformed potato tissues will be fed to 10 mice as a negative control. One group of
10 mice will be given equimolar amounts of purified viral NSP4 or VP6 proteins
(provided by Dr. M. Estes, Baylor College of Medicine) by gavage as a positive control.
Approximately 10 days after the beginning of the oral immunization schedule,
each female mouse will be transferred into a new cage for breeding. Once breeding is
confirmed by the presence of a vaginal plug, the female mice will be returned to the
original cages for continuation of the oral immunization schedule. On approximately day
30, the pregnant mice will be expected to give birth to 6 or more pups. The neonatal
mice will be allowed to suckle until day 37 (for one week). The pregnant female adult
mice will be anesthetized by intraperioneal injection with ketamine (100 mg/kg body wt.)
and xylazine (80 mg/kg body wt.) in 0.5 ml physiological saline with a 27 gauge needle.
The level of consciousness will be checked by eye reflex response. After complete
anesthesia, the animals will be exsanguinated by brachial artery bleeding. The blood will
be collected from each animal in a 1.5 ml volume centrifuge tube and incubated at room
temperature for 4 h to permit clot formation, followed by overnight incubation of the tube
at 4 °C to retract the blood clot. The serum will be transferred from the tube to a clean
tube and immediately analyzed for anti-NSP4 antibody by ELISA or stored at -20 °C.
The small intestines of the sacrificed animals will be removed and the lumen of the
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intestine washed with PBS to collect mucosal antibodies (slgA and IgG). In addition,
fecal pellets will be collected throughout the experimental period for detection of
coproantibodies (slgA and IgG). Fecal antibodies will be collected according to the
coproantibody preparation procedure described by de Vos and Dick (1991). Fecal
materials will be collected by placing mice in cages without shavings. One gram of fecal
sample will be placed in 10 ml PBS, pH 8.5, containing 10 mM phenylmethylsulfonyl
fluoride (PMSF) (1:10 w/v) for 15 min at room temperature. The samples will be
vortexed, incubated for 30 min at room temperature and vortexed again. Insoluble
materials will be removed by centrifugation of the samples at 5000 rpm for 10 min at
4 °C in a Sorvall RT 6000B centrifuge. The supernatant will be immediately analyzed by
ELISA for CTB-specific IgA and IgG antibodies or stored at -80 °C.
To evaluate the protective efficacy of artificial passive immunization in the
neonatal mice, antiserum prepared from immunized female adult CD-I mice will be
delivered intraperitoneally (i.p.) to 7-day-old mice 5 min prior to i.p. delivery of
1 nmol NSP4 protein or 100 nmol NSP4 (114-135) peptide, or simian rotavirus SA11
into neonatal mice (Table 3A). To evaluate the efficacy of natural passive immunization,
pups bom to dams immunized with the plant-produced NSP4 (114-135) and/or VP6
(Fig. 4 and Table 1) will be challenged with either NSP4 (114-135) peptide (100 nmol
i.p. inoculation) or NSP4 protein (1 nmol i.p. inoculation), or a dose of infectious SA11
by oral inoculation (Table 3B). The severity and duration of diarrheal symptoms and
virus shed in the neonatal mice will be measured to evaluate the protective efficacy of
food plant based oral immunization. To determine the presence of diarrhea, we will
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examine each mouse pup every 1 to 2 h for the first 8 h and at 24 h after inoculation by
gently pressing the abdomen. Diarrhea severity is noted and scored from 1 to 4, with a
score of 1 reflecting unusually loose yellow stool and a score of 4 indicating completely
liquid stool. A score of 2 (mucous with liquid stool, some loose but solid stool) and
above will be considered indicative of diarrhea. A score of 1 will be noted but will not be
considered as diarrhea. The scoring will be done by one person and the pups will be
coded during analysis of diarrhea.
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Table 1.
Oral Immunization (pregnant CD-I mice)*
Treatment
NSP4 or VP6 Protein

Amount
50 pg

Untransformed
Potato tissues

3 to 5 g

# of Mice
10
10

10
Transformed
3 to 5 g
Potato tissues (constructs #1 through #4)

* Immune serum will be used for anti-NSP4 and anti-VP6 antibody assays
and neonatal mice challenging experiment in Table 3 A.

Table 2.
Oral Challenge Experiment with SA11 (adult CD-I mice)*
Treatment
# of Mice
SA11 (i.p. inoculation)
10
SA11 (p.o. inoculation)
10
*This experiment is only for construct #2 in Fig. 4.
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Table 3.
Oral Challenge Experiment (neonatal CD-I mice)
A. Artificial Passive Immunization*
Treatment (i.p. inoculation)
NSP4 (114-135) (100 nmol) + antiserum**

# of Mice
10

NSP4 enterotoxin (1 nmol) + antiserum**

10

SA11 + antiserum**

10

SA11 + NSP4 (114-165) (100 nmol)+ antiserum**

10

SA11 + NSP4 enterotoxin (1 nmol) + antiserum**

10

B. Natural Passive Immunization
Treatment (i.p. inoculation)
NSP4 (114-135) (100 nmol)

# of Mice
All the pups bom from
immunized mothers

NSP4 enterotoxin (1 nmol)

Same as above

SA11

Same as above

*Neonatal mice purchased for oral challenge experiment.
**Antiserum derived from orally immunized mice in Table 1.
♦♦♦Neonatal mice bom from immunized mother mice in Table 1.
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H.

Concluding remarks
The production of recombinant vaccine proteins in edible plants with

demonstrable medical and nutritional values will contribute to improved public health,
especially in economically emerging countries. Palatable food plant cultivars and
varieties native to these countries must be evaluated for their abilities to serve as vaccine
production systems. Due to their palatability and common availability they would be
particularly useful as oral delivery source for children. The combination of modem plant
genetic engineering and medical technology may benefit our well-being, and remind us
once again of our dependence on the useful nature of the plant world surrounding us.
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